innovate - GuideStar

87
advance heal transform discover innovate Memorial Sloan-Kettering Cancer Center 2010 ANNUAL REPORT pioneer

Transcript of innovate - GuideStar

Page 1: innovate - GuideStar

advance

heal

transform

discover

innovate

Memorial Sloan-Kettering Cancer Center2010 ANNUAL REPORT

pioneer

Page 2: innovate - GuideStar

MSKCC …

Introduces 2 our new President

Message from the Chairman and the President 3

Transforms 8

Discovers 14

Innovates 20

Advances 24

Pioneers 26

Educates 30

Heals 34 Statistical Profile 50

Financial Summary 52

The Campaign for MSKCC 56

The Society of MSKCC 57

Ways of Giving 60

Page 3: innovate - GuideStar

www.mskcc.org/annualreport2010

Change presents challenges but also opportunities — and the prospect of renewal and a reinvention of the future.

The year 2010 was a time of significant change at Memorial Sloan-Kettering Cancer Center.

Change is exciting, energizing, revitalizing.

MSKCC 1

Page 4: innovate - GuideStar

2 MSKCC

In August 2010, nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center. He succeeded Harold Varmus, now Director of the National Cancer Institute.

“Craig Thompson is an exemplary physician-scientist, educator, and academic leader,” says Douglas A. Warner III, Chairman of the MSKCC Boards of Overseers and Managers. “He brings to his new role significant contributions to the understanding of the biology of cancer, a strong and committed appreciation for the needs of patients with cancer, and superb

executive skills. We are fortunate to have him as we seek to maintain and enhance the accomplishments of Memorial Sloan-Kettering and move ambitiously into the future.”

Beginning in 2006, Dr. Thompson served as Director of the Abramson Cancer Center at the University of Pennsylvania and Associate Vice President for Cancer Services of the University of Pennsylvania Health System. As Director of the Abramson Cancer Center, Dr. Thompson — a board-certified internist and medical oncologist with extensive research experience in cancer, immunology, and translational medicine — oversaw the work of several hundred cancer

researchers as well as more than 300 full-time physicians and faculty across the University of Pennsylvania Health System involved in cancer prevention, diagnosis, and treatment. During his tenure, his accomplishments included the opening of a new multidisciplinary cancer outpatient treatment facility, the development of the first proton therapy center in the Mid-Atlantic region, and the expansion of Abramson’s translational research effort.

“We are at a time when transformative developments in biomedical research are greatly expanding the opportunities to understand disease and to improve human health,” Dr. Thompson says. “The mandate for MSKCC is to take the gains of the past

“ The mandate for MSKCC is to take the gains of the past 25 years to provide more-effective and safer treatments for patients; to define strategies to help people reduce their risks of developing cancers they might be genetically predisposed to develop; and, ultimately, to prevent the disease from occurring at all.”

– Craig Thompson, MD President of MSKCC

MSKCC

introduces

Page 5: innovate - GuideStar

MSKCC 72010 ANNUAL REPORT

25 years to provide more-effective and safer treatments for patients; to define strategies to help people reduce their risks of developing cancers they might be genetically predisposed to develop; and, ultimately, to prevent the disease from occurring at all.”

“I want us to realize the full clinical potential of all the extraordinary research that goes on here,” Dr. Thompson elaborates. “We need to continue to strengthen the bridges between our basic scientists and clinicians — to bring these communities closer together — so that observations made

at the bedside inform the kind of research we do, and research discoveries made in the laboratory are adapted into therapies that can be delivered to patients.”

Dr. Thompson’s own research focuses on the role that metabolic changes play in the origin and progression of cancer. He has also done pioneering work on the genes that control programmed cell death and on how the misregulation of such genes can contribute to cancer. In earlier work, he contributed to the development of innovative treatments for autoimmune

diseases and leukemia. Dr. Thompson has established a laboratory in MSKCC’s Zuckerman Research Center.

“I could not be more enthusiastic about this new role and new challenge,” he concludes. “I look forward to building on MSKCC’s achievements and tradition of excellence and to working with my colleagues in making progress in controlling and ultimately curing cancer.”

Page 6: innovate - GuideStar

MSKCC a2010 ANNUAL REPORT

Before Sandy and I begin our joint letter — and my first as President of Memorial Sloan-Kettering Cancer Center — I’d like to share a few personal observations.

I arrived on the MSKCC campus in November 2010 and every day since then has been inspiring. During the early months of my tenure, I traveled around the Center visiting as many locations and staff members as I could. I came away from these visits with one overwhelming impression: The dedication of the men and women of Memorial Sloan-Kettering is unparalleled. Whether they escort patients in the hospital or deliver the most advanced care, work in a laboratory or in the cafeteria — all are committed to serving a purpose higher than themselves.

What brought me to Memorial Sloan-Kettering is what I believe attracts the finest new staff, students, and generous donors — shared ideals: a promise to deliver the highest-quality patient care, to make major contributions to cancer research and discovery, and to educate the next generation. Pioneering efforts undertaken at MSKCC to advance science and apply our findings to the development of new treatments and therapies that reduce death and suffering has an impact that reaches far beyond the walls of this institution.

I look forward to many exciting years ahead, working together to bring the benefits of our world-class research to patients and setting national and international standards in advancing the knowledge that will ultimately conquer cancer.

– Craig Thompson

Message from the Chairman and the President

Craig B. Thompson

President and Chief Executive Officer

Douglas A. Warner III

ChairmanBoards of Overseers and Managers

During the past year, we have made great progress at Memorial Sloan-Kettering. Prospects for the future are bright — due in large measure to the members of our MSKCC community, who come to work every day united in their desire to make a difference in the fight against cancer.

A 2010 visit by the Joint Commission offers evidence of the excellence of our people. (The Joint Commission is the nation’s oldest and largest hospital accrediting organization.) At their exit interview with hospital leadership, the surveyors praised staff members in all areas of the hospital for their professionalism, expertise, and compassion. The on-site visit team emphasized that our results were outstanding for an institution of our size and complexity.

Our vibrant research community thrived in 2010. In this year’s Report we’ve highlighted just a few of the many achievements of MSKCC’s investigators and clinicians. Breakthrough contributions were made by our basic science researchers in areas ranging from immunology, to cancer genome sequencing, to elucidating the mechanisms that control tumor cell growth and survival. Our physician-scientists pioneered clinical research that has moved laboratory findings into clinical applications in patients, some of which you’ll read about in the pages that follow.

We continue to enhance the physical spaces housing our clinical and research enterprises. In 2010 construction resumed on Phase II of the Zuckerman Research Center, including the build-out of two below-ground vivarium floors, the main level auditorium and conference space, two floors of academic office space, and one floor that will house the Gerstner Sloan-Kettering Graduate School, the Computational Biology Program, and the cell therapy and cell engineering facility. We anticipate completion in early 2012.

Making Memorial Sloan-Kettering’s expert cancer care more accessible to patients is a fundamental touchpoint of our mission. Our clinicians and state-of-the-art technology need to be available where our patients live and work. And so we recently filed an application with the New York State Department of Health that will allow us to expand our regional care network even further. If approved, a new freestanding 114,000-square-foot outpatient facility in Harrison, New York, will join our family of ambulatory oncology centers in New Jersey, on Long Island, and in Westchester County, staffed by MSKCC physicians, nurses, and other healthcare professionals.

Page 7: innovate - GuideStar

B MSKCC

Attracting the best and brightest talent is vital to the health of any organization and we had notable success in recruiting clinical and research staff to the Center in 2010. Among those who joined us was Joseph Deasy as Chair of the Department of Medical Physics and incumbent of the Enid A. Haupt Chair in Medical Physics. Dr. Deasey comes to MSKCC from the Washington University School of Medicine, in St. Louis, where since 2005 he had been Director of the Division of Bioinformatics and Outcomes Research in the Department of Radiation Oncology.

MSKCC’s distinguished physicians and scientists are consistently recognized with national and international awards. In 2010, two of our investigators received particularly outstanding honors. Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences (NAS). Zvi Fuks, the incumbent of the Alfred P. Sloan Chair in Radiation Oncology and a member of the Sloan-Kettering Institute’s Molecular Pharmacology and Chemistry Program, was elected a member of the Institute of Medicine (IOM), a branch of the National Academies. Memberships in the NAS and IOM are among the highest honors in the fields of science and medicine.

The Campaign for Memorial Sloan-Kettering maintained steady progress in 2010, with gifts and pledges reaching $2,224,825,637 since its inception in 2001. The Center received an all-time high of 1,022,400 contributions during the year, for a total of $208.7 million received. Led by Anne M. McSweeney and Richard K. Naum, the MSKCC development office has generated the strong forward momentum required for the ongoing success of the Center. We are delighted to report that the Boards of Overseers and Managers have recently authorized a five-year extension of the Campaign and have increased the total goal to $3.5 billion.

During 2010, MSKCC continued to operate efficiently and effectively as cost-saving opportunities allowed the institution to limit its cost growth to 3.2 percent for the year. Our clinical volume and revenues continued to grow. We are particularly pleased to report that our investment portfolio experienced an excellent year. The Center’s financial position is strong and we continue to enjoy an AA bond rating from each of the three major bond rating agencies.

The theme of this year’s Report is change. You will read about how the MSKCC community embraced change in 2010, transforming the way we deliver care and battle cancer in the clinic and the laboratory. And the stories of four MSKCC patients that conclude the Report dramatize how, in the final analysis, everything we do here is about them.

The men, women, and children who come to Memorial Sloan-Kettering entrust their lives to us. All our work is aimed at returning them to their families, to their work — to the lives that were once disrupted by cancer — healed.

John R. Gunn

Executive Vice President

Robert E. Wittes

Physician-in-Chief Memorial Hospital

Thomas J. Kelly

Director Sloan-Kettering Institute

James D. Robinson III

Honorary Chairman Boards of Overseers and Managers

Douglas A. Warner III

ChairmanBoards of Overseers and Managers

Craig B. Thompson

President and Chief Executive Officer

Page 8: innovate - GuideStar

the way we do surgery

MSKCC

transforms

Page 9: innovate - GuideStar

(Left) Stephen Solomon (far left), Director of CIGI and Chief of the Interventional Radiology Service, with interventional radiologist Majid Maybody. (Top) Breast surgeon Alexandra Heerdt (left) and surgical fellow Kshama Jaiswal (Above) A CT scanner.

the way we do surgery

In June 2010, Memorial Sloan-Kettering opened the Center for Image-Guided Interventions (CIGI). Located on the second floor of the hospital, CIGI also houses a suite of endoscopy rooms and new operating rooms for the Surgical Day Hospital (SDH).

Page 10: innovate - GuideStar

10 MSKCC

The multidisciplinary facility is anchored by CIGI and features state-of-the-art imaging tools for guiding cancer diagnosis and treat-ment. Interventional radiologists, surgeons, and endoscopists working in CIGI collaborate to deliver minimally invasive cancer therapies that reduce risks, shorten hospital stays, and decrease patient costs.

“This magnificent facility is a result of shared vision and collaboration,” says Hedvig Hricak, Chair of the Department of Radiology, who, along with Peter T. Scardino, Chair of the Department of Surgery, was instrumental in conceptualizing and planning CIGI and the SDH. “The proximity of radiology, surgery, and endoscopy provides a superb environment for our patients and will also produce innovations that will advance the medicine of the 21st century.”

Interventional radiologists, also called interventional radiology (IR) physicians, specialize in minimally invasive treatments using image guidance. Their tools include fluoroscopy, computed tomography (CT), ultrasound, positron emission tomography (PET), and magnetic resonance imaging (MRI). CIGI has six procedure rooms that contain leading-edge imaging equipment.

“CIGI is an unbelievable platform for imaging and treating cancer,” says Stephen B. Solomon, Director of CIGI, Chief of the Interventional Radiology Service, and Co-Chair of the Image-Guided Intervention Program along with Yuman Fong, Vice Chair of Technology Development in the Department of Surgery. (CIGI falls under the umbrella of MSKCC’s Image-Guided Intervention Program, established in 2008 to oversee and coordinate activities in the medical disciplines that use image guidance.)

MSKCC

transforms the way we do surgery

Page 11: innovate - GuideStar

MSKCC 112010 ANNUAL REPORT

Transforming the Patient Experience

The CIGI/SDH offers amenities that enhance the patient experience, the most significant of which is privacy. A patient preparation area consisting of 48 individual bays serves the facility. After checking in, each patient is escorted to his or her private bay in the pre-procedure area. The bays include a bed, sliding glass doors, a television, and a guest chair. In addition, they contain equipment to monitor vital signs and administer intravenous fluids, as well as a computer so medical staff can complete documentation without leaving the patient’s bedside. After a procedure is completed, the patient is brought to a similar bay in the post-procedure area for recovery before being discharged.

The CIGI/SDH also has a pharmacy and five consultation rooms where patients, family members, or friends can meet privately with physicians. CIGI and the SDH serve approximately 120 patients per day.

Transforming Operating Rooms

Seven new Surgical Day Hospital operating rooms replace MSKCC’s former SDH operating rooms. Procedures done in the SDH—such as breast lumpectomies, mastectomies, and reconstructions; prostate biopsies; or removal of certain head and neck lesions—are of shorter duration than those performed in MSKCC’s main surgical center.

However, the new SDH operating rooms have many of the same features found in the surgical center. These include ceiling-mounted “booms” that provide operating room essentials such as anesthesia, oxygen, and suction; “Walls of Knowledge” that display patient clinical and laboratory data; and video-conferencing capabilities with physicians in other rooms.

Page 12: innovate - GuideStar

12 MSKCC

“ The proximity of radiology, surgery, and endoscopy provides a superb environment for our patients and will also produce innovations that will advance the medicine of the 21st century.” – Hedvig Hricak

Chair, Department of Radiology

MSKCC

transforms the way we do surgery

Page 13: innovate - GuideStar

MSKCC 132010 ANNUAL REPORT

to think and work together for the benefit of patients.” Among CIGI’s features are procedure rooms that contain a communica-tion system that allows physicians in separate rooms to consult via video-conferencing and share real-time images.

Dr. Scardino elaborates, explaining that the new platform makes it possible to consolidate several procedures performed by different specialists into a single patient visit. “A patient with an unspecified mass in the chest could typically require a CT scan by an interventional radiologist to biopsy it, an ultrasound by an endoscopist to stage it and determine its size, and a surgical procedure called a mediastinoscopy to take out a lymph node,” he explains. “In the past, getting all three procedures would require three separate trips to the hospital over several weeks. Now we can do them consecutively on the same day and move promptly to therapy.”

“For example, we have an interventional PET/CT scanner in the center that allows us to take advantage of new markers and tracers to pinpoint cancers in ways that were impos-sible before,” explains Dr. Solomon. “Two new MRI rooms enable us to continue refining a new approach in which we use MRI not as a diagnostic tool but to guide and monitor therapies in real time.”

CIGI, a multidisciplinary facility in which IR physicians can work with surgeons and other medical interventionalists, offers opportunities for combining interventions in new ways. “If you think about how surgeons, interventional radiologists, gastroenterologists, and pulmonologists work — everyone with an instrument that physically manipulates an anatomic structure or tumor — we all have our area that we specialize in,” Dr. Fong says. “Now we have a facility that allows all these different people, from different disciplines,

Endoscopy Suites

(Top left) Robert C. Kurtz, Chief of the Gastroenterology and Nutrition Service, performs a procedure in one of the new gastrointestinal endoscopy suites. The suites are equipped with the most modern endoscopic technology available and help MSKCC physicians address the demand for complex interventional endoscopic procedures. (Below center) MRIs are used in diagnosis as well as to help guide and monitor therapy in real time. (Below left) An image-guided intervention room. These rooms contain a combined CT-angiography unit used by IR physicians to guide them in the performance of minimally invasive diagnostic and therapeutic procedures.

Page 14: innovate - GuideStar

Glioblastoma cells (cell nuclei in blue) Circulating breast tumor cells (green and yellow) exiting from capillaries (red) into brain tissue

Page 15: innovate - GuideStar

the biological underpinnings of cancer

discoversMSKCC

Developing T cells (in green)

Page 16: innovate - GuideStar

16 MSKCC

MSKCC

discovers the biological underpinnings of cancer

MetastasisCells that have broken away from a primary tumor and entered the bloodstream — called circulating tumor cells (CTCs) — can travel to distant organs and seed new tumors. But an MSKCC study led by Joan Massagué, Chair of the Sloan-Kettering Institute’s Cancer Biology and Genetics Program, along with Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, and research fellow Mi-Young Kim, now shows that such spread of disease (metastasis) operates in the opposite direction as well: Some CTCs can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.

The newly described phenomenon, called self-seeding, might explain why, in some patients, tumors removed by surgery or radia-tion reappear in the same place later in life.

The researchers created experimental models of different human cancers — includ-ing breast, colon, and skin cancers — that allowed them to track the journey of CTCs. Their studies showed that primary tumors emit molecular signals that attract some CTCs back to their source. The investigators identi-fied two genes, IL-6 and IL-8, that produce the signals attracting the most aggressive segment of the CTC population, plus three other genes that the returning CTCs use to invade the tumor when they return. The researchers hope that opportunities to target these genes therapeutically will present new strategies to stop cancer from progressing.

(Above) Joan Massagué and (right) Larry Norton

(Above, right) Circulating tumor cells (also on overleaf); image created by Manuel Valiente and Aléjandro Lopez-Soto in the laboratory of Joan Massagué

Page 17: innovate - GuideStar

MSKCC 172010 ANNUAL REPORT

(Above, right) Alexander Rudensky

T CellsResearchers led by immunologist Alexander Y. Rudensky have gained new understanding about regulatory T cells — a subtype of immune cell that suppresses the immune system’s reactivity. Regulatory T cells are critical for life. In their absence, the immune system — instead of attacking foreign intrud-ers — attacks normal cells and tissues, causing potentially fatal inflammatory responses.

In recent years, Dr. Rudensky and others have studied regulatory T cells, positing that they might one day be manipulated — for example, to prevent dangerous immune reac-tions in people with autoimmune disorders such as multiple sclerosis or in cancer patients who have received bone marrow transplants from donors.

But it has remained to be established that regulatory T cells could be exploited safely. “Concerns have been raised that regulatory T cells under certain conditions — for example,

in a disease setting — might be induced to transform into other T cell types of the immune system,” explained Dr. Rudensky, “in effect changing the cells’ function.” If such change of function occurred in a patient whose immune system was already overactive, the cells might boost that immune system even further, instead of calming it down.

By experiments in mice, the researchers were able to examine the lifespan of regulatory T cells. The study showed that the cells are constantly replenished as they divide to yield identical copies and so remain stable, their function unchanged — both under normal conditions and when a mouse’s immune system had been challenged by infection or autoimmune reaction. The findings give reassurance that future therapies based on regulatory T cells could provide a durable and safe way to control a patient’s immune system.

“ Concerns have been raised that regulatory T cells under certain conditions — for example, in a disease setting — might be induced to transform into other T cell types of the immune system, in effect changing the cells’ function.”

– Alexander Rudensky Immunologist

Page 18: innovate - GuideStar

18 MSKCC

(Above) Ingo Mellinghoff (Left) Timothy Chan

Cancer GeneticsA team of MSKCC investigators has shown for the first time that the gene that causes the inherited form of Parkinson’s disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer. The study was led by radiation oncologist Timothy A. Chan, a member of the Human Oncology and Pathogenesis Program and the Brain Tumor Center. The gene, called PARK2, acts as a tumor suppressor, preventing the formation of cancerous cells. When mutated and unable to function tumor suppressors can allow tumors to develop.

In inherited Parkinson’s disease, mutation of PARK2 leads to inappropriate activation of the cell-division cycle in neurons. But because neurons are cells that are unable to divide, they die, leading to Parkinson’s disease. When PARK2 is mutated in cell types that can divide, levels of a protein called cyclin E rise and cause the cells to multiply out of control, sometimes leading to cancer.

Future research will focus on develop-ing mouse models to study the mutation in cancer progression and on trying to deter-mine additional genetic mutations that cause PARK2-deficient tumors to develop into can-cer. Investigators are also looking at whether people with the inherited forms of Parkinson’s disease have a higher cancer risk.

Brain CancerA multicenter team led by neurologist and researcher Ingo K. Mellinghoff has uncov-ered the relationship between two proteins that play a critical role in the brain cancer glioblastoma. The discovery may lead to better treatments for glioblastoma patients whose tumors have certain molecular changes.

The protein epidermal growth factor receptor (EGFR) is frequently overexpressed or mutated in glioblastoma, yet studies have shown that less than 10 percent of glioblas-toma patients respond to drugs, such as erlotinib (Tarceva®) and gefitinib (IressaTM), that target EGFR.

In an earlier study, Dr. Mellinghoff found that a protein called PTEN, which belongs to a class of proteins known as tumor

Page 19: innovate - GuideStar

MSKCC 192010 ANNUAL REPORT

(Above, from left) Peter Scardino, Kenneth Offit, Howard Scher

suppressors, is frequently inactivated in tumors from glioblastoma patients who did not respond to these drugs.

Dr. Mellinghoff ’s team has now deter-mined how PTEN and EGFR interact, demonstrating that PTEN plays a key role in the reduction of EGFR inside cells. When the function of PTEN is lost, EGFR becomes more abundant and stable, making it more difficult to block with targeted drugs. “Erlotinib is currently in clinical trials for glioblastoma,” Dr. Mellinghoff says. “Based on our findings, we have designed a clinical trial in which higher doses of erlotinib will be used to try to overcome the resistance resulting from PTEN mutations.” Future research will focus on pinpointing how PTEN regulates EGFR, and could lead to the development of new drugs.

Prostate CancerA team of MSKCC researchers — led by Kenneth Offit, Chief of the Clinical Genetics Service; Peter T. Scardino, Chair of the Department of Surgery; Howard I. Scher, Chief of the Genitourinary Oncology Service; and genetics fellow David Gallagher — reports that prostate cancer often takes an aggressive course in men who have inherited mutations in the genes BRCA1 or BRCA2, which are associated with (inherited) breast and ovarian cancer.

The investigators collected anonymous DNA samples and clinical data from close to 900 prostate cancer patients of Ashkenazi Jewish ancestry, a substantial resource that allowed them to explore the heritable compo-nents of the disease. The researchers showed

that patients who carry BRCA mutations have an increased risk of dying or having their disease recur after treatment. “We also found that tumors were of more advanced grade in BRCA2 mutation carriers,” Dr. Offit says. “These men are genetically susceptible to a form of prostate cancer that is particularly aggressive.” He and his colleagues are hope-ful that the patient group will benefit from a new class of drugs called PARP inhibitors, which are being developed for treatment of BRCA-related breast and ovarian cancer. They estimate that such therapy, if proven success-ful, could be used in treating about 2,800 men with prostate cancer and BRCA mutations in the United States yearly.

MSKCC

discovers the biological underpinnings of cancer

Page 20: innovate - GuideStar

20 MSKCC

MSKCCinnovates treatment delivery and patient care

Page 21: innovate - GuideStar

MSKCC 212010 ANNUAL REPORT

Today many patients receive chemotherapy over extended periods of time and often have to struggle to fit this time-consuming routine into their lives — in addition to dealing with the physical and emotional aspects of their disease and its treatment. MSKCC’s new Brooklyn Infusion Center is an innovative facility designed to meet the special needs of patients receiving chemotherapy and the caregivers who accompany them.

The site offers leading-edge chemotherapy services to current MSKCC patients who live in or near the borough — which amounts to more than 15 percent of those currently being treated in Manhattan. Many of these patients can now be spared the rigors of a commute and

receive their treatment in a setting conveniently located in downtown Brooklyn.

The facility has the capacity to accom-modate 30 patients and their visitors a day, with 12 private treatment rooms enclosing an indoor garden and adjoining library where patients may spend time both during and between treatments. Each room is equipped with a touch-screen computer, so patients may also get work or shopping done on the Internet, or make videophone calls with friends and family.

In addition to relieving space constraints at MSKCC’s Manhattan sites, the Brooklyn Infusion Center will serve as a prototype for exploring innovative cancer care models. For

example, on the day before a patient’s appoint-ment, a nurse ensures that he or she is fit for treatment by reviewing blood tests and calling the patient. The phone call initiates the process of preparing chemotherapy for the next day’s visit. This “chemo-ready” approach reduces waiting times for patients and allows for more cost-effective drug preparation. Nurses at the Brooklyn center are also trained in providing complementary therapies such as acupressure and Reiki massage.

In addition, Memorial Sloan-Kettering is piloting telemedicine visits between patients in Brooklyn and their physicians at MSKCC’s Manhattan locations.

MSKCC’s new Brooklyn Infusion Center is an innovative facility designed to meet the special needs of patients receiving chemotherapy and the caregivers who accompany them.

The Brooklyn Infusion Center is located on a tree-lined stretch of Atlantic Avenue near a major transportation hub, including subways, a Long Island Rail Road station, and several parking facilities.

Brooklyn Infusion Center Improves Patients’ Chemotherapy Experience

Page 22: innovate - GuideStar

22 MSKCC

With the opening of its state-of-the-art Outpatient Rehabilitation Center, Memorial Sloan-Kettering greatly expanded its capacity to help patients with cancer regain physical function and a sense of well-being.

Treatments for cancer — including surgery, chemotherapy, and radiation — can interfere with the proper function of nerves and muscles. Patients may have trouble regain-ing strength and mobility after treatment and can struggle with everyday tasks such as walk-ing, dressing, cooking, bathing — and even eating or speaking clearly. To help alleviate symptoms and restore functional capacity to the fullest extent possible, MSKCC physicians refer their patients to rehabilitation specialists, who have expertise in helping patients to regain functional independence.

The new 22,500-square-foot rehabilita-tion center occupies the fourth and fifth floors of 515 Madison Avenue “and allows us to improve our quality of care and help patients maximize their physical potential,” says Teresa W. Fitzpatrick, Manager of the Outpatient Rehabilitation Center. “With more space and a larger staff, we can meet the increased demand for our services, and patients are able to recover in a beautiful environment.”

MSKCC’s physical and occupational therapists previously served inpatient and outpatient needs in Memorial Hospital. As demand for their services increased, the department needed more space and staff for outpatient therapy. A generous gift from Robert F. X. Sillerman and Laura Baudo

MSKCC Opens Outpatient Rehabilitation CenterMSKCC

innovatestreatment delivery and patient care

Page 23: innovate - GuideStar

MSKCC 232010 ANNUAL REPORT

Sillerman through their Tomorrow Foundation enabled the building of the new outpatient center and the hiring of additional therapists.

Specialists include physiatrists (physi-cians who treat and manage neuromuscular, musculoskeletal, and cardiopulmonary disorders) as well as physical therapists (PTs) and occupational therapists (OTs), who help patients recover physical skills through a vari-ety of approaches, such as therapeutic exercise, neuromuscular training, and cardiopulmonary rehabilitation. In addition, lymphedema thera-pists help patients manage lymphedema — the swelling of an extremity that can be a side effect after surgery for some types of cancer, particularly breast cancer, in which lymph nodes may be removed for examination by pathologists.

Fifteen treatment bays enable PTs and OTs to provide hands-on care in a private setting, and three additional rooms are dedi-cated to the management of lymphedema. A spacious gymnasium resembles a full-service health club with advanced equipment. Many of the machines are wheelchair compatible or have other adaptations to accommodate people who have physical impairments. One even combines sophisticated pressure sensors with computer games, offering patients an enjoyable and effective way to build strength and coordination.

The fifth floor houses the center’s clini-cal component, including the offices of four physiatrists. The physiatrists see patients referred by their primary MSKCC physicians

and assess and treat pain and dysfunction in nerves, muscles, and bones that may be limiting mobility or causing discomfort.

After performing a thorough evaluation, the physiatrist refers the patient to an appropri-ate therapist for the necessary exercise program. Sometimes the physiatrist outfits the patient with a specialized brace to improve function and independence.

Ms. Fitzpatrick notes that the need for rehabilitative services will become more critical over the long term as new treatments trans-form cancer into a less fatal, more chronic disease. The hope is that the new center will help MSKCC’s specialists use their expertise to advance the entire field of cancer rehabilitation.

“ With more space and a larger staff, we can meet the increased demand for our services, and patients are able to recover in a beautiful environment.” – Teresa Fitzpatrick

Manager, Outpatient Rehabilitation Center

Page 24: innovate - GuideStar

24 MSKCC

MSKCC

A New Targeted Therapy Shows Promise for Advanced Melanoma

“We have never before had a specific target in melanoma that we could attack,” says MSKCC medical oncologist Paul B. Chapman, senior author of the study. “But we now know half of melanomas depend on a mutated gene called BRAF for their growth. PLX4032 inhibits BRAF at the cellular level and shuts off these tumors. We have seen many tumors shrink rapidly, and in some patients quality of life improved dramatically.”

A phase I trial determined the maximum dose of the drug that could be given with-out adverse side effects and was followed by an extension of the trial, a phase II trial, at that recommended dose. Fifty-five patients were enrolled in the first portion of the study. Screening for BRAF mutations was not a requirement for initial entry, but as the trial progressed, an increasing percentage of patients were identified as having the muta-tion. Later, 32 patients with BRAF-mutated melanomas were added to the second phase.

In the phase I group, ten partial responses and one complete response were noted among 15 melanoma patients with BRAF mutations who were treated with mod-erate to full doses of the drug. In the extension group, two complete and 24 partial responses were seen among the 32 patients treated with a full dose of the drug. To date, 16 of 32 patients are still on the study. The side effects were minor and did not result in any patients leaving the study.

In January 2011, the phase III trial of PLX4032, which was led by Dr. Chapman, showed that the drug improved survival in patients. “Past treatments for melanoma that appeared to have a higher response rate did not lead to improved survival,” Dr. Chapman says. “This is very exciting since it is the first treatment for melanoma in which a superior response rate did indeed translate into longer survival for the patient.”

A multicenter study led by MSKCC investigators concluded that treatment with a new targeted therapy called PLX4032 resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma.

how we fight cancerMelanoma cells (in orange) with cell nuclei (in blue); normal skin cells (in green)

advances

Page 25: innovate - GuideStar

MSKCC 252010 ANNUAL REPORT

New Technology Improves Molecular Testing of Tumors for Targeted Cancer Therapies

In 2010, MSKCC took an important step for-ward in diagnosing gene mutations in patients’ cancers on an individual basis. The Center now uses a new technology from a company called Sequenom to look for mutations in the genes EGFR, KRAS, and BRAF in biopsy samples from patients with lung, colorectal, and thyroid cancers, as well as melanoma.

In patients with certain types of cancer, the presence or absence of specific genetic mutations determines which therapies they are likely to respond to and, therefore, should receive. Knowing as much as possible about the genetic makeup of tumors helps ensure that patients get the treatments most likely to help them, while avoiding drugs that will not benefit them and the side effects that can accompany those drugs.

For example, lung cancer patients with mutations in the gene EGFR can be treated with the drug erlotinib (Tarceva®), which targets the product of the mutated EGFR gene. However, if patients instead have a mutation in the gene KRAS, they will not

respond to erlotinib. In colorectal cancer, patients with mutations in KRAS and BRAF do not respond to the drugs cetuximab (Erbitux®) and panitumumab (Vectibix®), both of which also target the EGFR protein.

MSKCC has been at the forefront of test-ing for these mutations, starting with EGFR mutation testing in lung cancers in 2004, using older DNA testing approaches.

“There’s really been an evolution in molecular diagnostics,” explains Marc Ladanyi, incumbent of the William Ruane Chair in Molecular Oncology and attending patholo-gist on the Molecular Diagnostics Service. “We are moving from tests that are very labor intensive to ones that can be done in an automated, high-throughput manner. This new testing technology can provide results more quickly, as well as look for multiple mutations at the same time, something the old tests couldn’t do.”

The new technology also is more sensitive, allowing pathologists to perform molecular testing on biopsy samples that

contain fewer tumor cells than what was required with earlier approaches. “This is important especially for patients who have already received therapy,” he explains. “Treatments can cause a lot of inflammation in the tumor, which means that immune cells and other normal cells can outnumber the actual tumor cells. It’s also important in cancers where tumor cells are infiltrating connective tissue. This sensitivity and the ability to work with smaller tumor samples should make molecular diagnostic testing possible in cases where it was not before. At the same time, we are already evaluat-ing new sequencing technologies to further expand this molecular testing in the future.”

In addition to testing for mutations in the EGFR, KRAS, and BRAF genes, the new technology enables investigators to look for mutations in other, less well-known genes that are now emerging as possible new drug targets and for physicians to enroll patients in clinical trials for new, experimental therapies.

Pathologist Marc Ladanyi with lab member Laetitia Borsu

“ We are moving from tests that are very labor intensive to ones that can be done in an automated, high-throughput manner.”

– Marc Ladanyi Pathologist

Page 26: innovate - GuideStar

26 MSKCC

new collaborations

pioneersMSKCC

(This image) Nanotubes; (Upper right) Neural stem cellsInflammatory cells

Page 27: innovate - GuideStar

MSKCC 272010 ANNUAL REPORT

Nanotechnology Center Combines Cutting-Edge Science with Expertise in Patient Care

Hedvig Hricak and David Scheinberg

To take advantage of the growing field of nanotechnology, MSKCC has established a Nanotechnology Center. Nanotechnology is the science of manipulating materials on an extremely small scale, based on the nanometer (one-billionth of a meter). The field began taking off in the 1980s, but it has only been in the past few years that many of the tech-nologies developed by chemists and materials scientists for other applications have begun to be applied in biomedical settings.

“The development of nanotechnology has reached a point at which many of the tools can be used in translational research to advance patient care,” says Hedvig Hricak, Chair of the Department of Radiology in Memorial Hospital. “We have a critical mass of investigators interested in translational nanoscience. The new nanocenter not only provides a forum for them to talk about their projects and their ideas, but also facilitates collaboration with other institutions and offers resources for pilot projects. It’s moving forward extremely well.”

“The reason nanoscale is of such interest is that it is the scale on which the machinery of the cell operates,” elaborates David A. Scheinberg,

Chair of the Molecular Pharmacology and Chemistry Program in the Sloan-Kettering Institute. “The proteins that make DNA, the complexes that make proteins, and the receptors that allow the cell to communicate with and receive signals from the outside world all operate at the nanoscale. Indeed, chemotherapy drugs are actually much smaller than nanoscale; hence, these nanoscale drugs can be bigger and more complex than the kinds of drugs with which we usually work, and provide us with more versatile, multifunc-tional agents for diagnosis and therapy.”

Dr. Scheinberg, who also heads MSKCC’s Experimental Therapeutics Center, is serving as the new center’s Interim Chair. Dr. Hricak is a member of the Nanotechnology Center’s executive committee, along with Nuclear Medicine Service Chief Steven M. Larson and Human Oncology and Pathogenesis Program Chair Charles L. Sawyers. (The late chemist David Y. Gin was also a founding member of the committee.)

The two main focuses of nanotechnology research at MSKCC are the development of more-specialized, targeted drugs and the devel-opment of more-accurate diagnostic agents.

On the diagnostic side, applications include both in vitro applications, such as looking for circulating tumor cells or other markers in the bloodstream, and in vivo applications, using MRI, PET, and optical imaging to study cancer in the body. Another area under devel-opment involves what are called theranostic agents, which would allow imaging of a tumor and provide treatment to the tumor at the same time.

More than a dozen investigators in both SKI and Memorial Hospital — in fields rang-ing from pathology and chemistry to surgery and radiology — are participating in the center. There also are plans to recruit research fellows who are interested in working on nanotechnology-related projects. MSKCC has also established formal collaborative agree-ments with leaders in nanotechnology from other institutions: Joseph DeSimone, of the University of North Carolina, and Ulrich Wiesner, of Cornell University, researchers who already were collaborating on projects with many investigators at MSKCC.

“ The reason nanoscale is of such interest is that it is the scale on which the machinery of the cell operates.”

– David Scheinberg Chair, Molecular Pharmacology and Chemistry Program

Page 28: innovate - GuideStar

28 MSKCC

“ Although there were already many investigators at Memorial Sloan-Kettering who were focusing on various aspects of microbial infections, bringing these investigators together and creating new facilities to help them advance their research really made sense.”

– Eric Pamer Chief, Infectious Diseases Service

Experts estimate that as many as 30 percent of all cancers result from infection with a microbe, such as a virus or bacterium, or from the inflammation caused by an infection. Additionally, infection is one of the leading complications for patients undergoing cancer treatment.

Memorial Sloan-Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body’s inflammatory and immunological responses to them play in the development of cancer.

The Lucille Castori Center for Microbes, Inflammation, and Cancer unites researchers in the areas of molecular biology, immunol-ogy, computational biology, and microbiology and members of the Infectious Diseases and Clinical Microbiology Services.

“Although there were already many investigators at Memorial Sloan-Kettering who were focusing on various aspects of microbial infections, bringing these investiga-tors together and creating new facilities to

help them advance their research really made sense,” explains Eric G. Pamer, who is leading the Castori Center. Dr. Pamer is also Chief of the Infectious Diseases Service in Memorial Hospital and a researcher in the Sloan-Kettering Institute’s Immunology Program.

The Castori Center will promote research in the development of technologies to examine the causes of infections in patients, the characterization of infections associated with cancer treatment and hospitalization, the study of how inflammation can promote the development of cancer, and the study of the relationships between specific microbes and the development or progression of cancer.

The Castori Center will take advantage of two existing facilities, the Genomics Core Laboratory and the Bioinformatics Core Laboratory, to develop leading-edge technolo-gies for studying microbes and characterizing complex microbial populations in the clinical setting. The newly established Molecular Microbiology Core Facility will provide exper-tise and resources to clinical, laboratory, and translational investigators studying infections in cancer patients.

In addition to facilitating research among established investigators and clinicians at Memorial Sloan-Kettering and offering funding for specific projects, the Castori Center will support the work of the next gen-eration of investigators interested in the field by providing grants for clinical and labora-tory-based fellows to extend their research and training. Members of the center are also organizing workshops and symposia focusing on cutting-edge approaches to characterize complex microbial populations that inhabit the human intestine, to identify microbes associated with the development of cancer, and to discover microbial molecules that limit cancer growth or prevent infections.

Establishment of the Lucille Castori Center for Microbes, Inflammation, and Cancer and the new Molecular Microbiology Core Facility was made possible with a $5 million grant from The Tow Foundation. The new center is named in honor of Lucille Castori, the sister of Claire Tow.

Lucille Castori Center for Microbes, Inflammation, and Cancer Established

MSKCC

pioneers new collaborations

Page 29: innovate - GuideStar

MSKCC 292010 ANNUAL REPORT

The creation by the Sloan-Kettering Institute of the new Center for Stem Cell Biology (CSCB) will allow scientists to exploit recent advances in stem cell biology and the poten-tial of embryonic stem cells as well as human adult cells to produce regenerative treatments and provide insights into cancer. The virtual center, led by stem cell biologist Lorenz P. Studer, consists of a hub of several SKI labora-tories, dedicated facilities, and administrative support to foster collaborations among Center investigators working in the field.

“We’ve made important discoveries here, and this new center will allow us to capitalize on them,” says Dr. Studer. He explains that the CSCB has four main areas of interest. One involves the mechanisms of stem cell

self-renewal and pluripotency, which allows stem cells to continuously replicate while retaining their capacity to develop into various cell types. A second area focuses on how stem cells naturally differentiate into specialized cell types in order to learn how to mimic this process in the laboratory. A third area concentrates on the relationship between stem cells and cancer, particularly the study of stem-like cells within tumors, which may help explain resistance to therapy and why some cancers return after treatment. Finally, research will explore the use of induced pluripotent stem cells, a new kind of stem cell produced when a human adult cell is reprogrammed to a pluripotent state, capable of developing into any cell type.

Scientists working under the umbrella of the CSCB will collaborate with other MSKCC colleagues to develop novel tech-nologies, recruit faculty, and provide training. The CSCB will complement MSKCC’s Center for Cell Engineering (CCE), estab-lished in 2007. The CSCB investigates the basic biology of stem cells, while the CCE explores how therapies based on stem cells and other cell types could be brought to the clinic.

The CSCB, bolstered by training grants of approximately $1.86 million over five years from New York State, will support five postdoctoral fellows pursuing stem cell research. MSKCC is one of only four institu-tions in the state to secure such grants, which were awarded in September 2010.

New Center for Stem Cell Biology Launched

“ We’ve made important discoveries here, and this new center will allow us to capitalize on them.” – Lorenz Studer

Stem cell biologist

With the launch of a new Center for Health Policy and Outcomes, MSKCC is stepping up its efforts to develop policy that specifi-cally applies to cancer care. Studies will be directed at how to optimize clinical out-comes while curbing costs.

Robert E. Wittes, Physician-in-Chief of Memorial Hospital, says the new center will assemble a multidisciplinary faculty to address an eclectic menu of issues — for example, how new information technologies could help integrate the many aspects of a patient’s treatment, or how the procedures by which new therapies are tested and approved could be made more efficient. “The devel-opment of cancer-related health policy is especially crucial at a time when national

efforts to reform our healthcare system are moving into high gear,” he observes.

Many of the problems patients and hospitals grapple with confront all branches of medicine alike. But in some aspects, “cancer care is special,” says Peter B. Bach, a pulmonary and critical care physician and epidemiologist, who heads the new center. “For example, the interplay between research and clinical practice is very advanced in the area of cancer. And new guidelines are needed to better fit our care model.” And in no other area of medicine have the costs for diagnosis and treatment soared as high.

“Our most pressing issue is to help establish reforms that will lower healthcare spending without harming the quality of cancer care or interfering with innovation,” Dr. Bach notes, adding that this will require rigorous analysis and evaluation.

New Collaborative Center Addresses Policy Issues Related to Cancer Care

Peter Bach Pulmonologist and Director of the Center for Health Policy and Outcomes

Page 30: innovate - GuideStar
Page 31: innovate - GuideStar

MSKCC 312010 ANNUAL REPORT MSKCC 31

the next generation

educatesMSKCC

(Above) Cancer biologist Johanna Joyce (center) with research fellows Jimenez Schumacher and Leila Akkari.

(Left) Philip H. Gutin (center), Chair of the Department of Neurosurgery, makes rounds with clinical fellows and nurses.

Memorial Sloan-Kettering’s training programs prepare the next generation of physicians, scientists, and other healthcare professionals to take up leadership roles in the life sciences and medicine. In 2010 MSKCC trained 1,625 residents and clinical fellows; 545 postdoctoral research fellows, research scholars, research associates and graduate research assistants; 231 PhD candidates; 26 MD/PhD candidates;105 nursing students; and 391 medical students.

Page 32: innovate - GuideStar

32 MSKCC

In October, postdoctoral research fellows — along with their mentors, laboratory colleagues, and other members of the MSKCC and Tri-Institutional communities — gathered in the Rockefeller Research Laboratories for the fourth annual Postdoctoral Fellow Research Symposium. The daylong event allows fellows to present their latest work in two poster sessions and interact with colleagues Center-wide, gaining insight and guidance from those who have faced similar research challenges. This year, 84 posters

were presented on topics that ranged from basic research on gene functions and immune system activities to more-applied research that addressed improving imaging technologies and potential new cancer treatments. The event culminated with a keynote address by Nick Hastie, Director of the Medical Research Council Human Genetics Unit and Institute of Genetics and Molecular Medicine in Edinburgh, Scotland.

(Counterclockwise, from top left) Nick Hastie; SKI Director Thomas Kelly; and (from left) Pengpeng (Perry) Zhang, Margie Hunt and Yingli Yang from MSKCC’s Department of Medical Physics

(Above) Medical oncologist Dana Rathkopf with clinical fellows on rounds

2010 Postdoctoral Fellow Research Symposium

Clinical Training Memorial Sloan-Kettering’s renowned clinical training programs offer rich educational opportunities. Our world-class faculty prepares physicians and nurses to take up leadership roles in medicine, both in patient care and clinical research. And our affiliation with and proximity to

NewYork-Presbyterian Hospital, Weill Cornell Medical College, and The Rockefeller University provides a unique environment for learning, allowing students to participate in one of the world’s most vibrant medical and scientific communities.

Page 33: innovate - GuideStar

MSKCC 332010 ANNUAL REPORT

(Clockwise, from top left) Timothy Chan, Mary Baylies, students at symposium, and Craig Thompson

(Above) Biostatistician Marinela Capanu (in jacket) with GSK students Yilong Zou (in glasses) and Shefali Krishna

Major Trends in Modern Cancer Research Symposium

More than 500 people filled the Rockefeller Research Laboratories Auditorium in November 2010 for the fifth annual Major Trends in Modern Cancer Research symposium. Created to expose members of the public, especially high school students and their teachers, to cutting-edge research that is improving the understanding of cancer, the symposium was moderated by MSKCC’s new President, Craig B. Thompson, who also gave one of the evening’s three lectures. Joining him were developmental biologist Mary K. Baylies and radiation oncologist Timothy A. Chan.

MSKCC

educates the next generation

Gerstner Sloan-Kettering Graduate School of Biomedical Sciences

In 2006, the first class of six students matriculated at the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences (GSK). Currently, 42 students are enrolled in the school. Dimiter Tassev, a student from the inaugural class, was the first to complete all the require-ments for his PhD; the degree was conferred in May 2011.

GSK, established with a gift from MSKCC Board member Louis V. Gerstner, Jr., seeks to bridge basic research and real-life clinical challenges by offering its students an intensive PhD program to study the biological sciences through the lens of cancer. The faculty includes many Sloan-Kettering Institute investigators and Memorial Hospital physician-scientists, with the clinical faculty taking students directly into the clinic to expose them not only to research about cancer but to the clinical experience of the disease.

Page 34: innovate - GuideStar

MSKCC

A cancer diagnosis puts life on hold — the life of the patient as well as the lives of his or her loved ones. At Memorial Sloan-Kettering, all the efforts of our doctors, nurses, and other healthcare professionals are focused on getting these men, women, and children back to lives interrupted by this terrible disease.

Every day, our basic researchers and physician-scientists push the boundaries of understanding about what goes wrong in cancer and work tirelessly to speed discoveries into more-effective therapies.

The stories you are about to read feature four patients who entrusted their lives to our care. We are proud to say that we have sent them back to the lives they knew before cancer…healed.

heals

Page 35: innovate - GuideStar

MSKCC 352010 ANNUAL REPORT

CJ Postighonehigh school student and varsity hockey player / page 38

Halina Frydmanprofessor / page 36

Michael Quinlanactor / page 42

Stephanie Luedkefinancial professional / page 44

Page 36: innovate - GuideStar

36 MSKCC

Professor NYU Stern School of Business

New York

diagnosis: Primary central nervous system lymphoma

Halina Frydman

Can a husband dance too much with his wife on New Year’s Eve?

Roman Frydman’s motives for dancing the night away with his wife, Halina — while loving — were not entirely to ensure that she would have a good time at a New Year’s party welcoming 2005. Instead, he was concerned about recent, disturbing personality changes he had observed in her — including unchar-acteristic anger toward a friend attending that night’s celebration. “My husband danced with me a lot that evening because he didn’t want me to interact with too many people,” says Dr. Frydman. “He recognized there was something wrong.”

Several days later, in her office at New York University’s Stern School of Business, where she is a professor of statistics, Dr. Frydman realized she was unable to focus on her work. Returning to her apartment, she tried to read a book. Her husband, also a

professor at NYU, asked what she was reading. “I couldn’t tell him,” Dr. Frydman recalls. “That’s when he got very upset and called a friend, a psychiatrist, who said, ‘Take Halina to the emergency room now.’ ”

At NYU Medical Center, an MRI scan of Dr. Frydman’s brain showed a tumor. Immediately admitted to the hospital, she began a course of steroids. The tumor shrank dramatically. She explains: “At first, the doc-tors suspected it was a metastasis from the breast cancer I had in 1999. But because it shrank so much and so fast, they thought, ‘This is not a solid tumor.’ ” A brain biopsy followed and finally a diagnosis: primary central nervous system (CNS) lymphoma. Dr. Frydman had been treated for breast cancer at MSKCC by medical oncologist Clifford A. Hudis (now Chief of the Breast Cancer Medicine Service) and wished to be treated at the Center again.

Page 37: innovate - GuideStar

MSKCC 372010 ANNUAL REPORT

Halina Frydman has returned to a full life of teaching, researching, writing, and publishing. And today, she and her husband dance just for the fun of it.

Dr. Hudis referred the Frydmans to neuro-oncologist Lisa M. DeAngelis, Chair of the Department of Neurology and now Co-Executive Director of the Brain Tumor Center.

“CNS lymphoma is a rare cancer that can involve the brain, spinal cord, eyes, or the coverings of the brain and optic nerve, called the meninges,” says Dr. DeAngelis. “The designation of the disease as a lymphoma reflects the fact that the cells from which this cancer arises are lymphocytes, a type of white blood cell.”

Dr. DeAngelis enrolled Dr. Frydman in a clinical trial consisting of methotrexate — a chemotherapy drug that was given in very high doses — along with the chemotherapy drugs vincristine and procarbazine, and a monoclonal antibody called rituximab. “CNS lymphoma of the type that Dr. Frydman had used to be treated with whole-brain radiation,

which can damage normal brain structures and affect cognitive function,” explains Dr. DeAngelis. “At MSKCC, we’ve pioneered the use of chemotherapy for these tumors. Although radiation continues to play a role, we are exploring significantly reducing the doses. In patients who have received chemo-therapy and low-dose radiation we don’t see cognitive damage and the majority of them are doing extraordinarily well.”

The protocol for the trial still called for whole-brain radiation, albeit at a reduced dose. However, following chemotherapy, a scan of her brain showed no signs of cancer and Dr. Frydman decided against it. “I was worried that I wouldn’t have been able to go back to my work,” says Dr. Frydman. “I asked Dr. DeAngelis, ‘In your opinion, if I don’t do the radiation, will I put myself at a higher risk of a recurrence?’ She said no. She was very open-minded about it.”

“Dr. Frydman had gone into complete remission and had made a full clinical recovery,” says Dr. DeAngelis, “so I felt I could support her decision.” Dr. DeAngelis concludes, “What we have learned — and lymphoma is one of the best examples of this — is that underlying brain tissue is not necessarily destroyed by tumors; therefore effective treatment really can restore people to functionality.”

Halina Frydman has certainly been restored. She has returned to a full life of teaching, researching, writing, and publishing. And today, she and her husband dance just for the fun of it.

Page 38: innovate - GuideStar

38 MSKCC

High school student

New Jersey

diagnosis: RhabdomyosarcomaCJ Postighone

Page 39: innovate - GuideStar

MSKCC 392010 ANNUAL REPORT

The title of Carl Joseph “CJ” Postighone’s story should be Fierce Determination. The characters include a courageous and fiercely determined child. A fiercely determined, multidisciplinary, and creative medical team. And an extraordinary family, fiercely determined not only to survive an ordeal few can imagine but to emerge stronger than ever.

Pediatric oncologist Leonard H. Wexler is gentle in manner but blunt in describing CJ’s circumstances when they first met: “He was a beautiful five-year-old boy with a very bad cancer.” CJ, now 16, was diagnosed in 2000 with a rare pediatric cancer called rhab-domyosarcoma. The disease arises from cells that normally develop into skeletal muscles. It can affect almost any part of the body: the head and neck, the urinary and reproductive organs, the chest and abdomen, or, as in CJ’s case, the extremities. CJ’s rhabdomyosarcoma arose in his right buttock. “There is a common

Page 40: innovate - GuideStar

40 MSKCC

variant called embryonal rhabdomyosarcoma,” explains Dr. Wexler, “and a less common and more virulent variant called alveolar rhabdo-myosarcoma, more typically found in tumors of the extremities. That’s what CJ had.”

It began when CJ complained that his thigh was “itchy.” Within days, his parents, Carl and Robyn — an internist and nurse respectively — noted that CJ’s thigh “had more than doubled its original size and had turned a mottled color,” Mrs. Postighone recalls. An x-ray suggested a possible injury. CJ played ice hockey. At five he was already a gifted athlete.

But an injury heals. This did not. Then, several days later, came devastating news: An MRI scan showed “that in all likelihood this was a muscle tumor consistent with a rhabdo-myosarcoma,” says Dr. Postighone. “We were in disbelief.”

Initial consultations with oncologists in New Jersey, where the family lives, convinced

the Postighones that Memorial Sloan-Kettering was the institution at which they wanted their child treated.

Treatment for rhabdomyosarcoma, then and now, consists of chemotherapy and radiation and, in selected cases, surgery. CJ was treated first with “a very intensive five-drug chemotherapy regimen not considered standard at the time,” says Dr. Wexler. It was a profoundly rigorous course. “They had to make him very, very sick to make him better,” says Dr. Postighone.

Then Michael P. La Quaglia, Chief of the Pediatric Surgical Service, and John H. Healey, Chief of the Orthopaedic Service, collaborated on surgery to remove all remain-ing disease. But even before surgery, imaging studies showed that the news was good: “After the initial 12 weeks of chemotherapy, the cancer in the lymph nodes in CJ’s pelvis and abdomen to which the disease had spread had virtually disappeared,” Dr. La Quaglia says. “And the primary tumor, in his buttock,

showed an approximately 90 percent reduc-tion in volume. I removed the lymph nodes and worked with Dr. Healey to remove the residual tumor.” But that was not the end of CJ’s time in the operating room.

To decrease the dose of external beam radiation that CJ would receive after surgery, radiation oncologist Suzanne L. Wolden collaborated with her surgical colleagues and MSKCC medical physicists to deliver a dose of intraoperative radiation to CJ’s pelvis and abdomen. “Radiotherapy works very well to help cure rhabdomyosarcoma,” says Dr. Wolden. “However, the doses needed to treat it effectively are associated with severe long-term side effects. Our challenge is to maximize effectiveness while being very creative at minimizing those side effects. This is something we’re uniquely suited to do here. Very few places in the world do intraopera-tive radiation for children.” As a result of the intraoperative radiation, Dr. Wolden was indeed able to reduce the dose of external

(Top) CJ on the ice. (Right) CJ surrounded by his Morristown-Beard Crimson teammates and coaches.

Page 41: innovate - GuideStar

MSKCC 412010 ANNUAL REPORT

beam radiation that followed — every day for six weeks — along with six additional rounds of chemotherapy.

Asked how the family persevered, CJ’s sister, Cassandra, eight at the time of his diagnosis and now a sophomore at Villanova University, gestures at her brother: “Because of him. I remember one day our mother was cry-ing and CJ, who was still only five, went up to her and said, ‘Mommy, you have to believe.’ ”

Carl Postighone adds, “It’s also hard to imagine how we could have gotten through this without Lenny and the entire MSKCC team. They had an extraordinary ability to give us the confidence that we could get through the journey, that there was no mountain we couldn’t climb.”

“Later, after it was all over, I had these bracelets made,” CJ says. A small pile rests on the kitchen table. They are blue rubber. He sells them to raise money for the American Cancer Society. They read, simply, Believe.

Even at five years old, even through the most grueling days of treatment, CJ believed he would recover — and he remained an athlete. During numerous hospitalizations, his parents brought him his hockey stick so he could play in the hospital corridors. And when he was home and well enough, he was back on the ice — sometimes wearing a knapsack containing his chemotherapy. Today, despite his illness and the resultant loss of muscle, he plays competitive ice hockey with his high

school team, the Morristown-Beard Crimson, ranked one of the top ten high school teams in New Jersey. His position is forward. “He is lucky Number Five,” says his mother.

“I remember Dr. Wexler saying, ‘CJ’s going to be fine. I’m going to be at his high school graduation,’ ” continues Mrs. Postighone, her eyes reddening. “We’re almost there, and he will be.”

B e l i e v e .

“ It’s hard to imagine how we could have gotten through without Lenny and the MSKCC team. They had an extraordinary ability to give us the confidence that we could get through the journey, that there was no mountain we couldn’t climb.”

– Carl Postighone

(Above, left) Robyn, Cassandra, Carl, and CJ Postighone. (Above, right) CJ with another member of the Postighone family, Coco.

Page 42: innovate - GuideStar

42 MSKCC

Michael Quinlan

Actor

New Jersey

diagnosis: Prostate cancer

Page 43: innovate - GuideStar

MSKCC 432010 ANNUAL REPORT

After numerous consultations that included exploring the option of radiation therapy, Mr. Quinlan chose to have his pros-tate removed by robot-assisted laparoscopic surgery, an approach that allows surgeons to perform operations through a few small incisions with enhanced vision and control.

“The robot is really just a sophisticated surgical tool,” explains Dr. Laudone. Seated at a console, the surgeon uses finger, eye, and foot controls to manipulate the arms of the robot. “There are several advantages from a surgeon’s point of view. First, you can see better because the eyes of the robot — the camera — can go right down into the tissue and project a three-dimensional image, magni-fied tenfold.” In addition, the robot translates a surgeon’s hand, wrist, and finger movements into real-time movements of the surgical instruments inside the patient. “The robot takes my motions, copies them, and scales them down,” Dr. Laudone says. “If I make a one-inch movement, the robot scales it down to a quarter-inch. A quarter-inch movement is scaled down to a sixteenth of an inch. The precision is extraordinary.”

In prostate cancer surgery, precision is key. “The primary goal of any cancer opera-tion no matter how it is done is to remove

all the cancer,” Dr. Laudone asserts. “This means removing the prostate and in most cases the surrounding pelvic lymph nodes. Not removing the lymph nodes in men with more-aggressive prostate cancer runs the risk of leaving cancer behind. The second consideration is to preserve urinary and sexual function. In properly selected patients, robot-assisted surgery can achieve exceptional curative and functional outcomes. However, as helpful as the robot is with the operation, it doesn’t replace the need for good surgical judgment, experience, and skill.”

In April 2010, Dr. Laudone removed Mr. Quinlan’s prostate and 18 lymph nodes. Final pathology revealed that all 18 nodes were negative for cancer and, following surgery, Mr. Quinlan’s PSA level was zero. Subsequent PSA levels have remained undetectable, and no further treatment has been necessary. Mr. Quinlan also says that his functional outcomes have been excellent.

“I think of what happened as good news,” Mr. Quinlan remarks. “It was caught in time and Dr. Laudone was able to do something about it. Friends ask, ‘So how are you feeling?’ And I reply, ‘About what?’ And then I remem-ber. Oh! That. To be back at work, back in my life, and actually able to forget is a great gift.”

Michael Quinlan is a working actor. His credits include Broadway revivals of Death of a Salesman and The Caine Mutiny Court-Martial; television shows such as Law and Order; commercials, voiceovers, and industrial films. He also coaches executives in giving effective speeches and presentations. But in 2009, his career was interrupted when, after a routine physical, “my internist called to say that my PSA [prostate-specific antigen] level was a little higher than he’d like. He suggested I see a urologist.”

Mr. Quinlan followed his internist’s recom-mendation. And on December 23, after a prostate biopsy, the urologist called with the results: Of 12 tissue samples removed from Mr. Quinlan’s prostate, six were positive for cancer. “So there was my Merry Christmas present,” Mr. Quinlan smiles dryly.

“The first thing we do when we meet a patient is reassure him that prostate cancer is a very treatable disease and then try to find out all we can about his cancer,” says Mr. Quinlan’s physician, urologic surgeon Vincent P. Laudone, Co-Director of Minimally Invasive Surgery for Robotics at Memorial Sloan-Kettering. “Some patients we don’t have to treat because their cancers are nonag-gressive and are unlikely to cause a problem for them during their lifetime. However, more-aggressive cancers must be treated.”

Preoperative predictors for Mr. Quinlan, including his elevated PSA and a Gleason score of 7 in one area of the prostate and 6 in another, indicated that treatment was neces-sary. (The Gleason grading system, which runs from 2 to 10, is used to characterize the aggressiveness of prostate cancer and provides an estimate of how likely a prostate cancer is to spread to other parts of the body.)

Page 44: innovate - GuideStar

44 MSKCC

Stephanie LuedkeFinancial professional

Connecticut

diagnosis: Cervical cancer

Page 45: innovate - GuideStar

MSKCC 452010 ANNUAL REPORT

“ I’ll never forget the sound,” says Stephanie Luedke, her eyes welling with tears as she describes hearing the cries of her son, Jackson Thomas Luedke, moments after his birth. It is not unusual for a mother to weep when recalling the birth of her child. But for Ms. Luedke, Jackson’s cries are an especially joyful memory. Her journey to that day was anything but routine.

Page 46: innovate - GuideStar

46 MSKCC

“ I don’t wish that any woman go through this, but if anyone does, I would want her to be with Dr. Abu-Rustum. He is a surgeon, a husband, a father, and a real human being. He’s remarkable.” – Stephanie Luedke

In the fall of 2008, Ms. Luedke had received a diagnosis of stage 1-B-1 cervical cancer. Just a decade earlier, the only option available to her would have been a radi-cal hysterectomy. And for a woman still in her childbearing years who wished to have children, the news would have been doubly devastating: You have cancer — and you will never bear a child.

However, for Ms. Luedke and other women in similar straits, there is now a procedure called a radical trachelectomy that can preserve fertility in patients with early-stage cervical cancer. Gynecologic surgeon Nadeem R. Abu-Rustum, Director of Minimally Invasive Surgery for Memorial

Sloan-Kettering’s Gynecology Service, and his colleagues have been performing and perfect-ing the operation since 2001. “We have done more than 100 cases and have proven that this is an excellent choice for certain patients,” says Dr. Abu-Rustum. Of the approximately 105 women who have had radical trachelectomies at MSKCC, 19 have given birth to healthy babies and several more are now pregnant.

In a radical trachelectomy, surgeons remove the cervix and several pelvic lymph nodes. During surgery, a pathologist deter-mines if the margins of the cervical tissue removed are free of cancer cells. If they are, surgeons can spare the healthy uterus. The remaining portion of the uterus is

sutured to the vagina, creating a new cervix. The operation can be performed laparo-scopically — which is a minimally invasive procedure — or as a traditional open surgery. The choice depends on the size of the tumor and other considerations. “Laparoscopy is good for very small cancers,” explains Dr. Abu-Rustum. “But if we are doing a more complex case or if it is a larger, more high-risk tumor, we will choose the open approach.”

“Our cure rate is outstanding,” he adds. “The reason is that we select patients very carefully and study them preoperatively. This includes a review of their biopsy sample with our pathologists and an evaluation of women using pelvic MRI and full-body PET scans to

Page 47: innovate - GuideStar

MSKCC 472010 ANNUAL REPORT

rule out any spread of cancer.” Dr. Abu-Rustum says that this meticulous preoperative planning has allowed MSKCC surgeons to broaden the inclusion criteria. “In the beginning, we were choosing only extremely small tumors. However as we have gained experience we’ve been able to operate on slightly larger lesions and more-advanced stages of disease, and so can offer this option to more women.”

Ms. Luedke, a senior-level executive of an investment management firm, had surgery with Dr. Abu-Rustum in mid-February 2009 and became pregnant in November. Her pregnancy was high risk and was not without its difficult moments. “But Dr. Abu-Rustum stayed in complete communication with

my obstetrician, which gave me tremendous peace of mind,” says Ms. Luedke. “I don’t wish for any woman to go through this, but if anyone does, I would want her to be with Dr. Abu-Rustum. He is a surgeon, a husband, a father, and a real human being. He’s remarkable.”

At 33 weeks into her pregnancy, on July 2, 2010, Stephanie Luedke and her husband, Fritz, welcomed Jackson into the world. He weighed five pounds, three ounces — “one perfect, beautiful little boy,” says his mother.

Fritz, Jackson, and Stephanie Luedke

Page 48: innovate - GuideStar

48 MSKCC

excellence

pursuesMSKCC

The pursuit of excellence occupies all of us, every day. Excellence is an attitude, not a skill. We strive to be better today than we were yesterday. We have a passion to innovate. We embrace change. These are the drivers of excellence. And at Memorial Sloan-Kettering excellence is what we do best.

Page 49: innovate - GuideStar

2010year in review

Page 50: innovate - GuideStar

50 MSKCC

PATIENT CARE 2006 2007 2008 2009 2010

Patient Admissions: Adults 19,626 20,195 21,039 21,932 22,852

Patient Admissions: Children 1,553 1,673 1,650 1,537 1,494

Total Admissions 21,179 21,868 22,689 23,469 24,346

Total Patient Days 136,920 137,787 139,847 140,224 143,532

Average Patient Stay (days) 6.5 6.3 6.2 6.0 5.9

Bed Occupancy Rate (1) 88.1% 87.4% 88% 88.5% 83.7%

Outpatient MD Visits: Manhattan 363,458 368,200 384,889 406,024 418,410

Outpatient MD Visits: Regional Network 67,702 75,631 81,995 94,293 97,425

Total Outpatient MD Visits 431,160 443,831 466,884 500,317 515,835

Screening Visits 31,198 30,200 28,888 27,369 23,373

Surgical Cases 16,329 16,951 18,035 19,233 19,362

Radiation Treatments and Implants: Manhattan 59,369 57,307 58,494 57,856 59,223

Radiation Treatments and Implants:

Regional Network 44,175 44,615 43,550 47,987 47,926

Total Radiation Treatments and Implants 103,544 101,922 102,044 105,843 107,149

X-ray Examinations and Special Procedures 305,404 329,329 346,157 358,052 362,609

Clinical Investigation Protocols (2) 460 493 522 507 552

(1) Based on adjusted bed count(2) Excludes studies closed to accrual

STATISTICAL PROFILE

Page 51: innovate - GuideStar

MSKCC 512010 ANNUAL REPORT

STAFF 2006 2007 2008 2009 2010

Center (1) (2) 798 766 826 873 911

Hospital Attending Staff 713 672 727 768 804

Sloan-Kettering Institute Members(2) 122 128 133 140 142

Registered Nurses 1,504 1,615 1,734 1,845 1,946

Total Employees (3) 9,309 9,917 10,505 11,039 11,474

Volunteers 895 848 871 917 942

(1) All Hospital Attendings and Institute Members hold appointments in the Center; in 2010, 35 staff members held appointments in both the Institute and the Hospital(2) Includes professional support staff appointments(3) Includes all clinicians, scientists, nurses, other health professionals, and support staff

EDUCATION 2006 2007 2008 2009 2010

Residents and Clinical Fellows — Positions 412 419 418 436 447

Residents and Clinical Fellows — Annual Total 1,421 1,687 1,609 1,651 1,625

Research Fellows 400 404 254 303 295

Research Scholars — — 140 121 132

Research Associates 62 63 87 90 94

Graduate Research Assistants — — — — 23

Frank A. Howard Scholars 1 1 1 1 1

PhD Candidates 163 195 232 227 231

MD/PhD Candidates 23 24 29 28 26

Registrants in Continuing

Medical Education Programs 2,140 2,035 2,115 2,395 2,554

Medical Observers 534 522 561 572 541

Medical Students 332 368 358 399 391

Nursing Students 71 61 72 109 105

Social Work Students 6 6 6 6 6

Radiation Oncology Technology Students 16 16 15 15 14

Cytotechnology Students 3 4 3 3 2

Physical Therapy Students 4 3 3 3 3

Occupational Therapy Students 2 1 5 4 3

STATISTICAL PROFILE

Page 52: innovate - GuideStar

52 MSKCC

OPERATING REVENUES AND EXPENSES (in thousands) 2006 2007 2008 2009 2010

OPERATING REVENUES

Patient Care Revenue $ 1,398,393 $ 1,531,639 $ 1,606,989 $ 1,723,313 $ 1,854,776

Grants and Contracts 129,693 149,275 163,352 167,495 186,327

Contributions Allocated to Operations 83,538 95,481 108,844 126,250 117,323

Royalty Income 44,558 38,302 94,131 62,232 68,663

Other Income 39,439 39,902 41,963 43,144 44,874

Investment Return Allocated to Operations 116,143 113,131 116,546 103,998 100,389

Transfer of Board-Designated

Annual Royalty Annuitization 26,083 29,440 33,122 37,158 41,578

Total Operating Revenues 1,837,847 1,997,170 2,164,947 2,263,590 2,413,930

OPERATING EXPENSES

Compensation and Fringe Benefits 966,034 1,061,946 1,164,155 1,286,536 1,361,032

Purchased Supplies and Services 594,671 659,488 684,872 757,863 772,968

Provision for Bad Debts and Assessments 41,978 13,387 6,823 10,881 11,046

Depreciation and Amortization 139,402 157,494 175,870 171,806 175,494

Interest Expense 45,463 54,872 59,023 64,997 47,931

Less Fund Raising Expenses Transferred to

Non-Operating Income (Expenses) (28,390) (33,523) (36,048) (40,320) (43,926)

Total Operating Expenses 1,759,158 1,913,664 2,054,695 2,251,763 2,324,545

Income from Operations $ 78,689 $ 83,506 $ 110,252 $ 11,827 $ 89,385

PHILANTHROPY (in thousands)

Philanthropy $ 298,728 $ 239,020 $ 279,103 $ 166,247 $ 237,666

CAPITAL SPENDING (in thousands)

Capital Spending $ 309,524 $ 273,944 $ 345,135 $ 226,049 $ 262,371

BALANCE SHEET SUMMARY (in thousands)

Assets $ 5,740,721 $ 6,143,433 $ 5,578,522 $ 6,068,707 $ 6,448,415

Liabilities 2,098,245 2,098,776 2,354,618 2,467,135 2,550,889

Net Assets $ 3,642,476 $ 4,044,657 $ 3,223,904 $ 3,601,572 $ 3,897,526

FINANCIAL SUMMARY

Page 53: innovate - GuideStar

MSKCC 532010 ANNUAL REPORT

Douglas A. Warner IIIChairman

James D. Robinson IIIHonorary Chairman

Richard I. BeattieVice Chairman of Boards;Chairman, Board of Managers, Memorial Hospital

Clifton S. RobbinsTreasurer

Louis V. Gerstner, Jr.Vice Chairman of Boards;Chairman, Board of Managers, Sloan-Kettering Institute

Norman C. SelbySecretary

Craig B. Thompson, MDPresident and Chief Executive Officer

Frederick R. AdlerRichard I. BeattieMrs. Edwin M. BurkeMrs. John J. ByrneMrs. Joseph A. Califano, Jr. Stanley F. DruckenmillerAnthony B. EvninRoger W. Ferguson, Jr.Steve ForbesWilliam E. FordRichard N. FosterStephen FriedmanEllen V. FutterPhilip H. Geier, Jr.Louis V. Gerstner, Jr.Jonathan N. GrayerJohn R. GunnBette-Ann GwathmeyWilliam B. Harrison, Jr.Jane D. Hartley

Benjamin W. Heineman, Jr.Mrs. Ann Dibble Jordan David H. KochMarie-Josée KravisMrs. Evelyn H. LauderMrs. Thomas V. LeedsMrs. Jean Remmel LittleMrs. John L. MarionPaul A. Marks, MDDonald B. MarronJamie C. NichollsJames G. NivenHutham S. OlayanE. Stanley O’NealBruce C. RatnerClifton S. RobbinsJames D. Robinson IIIVirginia M. RomettyBenjamin M. RosenDavid M. Rubenstein

Jack RudinLewis A. SandersFayez S. SarofimNorman C. SelbyStephen C. SherrillPeter J. SolomonWilliam C. Steere, Jr.J. McLain StewartScott M. StuartCraig B. Thompson, MDLucy R. Waletzky, MDDouglas A. Warner IIISanford I. WeillPeter A. WeinbergJon WinkelriedDeborah C. WrightJeff ZuckerMortimer B. Zuckerman

Board of Overseers Emeriti

Mrs. Elmer H. BobstPeter O. Crisp

Richard M. FurlaudJames W. Kinnear

Elizabeth J. McCormack, PhDMrs. Arnold Schwartz

Board of Scientific Consultants

Frederick R. Appelbaum, MDRichard Axel, MDPhilip A. Cole, MD, PhDNancy E. Davidson, MDTitia de Lange, PhD James R. Downing, MD

Laurie Glimcher, MDJoseph L. Goldstein, MDGregory Hannon, PhD Barnett S. Kramer, MD, MPHArthur Levinson, PhDPaul Nurse, PhD, FRS

Stanley R. Riddell, MD William R. Sellers, MDGregory L. Verdine, PhDRalph Weissleder, MD, PhDIrving L. Weissman, MD

BOARDS OF OVERSEERS AND MANAGERSMEMORIAL SLOAN-KETTERING CANCER CENTER

Page 54: innovate - GuideStar

54 MSKCC

Murray F. Brennan, MDVice President for International Programs and Director, Bobst International Center

Eric M. Cottington, PhDVice President, Research and Technology Management

Dennis Dowdell, Jr.Vice President, Human Resources

Michael P. GutnickSenior Vice President, Financeand Assistant Treasurer

Jason KleinVice President and Chief Investment Officer

Kathy LewisVice President, Public Affairs

Edward J. MahoneyVice President,Facilities Management

Kathryn MartinSenior Vice President andHospital Administrator

Richard K. NaumVice President, Development

Roger N. Parker, JDSenior Vice President andGeneral Counsel

Patricia C. SkarulisVice President, Information Systems and Chief Information Officer

Ellen Miller SonetVice President, Marketing

Paul A. Marks, MDPresident Emeritus

Harold Varmus, MDPresident Emeritus

For a listing of the members of the professional staffof Memorial Hospital and the Sloan-Kettering Institute,please visit www.mskcc.org/annualreport2010.

Craig B. Thompson, MD President and Chief Executive Officer, Memorial Sloan-Kettering Cancer Center

John R. GunnExecutive Vice President

Robert E. Wittes, MDPhysician-in-Chief, Memorial Hospital

Larry Norton, MDDeputy Physician-in-Chief,Breast Cancer Programs, Memorial Hospital

Thomas J. Kelly, MD, PhDDirector, Sloan-Kettering Institute

Maureen Killackey, MDDeputy Physician-in-Chief and Medical Director, MSKCC Regional Care Network

PRINCIPAL OFFICERSMEMORIAL SLOAN-KETTERING CANCER CENTER

Page 55: innovate - GuideStar

MSKCC 54A2010 ANNUAL REPORT

DEPARTMENTS OF MEMORIAL HOSPITAL

CHAIR

Robert E. Wittes, MD

Vincent Astor Chair of Clinical Research

David R. Artz, MD

Gay Bailey, RN

Boris C. Bastian, MD, PhD

Colin B. Begg, PhD

George J. Bosl, MD

Arthur E. Brown, MD

Kevin Browne, RN

Michelle Burke, RN

Lisa M. DeAngelis, MD

Joseph O. Deasy, PhD

Dawn P. Desiderio, MD

Mary Dowling, RN

Martin Fleisher, PhD

Hans Gerdes, MD

John R. Gunn

Philip H. Gutin, MD

William Hoskins, MD

Hedvig Hricak, MD, PhD

William R. Jarnagin, MD

Lewis J. Kampel, MD

Thomas J. Kelly, MD, PhD

Maureen Killackey, MD

Aileen Killen, PhD, RN

David W. Kissane, MD

Charles D. Lucarelli, RPh

Kathryn Martin

Mary Jane Massie, MD

Mary McCabe, RN

Elizabeth Nelkin McCormick, MSN, RN

Larry Norton, MD

Eileen M. O’Reilly, MB, BCh, BAO

Richard J. O’Reilly, MD

David G. Pfister, MD

Simon N. Powell, MD, PhD

Paul J. Sabbatini, MD

Leonard B. Saltz, MD

Charles L. Sawyers, MD

Peter T. Scardino, MD

Craig B. Thompson, MD

Roger S. Wilson, MD

CHAIR AND ATTENDING

Martin Fleisher, PhD

ATTENDINGS

Ann M. Dnistrian, PhD

Bo Dupont, MD, DSc

Hans G. Lilja, MD, PhD

Peter Maslak, MD

Eric Pamer, MD

Enid A. Haupt Chair in Clinical Investigation

Lilian M. Reich, MD, PhD

Gerald A. Soff, MD

David L. Wuest, MD

ASSOCIATE ATTENDINGS

Renier J. Brentjens, MD, PhD

Vincent F. LaRussa, PhD

Celia J. Menendez-Botet, PhD

Rekha Parameswaran, MBBS

Trudy Nan Small, MD

ASSISTANT ATTENDINGS

Maria Eugenia Arcila, MD

Ngolela Esther Babady, PhD

Laura K. Bechtel, PhD

Kazunori Murata, PhD

Christopher Yongchul Park, MD, PhD

Larry J. Smith, PhD

CHAIR AND ATTENDING

Roger S. Wilson, MD

Founder’s Chair

ATTENDINGS

David Amar, MD

Lisa R. Barr, MD

Ruth A. Borchardt, MD

Dawn P. Desiderio, MD

Mary Ellen Fischer, MD

Florence J. Grant, MD

Jeffrey Groeger, MD

Neil A. Halpern, MD

Paul M. Heerdt, MD, PhD

Anne C. Kolker, MD

Ronald A. Kross, MD

William L. Marx, MD

Stephen M. Pastores, MD

Diane E. Stover, MD

Alisa C. Thorne, MD

Robert A. Veselis, MD

ASSOCIATE ATTENDINGS

Kenneth H. Cubert, MD

Paul H. Dalecki, MD

Jamie A. Fortunoff, MD

Alan L. Kotin, MD

Vivek T. Malhotra, MD, MPH

Roger E. Padilla, MD

ASSISTANT ATTENDINGS

Kara Michelle Barnett, MD

Clara Broad, MD

Mohit Chawla, MD

Sanjay Chawla, MD

Anahita Dabo, MD

Oscar E. Del Valle, MD

Rodney H. Garcia, MD

Amitabh Gulati, MD

Eric R. Kelhoffer, MD

Amy Lu, MD, MPH

Jennifer Mascarenhas, MD

Eileen P. McAleer, MD

Leslie S. Ojea, MD

Alessia C. Pedoto, MD

Kane O. Pryor, MBBS

Vinay Ganesh Puttanniah, MD

Nina D. Raoof, MD

Elizabeth Fay Rieth, MD

Luis E. Tollinche, MD

Louis P. Voigt, MD

Cindy Beng-Imm Yeoh, MD

INSTRUCTORS

Diba Daneshrad, MD, MPH

Kaye E. Hale, MD

MEDICAL BOARD

DEPARTMENT OF ANESTHESIOLOGY AND CRITICAL CARE MEDICINE

DEPARTMENT OF CLINICAL LABORATORIES

Page 56: innovate - GuideStar

54B MSKCC

CHAIR AND ATTENDING

Colin B. Begg, PhD

Eugene W. Kettering Chair

ATTENDINGS

Peter B. Bach, MD

Jonine L. Bernstein, PhD

Glenn Heller, PhD

Malcolm C. Pike, PhD

Chris Sander, PhD

Venkatraman E. Seshan, PhD

ASSOCIATE ATTENDINGS

Lawrence S. Engel, PhD

Mithat Gonen, PhD

Irene Orlow, PhD

Katherine S. Panageas, DrPH

Jaya M. Satagopan, PhD

Howard T. Thaler, PhD

Andrew J. Vickers, DPhil

Ann G. Zauber, PhD

ASSISTANT ATTENDINGS

Ethan M. Basch, MD

Victoria S. Blinder, MD

Marinela Capanu, PhD

Elena B. Elkin, PhD

Anna Helena Furberg-Barnes, PhD

Shari Goldfarb, MD

Alexia E. Iasonos, PhD

Yuelin Li, PhD

Chaya S. Moskowitz, PhD

Susan Oliveria, ScD, MPH

Sara H. Olson, PhD

Irina Ostrovnaya, PhD

Sujata Patil, PhD

Li-Xuan Qin, PhD

Talya Salz, PhD

Ronglai Shen, PhD

Camelia S. Sima, MD

Zhigang Zhang, PhD

CHAIR AND ATTENDING

Joseph O. Deasy, PhD

Enid A. Haupt Chair of Medical Physics

ATTENDINGS

Howard I. Amols, PhD

Chandra M. Burman, PhD

John L. Humm, PhD

Peter Kijewski, PhD

Jason A. Koutcher, MD, PhD

Gloria C. Li, PhD

C. Clifton Ling, PhD

Thomas J. LoSasso, PhD

Gikas S. Mageras, PhD

Jean M. St. Germain, MS

Ellen D. Yorke, PhD

Marco Zaider, PhD

Pat Zanzonico, PhD

ASSOCIATE ATTENDINGS

Douglas J. Ballon, PhD

Maria F. Chan, PhD

Yusuf E. Erdi, DSc

Doracy P. Fontenla, PhD

Y. C. David Huang, PhD

Margie A. Hunt, MS

Andrew Jackson, PhD

Assen S. Kirov, PhD

Dale M. Lovelock, PhD

James G. Mechalakos, PhD

Sadek Nehmeh, PhD

Ceferino H. Obcemea, PhD

Joseph A. O’Donoghue, PhD

Kristen L. Zakian, PhD

ASSISTANT ATTENDINGS

Ase M. Ballangrud-Popovic, PhD

Lawrence T. Dauer, PhD

Amita Dave, PhD

Cesar Della Biancia, PhD

Paul Frisch, PhD

David H. Gultekin, PhD

Hongbiao Carl Le, PhD

Guang (George) Li, PhD

Jingdong Li, PhD

Ruimei Ma, PhD

Yousef Mazaheri, PhD

Kyung K. Peck, PhD

Charles R. Schmidtlein, PhD

Yulin Song, PhD

Sunitha B. Thakur, PhD

Weijun Xiong, PhD

Guozhen (Jenny) Yang, PhD

Pengpeng Zhang, PhD

Qinghui Zhang, PhD

INSTRUCTORS

Ellen Ackerstaff, PhD

Jazmin Schwartz, PhD

DEPARTMENT OF EPIDEMIOLOGY AND BIOSTATISTICS

DEPARTMENT OF MEDICAL PHYSICS

DEPARTMENTS OF MEMORIAL HOSPITAL

Page 57: innovate - GuideStar

MSKCC 54C2010 ANNUAL REPORT

CHAIR AND ATTENDING

George J. Bosl, MD

The Patrick M. Byrne Chair in Clinical Oncology

DIVISION HEADS AND ATTENDINGS

Ephraim S. Casper, MD

Division of Network Medicine Services

David R. Spriggs, MD

Division of Solid Tumor Oncology; Winthrop Rockefeller Chair in Medical Oncology

Diane E. Stover, MD

Division of General Medicine

Marcel R. M. van den Brink, MD, PhD

Division of Hematologic Oncology; Alan N. Houghton Chair

SENIOR ATTENDING

Bayard D. Clarkson, MD

Enid A. Haupt Chair of Therapeutic Research

ATTENDINGS

James P. Allison, PhD

David H. Koch Chair in Immuno-logic Studies; Howard Hughes Medical Institute Investigator

Peter Bach, MD

Dean F. Bajorin, MD

Michael S. Baum, MD

Ellin Berman, MD

William S. Breitbart, MD

Murray F. Brennan, MD

Benno C. Schmidt Chair in Clinical Oncology

Arthur E. Brown, MD

Philip C. Caron, MD, PhD

Albert R. Casazza, MD

Barrie R. Cassileth, PhD

Laurance S. Rockefeller Chair in Integrative Medicine

Hugo R. Castro-Malaspina, MD

Raju S.K. Chaganti, PhD

William E. Snee Chair

Paul B. Chapman, MD

Bo Dupont, MD, DSc

James A. Fagin, MD

Carlos D. Flombaum, MD

Kathleen M. Foley, MD

Society of Memorial Sloan- Kettering Cancer Center Chair

Francesca M. Gany, MD

Hans Gerdes, MD

Teresa Ann Gilewski, MD

Sergio A. Giralt, MD

Paul A. Glare, MBBS

Michael S. Glickman, MD

Richard D. Granstein, MD

Jeffrey S. Groeger, MD

José G. Guillem, MD

Allan C. Halpern, MD

Neil A. Halpern, MD

Brian Harper, MD, MPH

Alan N. Houghton, MD

Virginia and Daniel K. Ludwig Clinical Chair

Clifford A. Hudis, MD

David H. Ilson, MD, PhD

Suresh C. Jhanwar, PhD

Lewis J. Kampel, MD

David Paul Kelsen, MD Edward S. Gordon Chair in Medical Oncology

Nancy E. Kemeny, MD

Richard N. Kolesnick, MD

Jason A. Koutcher, MD, PhD

Mark G. Kris, MD

William and Joy Ruane Chair in Thoracic Oncology

Robert C. Kurtz, MD

Diana E. Lake, MD

Steven M. Larson, MD

Donna and Benjamin M. Rosen Chair in Radiology

Stuart M. Lichtman, MD

Hans G. Lilja, MD

Philip O. Livingston, MD

Michael D. Lockshin, MD

Steven K. Magid, MD

Joseph A. Markenson, MD

Paul A. Marks, MD

Steven C. Martin, MD

Peter G. Maslak, MD

Vincent A. Miller, MD

Nancy E. Mills, MD

Malcolm A. S. Moore, DPhil

Enid A. Haupt Chair of Cell Biology

Robert J. Motzer, MD

Patricia L. Myskowski, MD

Stephen D. Nimer, MD

Alfred P. Sloan Chair

Larry Norton, MD

Norna S. Sarofim Chair in Clinical Oncology

Kevin Oeffinger, MD

Herbert F. Oettgen, MD

Kenneth Offit, MD

Richard J. O’Reilly, MD

Claire L. Tow Chair in Pediatric Oncology Research

Stephen A. Paget, MD

Eric G. Pamer, MD

Enid A. Haupt Chair in Clinical Investigation

Esperanza B. Papadopoulos, MD

Gavril W. Pasternak, MD, PhD

Anne Burnett Tandy Chair of Neurology

Stephen Pastores, MD

David G. Pfister, MD

Carol S. Portlock, MD

Lilian M. Reich, MD, PhD

Isabel C. Rivière, PhD

Nancy Roistacher, MD

Neal Rosen, MD, PhD

Enid A. Haupt Chair in Medical Oncology

Michel Sadelain, MD, PhD

Stephen and Barbara Friedman Chair

Leonard B. Saltz, MD

Jean T. Santamauro, MD

Charles L. Sawyers, MD

Marie-Josèe and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Howard Hughes Medical Institite Investigator

David A. Scheinberg, MD, PhD

Vincent Astor Chair

Howard I. Scher, MD

D. Wayne Calloway Chair in Urologic Oncology

William J. Schneider, MD

Philip Schulman, MD

Gary K. Schwartz, MD

Andrew D. Seidman, MD

Kent A. Sepkowitz, MD

Moshe Shike, MD

Stewart Shuman, MD, PhD

Simon H. Rifkind Chair

Nancy T. Sklarin, MD

DEPARTMENT OF MEDICINE

DEPARTMENTS OF MEMORIAL HOSPITAL

Page 58: innovate - GuideStar

54D MSKCC

DEPARTMENTS OF MEMORIAL HOSPITAL

Gerald A. Soff, MD

Richard M. Steingart, MD

David J. Straus, MD

Steven M. Sugarman, MD

Martin S. Tallman, MD

Maria Theodoulou, MD

Craig B. Thompson, MD

R. Michael Tuttle, MD

Nicholas Jon Vander Els, MD

Stephen R. Veach, MD

Carolyn Wasserheit, MD

Sidney J. Winawer, MD

Paul Sherlock Chair

Robert E. Wittes, MD

Vincent Astor Chair of Clinical Research

David L. Wuest, MD

Han Xiao, MD

James W. Young, MD

ASSOCIATE ATTENDINGS

Carol Aghajanian, MD

David R. Artz, MD

Juliet Barker, MBBS

Anne R. Bass, MD

Renier J. Brentjens, MD, PhD

Jacqueline F. Bromberg, MD, PhD

Alan C. Carver, MD

Chih-Shan Jason Chen, MD, PhD

Gabriella M. D’Andrea, MD

Gary E. Deng, MD, PhD

Maura N. Dickler, MD

Pamela R. Drullinsky, MD

Alan L. Engelberg, MD

Theodore R. Fields, MD

John J. Fiore, MD

Stephanie A. Fish, MD

Venera Grasso, MD

Audrey M. Hamilton, MD

Hani Hassoun, MD

Mark L. Heaney, MD, PhD

Martee L. Hensley, MD

James Hsieh, MD, PhD

Katharine C. Hsu, MD, PhD

Ann A. Jakubowski, MD, PhD

Michelle N. Johnson, MD

Joseph G. Jurcic, MD

Marcia F. Kalin, MD

Noah D. Kauff, MD

Mary L. Keohan, MD

Jeffrey A. Knauf, PhD

Beatriz Korç-Grodzicki, MD, PhD

Lee M. Krug, MD

Mario E. Lacouture, MD

Sheron Latcha, MD

Jennifer E. Liu, MD

C. Ronald. MacKenzie, MD

Vivek T. Malhotra, MD, MPH

Ashfaq A. Marghoob, MD

Arnold J. Markowitz, MD

Franklin Marsh, Jr., MD

Michael R. McDevitt, PhD

Craig H. Moskowitz, MD

Mary E. Moynahan, MD

Kishwer S. Nehal, MD

Deena J. Nelson, MD

Kenneth K. Ng, MD

Ariela Noy, MD

Eileen M. O’Reilly, MB, BCh, BAO

Genovefa A. Papanicolaou, MD

Rekha Parameswaran, MBBS

Govindaswami Ragupathi, PhD

Milind Rajadhyaksha, PhD

Naiyer A. Rizvi, MD

Mark E. Robson, MD

Paul J. Sabbatini, MD

Mona Sabra, MD

Lisa R. Sammaritano, MD

Mark A. Schattner, MD

Sergio Schwartzman, MD

Susan K. Seo, MD

Susan F. Slovin, MD, PhD

Robert F. Spiera, MD

Richard Stern, MD

Andrew J. VIckers, PhD

Howard Weinstein, MD

Jedd D. Wolchok, MD, PhD

Ann G. Zauber, PhD

Andrew D. Zelenetz, MD, PhD

ASSISTANT ATTENDINGS

Ghassan K. Abou-Alfa, MD

Juliet B. Aizer, MD

Arlyn Apollo, MD

Abraham Aragones, MD

Dalit Ashany, MD

Christopher G. Azzoli, MD

Ethan M. Basch, MD

Katherine M. Bell-McGuinn, MD, PhD

Stefan Berger, MD

Jessica R. Berman, MD

Victoria S. Blinder, MD

Michelle S. Boyar, MD

Richard D. Carvajal, MD

Kathleen N. S. Cathcart, MD

Andrea Cercek, MD

Sarat Chandarlapaty, MD, PhD

Mohit Chawla, MD

Sanjay Chawla, MD

Carol L. Chen, MD

Gabriela Chiosis, PhD

Frederick R. Adler Chair for Junior Faculty

Dana M. Cutzu, MD

David R. D’Adamo, MD, PhD

Chau T. Dang, MD

Jennifer L. DeFazio, MD

Liang Deng, MD, PhD

Madhuri Devabhaktuni, MBBS

Mark A. Dickson, MD

Christopher J. DiMaio, MD

Stephen J. DiMartino, MD, PhD

Barbara C. Egan, MD

Doruk Erkan, MD

Azeez Farooki, MD

Julie Fasano, MD

Marc B. Feinstein, MD

Darren R. Feldman, MD

Monica N. Fornier, MD

Mark G. Frattini, MD, PhD

Matthew G. Fury, MD, PhD

John F. Gerecitano, MD, PhD

Monica Girotra, MD

Ilya G. Glezerman, MD

Jenna Goldberg, MD

Zoe Goldberg, MD

Shari Goldfarb, MD

Stephanie M. Goodman, DO

Susan M. Goodman, MD

Mila Gorsky, MD

Deena M. Atieh Graham, MD

Polly D. Gregor, PhD

Yvona Griffo, MD

Rebecca D. S. Guest, MD

Shellie L. Gumbs, MD

Paul A. Hamlin, MD

Alan Loh Ho, MD, PhD

Steven M. Horwitz, MD

Yelena Y. Janjigian, MD

Robert Jenq, MD

Erik K. Johnson, MD

Anna Kaitsas, MD

Mini Kamboj, MBBS

Rana Kaplan, MD

Amsale Ketema, MD

Magi M. Khalil, MD, PhD

Tomas Kirchhoff, PhD

Kyriakos A. Kirou, MD, DSc

Virginia M. Klimek, MD

Adam D. Klotz, MD

Guenther Koehne, MD, PhD

Jason A. Konner, MD

Nicole Lamanna, MD

Heather J. Landau, MD

Erica H. Lee, MD

Robert P. Lee, MD

Nikoletta Lendvai, MD, PhD

Jenifer C. F. Leng, MD, MPH

Ross Levine, MD

Geoffrey Beene Junior Faculty Chair

Emmy Ludwig, MD

Vicky Makker, MD

Lisa A. Mandl, MD

Debra Mangino, DO

Anna R. Marcelli, MD

Matthew J. Matasar, MD

Eileen P. McAleer, MD

Heather L. McArthur, MD

Charis Fan-Hui Meng, MD

Raymond D. Meng, MD, PhD

Taha Merghoub, PhD

Matthew I. Milowsky, MD

Shanu Modi, MD

Patricia and James Cayne Chair for Junior Faculty

Ana M. Molina, MD

Michael J. Morris, MD

Natalie Moryl, MD

Alison J. Moskowitz, MD

Michelle K. Nowak, MD

Roisin E. O’Cearbhaill, MB, Bch, BAO

Susan A. Oliveria, ScD, MPH

Barbara O’Sullivan, MD

Maria Lia A. P. Palomba, MD

Edward J. Parrish, MD

Miguel-Angel Perales, MD

Maria C. Pietanza, MD

Ian G. Pinto, MBBS

Doris Ponce, MD

Elizabeth A. Quigley, MD

Dragos Rancea, MD

Page 59: innovate - GuideStar

MSKCC 54E2010 ANNUAL REPORT

DEPARTMENTS OF MEMORIAL HOSPITAL

Nina D. Raoof, MD

Dana E. Rathkopf, MD

Diane L. Reidy, MD

Gregory J. Riely, MD, PhD

Todd L. Rosenblat, MD

Marina Rozenberg, MD

Linda A. Russell, MD

Mabel M. Ryder, MD

Cori Salvit, MD

Craig S. Sauter, MD

Wendy L. Schaffer, MD, PhD

Neil H. Segal, MD, PhD

Manish A. Shah, MD

Monika Shah, MD

Marni Sheren-Manoff, MD

Eric J. Sherman, MD

Stephanie Smith-Marrone, MD

David B. Solit, MD

Elizabeth and Felix Rohatyn Chair for Junior Faculty

Philip S. Spencer, MD

Zsofia K. Stadler, MD

Sung Wu Sun, MD

Sohail F. Tavazoie, MD, PhD

William P. Tew, MD

Dharmarao Thapi, PhD

Roma Tickoo, MD. MPH

Emily S. Tonorezos, MD, MPH

Tiffany A. Traina, MD

Tiffany Troso-Sandoval, MD

Lisa C. Vasanth, MD

Adrienne Vincenzino, MD

Louis P. Voigt, MD

Steven Q. Wang, MD

Kathleen M. Wesa, MD

Arthur M. F. Yee, MD, PhD

Diana A. Yens, MD

Joseph P. Yoe, MBBS

Kenneth Ho-Ming Yu, MD

INSTRUCTORS

Amina Abdeldaim, MD

Omar I. Abdel-Wahab, MD

Christina Hafermalz Adaniel, MD

Teimuraz Apridonidze, MD

Daniel Barkan, MD

Samarth Beri, MD

David Chung, MD, PhD

Lisa M. Czanko, MD

Daniel C. Danila, MD

Lauren Elena Ferrante, MD

Kaye E. Hale, MD

Douglas Koo, MD, MPH

Yelena Kopyltsova, MD

Chhavi Kumar, MD

James M. Lebret, MD

Alexander M. Lesokhin, MD

Jyoti Malhotra, MBBS, MPH

Anuj B. Mehta, MD

Devi Navamani, DO

Demetrios N. Panagiotou, MD

Shilen N. Patel, MD

Nelson F. Sanchez, MD

Jonathan H. Schatz, MD

Stacy Marie Stabler, MD, PhD

Ying Taur, MD, MPH

Frank Tsai, MD

George K. Wang, MD, PhD

Gulrukh Z. Zaidi, MBBS

CHAIR AND ATTENDING

Lisa M. DeAngelis, MD

Lillian Rojtman Berkman Chair in Honor of Jerome B. Posner

ATTENDINGS

Ronald G. Blasberg, MD

Robert B. Darnell, MD, PhD

Kathleen M. Foley, MD

The Society of Memorial Sloan-Kettering Cancer Center Chair

Paul A. Glare, MBBS

Eric Holland, MD, PhD

Emily Tow Jackson Chair in Oncology

Gavril W. Pasternak, MD, PhD

Anne Burnett Tandy Chair of Neurology

Jerome B. Posner, MD

American Cancer Society Clinical Research Professor; George C. Cotzias Chair of Neuro-Oncology

Neal Rosen, MD, PhD

Enid A. Haupt Chair in Medical Oncology

Jonathan D. Victor, MD, PhD

ASSOCIATE ATTENDINGS

Alan C. Carver, MD

Xi Chen, MD, PhD

Denise D. Correa, PhD

Adrian Cristian, MD

Ying-Xian Pan, PhD

ASSISTANT ATTENDINGS

Edward K. Avila, DO

Christian M. Custodio, MD

Igor T. Gavrilovic, MD

Yvona Griffo, MD

Adilia M. V. Hormigo, MD, PhD

Thomas Kaley, MD

Yasmin Khakoo, MD

Erik J. Kobylarz, MD, PhD

Andrew B. Lassman, MD

Ingo K. Mellinghoff, MD

Natalie Moryl, MD

Craig P. Nolan, MD

Antonio M. P. Omuro, MD

Sonia K. Sandhu, DO

Jonas M. Sokolof, DO

Michael D. Stubblefield, MD

Roma Tickoo, MD, MPH

Kaleb H. Yohay, MD

INSTRUCTORS

Milan Chheda, MD

Kevin C. De Braganca, MD

DEPARTMENT OF NEUROLOGY

CHAIR AND ATTENDING

Philip H. Gutin, MD

Fred Lebow Chair in Neuro-Oncology

ATTENDINGS

Mark H. Bilsky, MD

Eric C. Holland, MD, PhD

Emily Tow Jackson Chair in Oncology

Samuel H. Selesnick, MD

Philip E. Stieg, MD, PhD

Lorenz P. Studer, MD

ASSOCIATE ATTENDINGS

Michael Kaplitt, MD, PhD

Mark M. Souweidane, MD

Viviane S. Tabar, MD

ASSISTANT ATTENDINGS

Cameron W. Brennan, MD

Jeffrey P. Greenfield, MD, PhD

DEPARTMENT OF NEUROSURGERY

Page 60: innovate - GuideStar

54F MSKCC

DEPARTMENTS OF MEMORIAL HOSPITAL

CHAIR AND ATTENDING

Richard J. O’Reilly, MD

Claire L. Tow Chair in Pediatric Oncology Research

ATTENDINGS

David H. Abramson, MD

Nai-Kong V. Cheung, MD, PhD

Enid A. Haupt Chair in Pediatric Oncology

Patricia J. Giardina, MD

Nancy A. Kernan, MD

Brian H. Kushner, MD

Michael P. La Quaglia, MD

Joseph H. Burchenal Chair in Pediatrics

Paul A. Meyers, MD

Kevin C. Oeffinger, MD

Michel Sadelain, MD, PhD

Stephen and Barbara Friedman Chair

Charles A. Sklar, MD

Laurel J. Steinherz, MD

Peter G. Steinherz, MD

ASSOCIATE ATTENDINGS

Farid Boulad, MD

James B. Bussel, MD

Ira J. Dunkel, MD

Bruce M. Greenwald, MD

Kim Kramer, MD

Shakeel Modak, MBBS

Trudy Nan Small, MD

Tanya M. Trippett, MD

Maria G. Vogiatzi, MD

Leonard H. Wexler, MD

ASSISTANT ATTENDINGS

Abraham Bartell, MD

Naomi B. Bishop, MD

Sheila J. Carroll, MD

Alexander Ja-Ho Chou, MD

Jennifer S. Ford, PhD

Aisha N. Hasan, MBBS

Joy D. Howell, MD

Deyin Doreen Hsing, MD

Rosandra N. Kaplan, MD

Yasmin Khakoo, MD

Martha C. Kutko, MD

David C. Lyden, MD, PhD

Steven Pon, MD

Christine A. Pratilas, MD

Susan E. Prockop, MD

Peter M. C. Savard, MD

Chani Traube, MD

Kaleb H. Yohay, MD

INSTRUCTORS

Ellen M. Basu, MD, PhD

Kevin C. De Braganca, MD

Stephen W. Gilheeney, MD

Julia A. Kearney, MD

Rachel Kobos, MD

Heather Magnan, MD

Pamela Merola, MD

Thomas M. Renaud, MD

Neerav Shukla, MD

DEPARTMENT OF PEDIATRICS

CHAIR AND ATTENDING

Boris C. Bastian, MD, PhD

James Ewing Alumni Chair of Pathology

ATTENDINGS

Klaus J. Busam, MD

Daniel A. Filippa, MD

Meera R. Hameed, MBBS

Suresh C. Jhanwar, PhD

David S. Klimstra, MD

Marc Ladanyi, MD

William J. Ruane Chair in Molecular Oncology

Victor E. Reuter, MD

Marc K. Rosenblum, MD

Founder’s Chair

Robert A. Soslow, MD

Satish K. Tickoo, MD

William D. Travis, MD

Maureen F. Zakowski, MD

ASSOCIATE ATTENDINGS

Cristina Antonescu, MD

Edi Brogi, MD, PhD

Emily Cheng, MD, PhD

Ronald A. Ghossein, MD

Dilip D. Giri, MD

Oscar Lin, MD

André L. Moreira, MD, PhD

Khedoudja Nafa, PhD

Jinru Shia, MD

Lee K. Tan, MD

Julie Teruya-Feldstein, MD

Christina E. Vallejo, MD

ASSISTANT ATTENDINGS

Hikmat A. Al-Ahmadie, MD

Maria E. Arcila, MD

Michael F. Berger, PhD

Yingbei Chen, MD, PhD

Adriana Dionigi Corben, MD

Marcia Edelweiss, MD

Samson W. Fine, MD

Karuna Garg, MBBS

Anuradha Gopalan, MBBS

Cyrus V. Hedvat, MD, PhD

Jason T. Huse, MD, PhD

Nora Katabi, MD

Melissa Murray, DO

Christopher Y. Park, MD, PhD

Kay J. Park, MD

Melissa P. Pulitzer, MD

Natasha Rekhtman, MD, PhD

Laura H. Tang, MD, PhD

Efsevia Vakiani, MD, PhD

Lu Wang, MD, PhD

Yong Hannah Wen, MD, PhD

Liying Zhang, MD, PhD

INSTRUCTORS

Deborah F. DeLair, MD

Carlie Selbo Sigel, MD

DEPARTMENT OF PATHOLOGY

Page 61: innovate - GuideStar

MSKCC 54G2010 ANNUAL REPORT

DEPARTMENTS OF MEMORIAL HOSPITAL

CHAIR AND ATTENDING

David W. Kissane, MBBS

Jimmie C. Holland Chair

ATTENDINGS

Timothy A. Ahles, PhD

Philip A. Bialer, MD

William S. Breitbart, MD

Francesca M. Gany, MD

Jimmie C. Holland, MD

Wayne E. Chapman Chair of Psychiatric Oncology

Marguerite S. Lederberg, MD

Mary Jane Massie, MD

Andrew J. Roth, MD

ASSOCIATE ATTENDINGS

Carma L. Bylund, PhD

Katherine N. DuHamel, PhD

Jennifer L. Hay, PhD

Jamie S. Ostroff, PhD

ASSISTANT ATTENDINGS

Abraham Aragones, MD

Thomas M. Atkinson, PhD

Abraham S. Bartell, MD

Smith Banerjee, PhD

Jack E. Burkhalter, PhD

Jeanne Carter, PhD

Jennifer S. Ford, PhD

Miriam M. Friedlander, MD

Jenifer C. F. Leng, MD

Tomer T. Levin, MBBS

Yuelin Li, PhD

Christian J. Nelson, PhD

James C. Root, PhD

Elizabeth L. Ryan, PhD

INSTRUCTORS

Julia A. Kearney, MD

Wendy G. Lichtenthal, PhD

Taia I. Zaider, PhD

DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES

CHAIR AND ATTENDING

Simon N. Powell, MD, PhD

Enid A. Haupt Chair in Radiation Oncology

ATTENDINGS

David H. Abramson, MD

Adriana Haimovitz-Friedman, PhD

Gloria C. Li, PhD

Beryl McCormick, MD

Karen D. Schupak, MD

Joachim Yahalom, MD

Michael J. Zelefsky, MD

ASSOCIATE ATTENDINGS

Kaled M. Alektiar, MD

Daphna Y. Gelblum, MD

Nancy Lee, MD

Borys R. Mychalczak, MD

Suzanne L. Wolden, MD

Yoshiya Yamada, MD

ASSISTANT ATTENDINGS

Kathryn F. Beal, MD

Karen Borofsky, MD

Timothy A. Chan, MD, PhD

Brett Wayne Cox, MD

Pinaki R. Dutta, MD, PhD

Richard M. Gewanter, MD

Karyn A. Goodman, MD

Alice Yoosun Ho, MD

Marisa A. Kollmeier, MD

James E. Lee, MD

Boris Mueller, MD

Preeti K. Parhar, MD

Shyam S. D. Rao, MD, PhD

Melissa R. Remis, MD

Andreas Rimner, MD

Helen L. Sidebotham, MD

Abraham Jing-Ching Wu, MD

DEPARTMENT OF RADIATION ONCOLOGY

Page 62: innovate - GuideStar

54H MSKCC

DEPARTMENTS OF MEMORIAL HOSPITAL

CHAIR AND ATTENDING

Hedvig Hricak, MD, PhD

Carroll and Milton Petrie Chair

ATTENDINGS

Andrea F. Abramson, MD

Sara J. Abramson, MD

Ariadne M. Bach, MD

Michael S. Baum, MD

Ronald G. Blasberg, MD

Mark J. Bluth, MD

Karen T. Brown, MD

James F. Caravelli, MD

Jorge A. Carrasquillo, MD

Christopher E. Comstock, MD

D. David Dershaw, MD

Yuman Fong, MD

Murray F. Brennan Chair in Surgery

George I. Getrajdman, MD

Robert T. Heelan, MD

Andrei I. Holodny, MD

John L. Humm, PhD

Peter K. Kijewski, PhD

Jason A. Koutcher, MD, PhD

George Krol, MD

Steven M. Larson, MD

Donna and Benjamin M. Rosen Chair in Radiology

Carol H. Lee, MD

Jason S. Lewis, PhD

Laura Liberman, MD

Elizabeth A. Morris, MD

David M. Panicek, MD

Anita P. Friedman Price, MD

Stephen B. Solomon, MD

Richard M. Steingart, MD

H. William Strauss, MD

Jerrold B. Teitcher, MD

Pat B. Zanzonico, PhD

Robert D. Zimmerman, MD

ASSOCIATE ATTENDINGS

Linda R. Aboody, MD

Orguz Akin, MD

Douglas J. Ballon, PhD

Lynn A. Brody, MD

Betty A. Caravella, MD

Anne M. Covey, MD

Otilia-Liana Dumitrescu, MD

Arthur A. Fruauff, MD

Scott R. Gerst, MD

Michelle S. Ginsberg, MD

Marc J. Gollub, MD

Linda A. Heier, MD

Tunç A. Iyriboz, MD

Stefanie S. Jacobs, MD

Maxine S. Jochelson, MD

Karen B. Karlson, MD

Delia M. Keating, MD

Robert A. Lefkowitz, MD

Eric Lis, MD

Michael R. McDevitt, PhD

Sadek Nehmeh, PhD

Neeta Pandit-Taskar, MBBS

Harpreet K. Pannu, MD

Jurgen Rademaker, MD

Heiko Schöder, MD

Marc Z. Simmons, MD

Constantinos T. Sofocleous, MD, PhD

Hilda E. Stambuk, MD

Jean M. Torrisi, MD

Barbara Wajsbrot-Kandel, MD

Corinne B. Winston, MD

Kristen L. Zakian, PhD

Jingbo Zhang, MD

ASSISTANT ATTENDINGS

William Alago, Jr., MD

Michelle S. Bradbury, MD, PhD

Sandra Brennan, MB, BCh, BAO

Sean D. Carlin, PhD

Joshua L. Chaim, DO

Donna D. D’Alessio, MD

Amita Dave, PhD

Kinh Gian Do, MD, PhD

Mark Phillip S. Dunphy, DO

Joseph P. Erinjeri, MD, PhD

Kimberly N. Feigin, MD

Stephen E. Fleming, Jr., MD

Josef J. Fox, MD

James L. Fuqua III, MD

Athanasios P. Glekas, PhD

Ravinder K. Grewal, MD

Jan Grimm, MD, PhD

David H. Gultekin, PhD

Sofia S. Haque, MD

Valos Hatzoglou, MD

Mary C. Hughes, MD

Sinchun Hwang, MD

Sandra Joo, MD

Jennifer B. Kaplan, MD

Sasan Karimi, MD

Seth S. Katz, MD, PhD

Valencia King, MD

Moritz F. Kircher, MD

Yuliya Lakhman, MD

Jonathan Landa, DO

Duan Li, MD

John K. Lyo, MD

Weining Ma, MD

Majid Maybody, MD

Yousef Mazaheri, PhD

Svetlana Mironov, MD

Kyung Peck, PhD

Nagavarakishore Pillarsetty, PhD

Vladimir Ponomarev, MD, PhD

Elmer B. Santos, MD, PhD

Debra M. Sarasohn, MD

Rajesh Pravin Shah, MD

Robert Siegelbaum, MD

Janice S. Sung, MD

Sunitha Bai Thakur, PhD

Raymond H. Thornton, MD

Gary A. Ulaner, MD, PhD

Darren R. Veach, PhD

Robert J. Young, MD

DEPARTMENT OF RADIOLOGY

Page 63: innovate - GuideStar

MSKCC 54I2010 ANNUAL REPORT

DEPARTMENTS OF MEMORIAL HOSPITAL

CHAIR AND ATTENDING

Peter T. Scardino, MD

David H. Koch Chair

DIVISION HEAD AND ATTENDING

Ronald P. DeMatteo, MD

Division of General Surgical Oncology; Leslie H. Blumgart Chair in Surgery

ATTENDINGS

David H. Abramson, MD

Nadeem R. Abu-Rustum, MD

Manjit S. Bains, MD

Neil H. Bander, MD

Richard R. Barakat, MD

Ronald O. Perelman Chair in Gynecologic Surgery

Leslie H. Blumgart, MD

Bernard H. Bochner, MD

Patrick J. Boland, MD

Murray F. Brennan, MD

Benno C. Schmidt Chair in Clinical Oncology

Mercedes Castiel, MD

Dennis S. Chi, MD

Hiram S. Cody, III, MD

Daniel G. Coit, MD

Peter G. Cordeiro, MD

Guido Dalbagni, MD

Joseph J. Disa, MD

S. Machele Donat, MD

Robert J. Downey, MD

James A. Eastham, MD

Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology

Mahmoud El-Tamer, MD

Yuman Fong, MD

Murray F. Brennan Chair in Surgery

Harold P. Freeman, MD

José G. Guillem, MD

John H. Healey, MD

Harry W. Herr, MD

William J. Hoskins, MD

Joseph M. Huryn, DDS

William R. Jarnagin, MD

Enid A. Haupt Chair in Surgery

Maureen Killackey, MD

Dennis H. Kraus, MD

Michael P. La Quaglia, MD

Joseph H. Burchenal Chair in Pediatrics

Hans G. Lilja, MD

Monica Morrow, MD

Anne Burnett Windfohr Chair of Clinical Oncology

John P. Mulhall, MB, BCh, BAO

Raul O. Parra, MD

Philip B. Paty, MD

Valerie W. Rusch, MD

Miner Family Chair in Intrathoracic Cancers

Paul Russo, MD

Virgilio Sacchini, MD

Lisa M. Sclafani, MD

Jatin P. Shah, MD

Elliot W. Strong Chair in Head and Neck Oncology

Ashok R. Shaha, MD

Jatin P. Shah Chair in Head and Neck Surgery and Oncology

Joel Sheinfeld, MD

William G. Cahan Chair in Surgery

Samuel Singer, MD

Pramod C. Sogani, MD

Diane E. Stover, MD

Kimberly J. Van Zee, MD

E. Darracott Vaughan, MD

W. Douglas Wong, MD (deceased 1/20/2011)

ASSOCIATE ATTENDINGS

Peter J. Allen, MD

Edward A. Athanasian, MD

Oheneba Boachie-Adjei, MD

Jay O. Boyle, MD

Mary S. Brady, MD

Carol L. Brown, MD

Deborah M. Capko, MD

Michael D’Angelica, MD

Cherry L. Estilo, DMD

Mary L. Gemignani, MD

Henry G. Godfrey, MD

Deborah J. Goldfrank, MD

Alexandra S. Heerdt, MD

Murk-Hein Heinemann, MD

Noah Kauff, MD

Tari King, MD

Jeanne A. Petrek Junior Faculty Chair

Vincent Laudone, MD

Mario M. Leitao Jr., MD

Douglas A. Levine, MD

Ross T. Lyon, MD

Babak J. Mehrara, MD

Carol D. Morris, MD

Snehal G. Patel, MBBS

Sitaram Pillarisetty, MD

Andrea L. Pusic, MD

Glenn L. Schattman, MD

Bhuvanesh Singh, MD

Yukio Sonoda, MD

Vivian E. Strong, MD

Larissa K. F. Temple, MD

Martin R. Weiser, MD

Richard J. Wong, MD

ASSISTANT ATTENDINGS

Prasad S. Adusumilli, MBBS

Charlotte Eielson Ariyan, MD, PhD

George C. Bohle III, DDS

Jeanne Carter, PhD

Brett S. Carver, MD

Mohit Chawla, MD

Jonathan A. Coleman, MD

Aimee M. Crago, MD, PhD

David J. Finley, MD

Ian Ganly, MB, ChB, PhD

Ginger J. Gardner, MD

Leonard N. Girardi, MD

Allan D. Greenberg, DMD, PhD

Jerry L. Halpern, DDS

James Huang, MD

Elizabeth L. Jewell, MD

John Karwowski, MD

T. Peter Kingham, MD

John P. Lyden, MD

Charles A. Mack III, MD

Debra A. Mangino, DO

Brian P. Marr, MD

Evan Matros, MD

Colleen M. McCarthy, MD

Garrett M. Nash, MD

Nabil Rizk, MD

Jaspreet S. Sandhu, MD

Nitsana A. Spigland, MD

Inderpal Singh Sarkaria, MD

Karim A. Touijer, MD

Steven J. Tunick, DMD

Zhaoshi Zeng, MD, MPH

DEPARTMENT OF SURGERY

Page 64: innovate - GuideStar

54J MSKCC

DEPARTMENTS OF MEMORIAL HOSPITAL

CHAIR AND ATTENDING

Charles L. Sawyers, MD

Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Howard Hughes Medical Institute Investigator

ATTENDINGS

Boris C. Bastian, MD, PhD

James Ewing Alumni Chair of Pathology

James A. Fagin, MD

Marc Ladanyi, MD

William J. Ruane Chair in Molecular Oncology

ASSOCIATE ATTENDING

Emily H. Cheng, MD, PhD

Adriana Heguy, PhD

James Hsieh, MD, PhD

ASSISTANT ATTENDINGS

Cameron Brennan, MD

Timothy A. Chan, MD, PhD

Ross L. Levine, MD

Geoffrey Beene Junior Faculty Chair

Ingo K. Mellinghoff, MD

Christopher Y. Park, MD, PhD

David B. Solit, MD

Elizabeth and Felix Rohatyn Chair for Junior Faculty

HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM

CHIEF NURSING OFFICER

Elizabeth Nelkin McCormick, RN

Enid A. Haupt Chair of Nursing

DIRECTORS

Gay Bailey, RN

Kevin P. Browne, RN

Michelle Burke, RN,

MaryAnn Connor, RN

Mary E. Dowling, RN

Dennis Graham, DNSc, ANP, RN

Nancy Kline, PhD, ANP, CPNP, RN

Josephine Nappi, RN

R. David Rice, PhD, AOCNP, RN

Donna Schick, RN

NURSE LEADERS, MANAGERS, CLINICAL COORDINATORS

Abigail Baldwin, RN

Patricia Brosnan, RN

Jacquelyn Burns, RN

Carole M. Cass, RN

Kristin Cawley, RN

Stacie Corcoran, RN

Karen Cullum, RN

Susan L. Dosil-Loiacono, RN

Mary M. Eagan, RN

Susan Filshie, RN

Jeanine Gordon, RN

Judy M. Graham, RN

Barbara G. Hennessey, RN

Nancy G. Houlihan, RN

Catherine Hydzik, RN

Matthew Kennedy, RN

Stephanie Kennedy, RN

Michele Kranz, RN

Viviane Leveille, RN

Catherine T. Licitra, RN

Sulin Low, RN

Suzanne V. Maier, CPNP, RN

Annmarie Mazzella-Ebstein, RN

Shelley W. McKay, RN

Lorraine K. McEvoy, RN

Patricia A. McTague-Allen, RN

Donna Miale-Mayer, RN

Altagracia I. Mota, RN

Maryellen O’Sullivan, RN

Diane Paolilli, RN

Elizabeth S. Rodriguez, RN

Jane A. Sallustro, RN

Rori Salvaggio, RN

Robert Schley, RN

Anna M. Schloms, RN

Rosemary O. Semler, RN

Lenore Smykowski, RN

Patricia Spellman, RN

Lystra M. Swift, RN

Blanca M. Vasquez-Clarfield, RN

Keri Jean Wagner, RN

Marianne Wallace, RN

Maribeth Wooldridge-King, RN

CLINICAL NURSE SUPERVISORS

Nancy M. Borzain, RN

Marie E. Cox, RN

Barbara K. Hutton, RN

Susan LaBombardi, RN

Christine E. Lantier, RN

Katleen Maher, RN

Esther M. Ruiz, RN

NURSE EDUCATORS

Gretchen A. Copeland, EdD, RN

Kristy Dunleavy, RN

Wendy Facey, RN

Lisa Kennedy, RN

Joan E. McKerrow, RN

Marjorie E. Mosley, RN

Janice R. Reid, RN

Beth Sferrazza, RN

Hrafn Oli Sigurdsson, RN

Shaneka D. Storey, RN

Inderani M. Walia, RN

CLINICAL NURSE SPECIALISTS

Jean Adelhardt, RN

Angela A. Adjetey, RN

Rose Ali, RN

Roberta H. Baron, RN

Lisa Bazos, RN

Beth Marie Boseski, RN

Gloria Coffey, RN

Suzanne Costello, RN

Maureen F. Cunningham, RN

Mary Elizabeth Davis, RN

Nkechi Fearon, RN

AnneMarie Flaherty, RN

Ruth Ford, RN

Michele L. Frank, RN

Elizabeth R. Grahn, RN

Cathyann M. Hanson-Heath, RN

Melanie Harold, RN

Sandra E. James, RN

Noelene A. Johnson, RN

Joyce E. Kane, RN

Nancy Karon, RN

Joanne F. Kelvin, RN

Janine Kennedy, RN

Mary Lakaszawski, RN

Ethel Beeling Law, RN

Beth Dee Licht, RN

Vashti Livingston, RN

Diane M. Llerandi, RN

Nora A. Love, RN

Nancy McEntee, RN

Kim Mertens, RN

Linda Muller, RN

Maureen G. O’Brien, RN

Wayne Alec Quashie, RN

Natasha Ramrup, RN

Debra Rodrigue, RN

Wanda Rodriguez, RN

Patricia Schaindlin, RN

Kathleen Short, RN

Joanne M. Taylor, RN

Elisabeth M. Wall, RN

Eileen M. Walsh, RN

Cecilia Watson, RN

Donna J. Wilson, RN

DEPARTMENT OF NURSING

Page 65: innovate - GuideStar

MSKCC 54K2010 ANNUAL REPORT

DEPARTMENTS OF MEMORIAL HOSPITAL

NURSE PRACTITIONERS, NP COORDINATORS

Megan P. Abate, ANP, RN

Lynn Adams, ANP, RN

Linda Ahn, ANP, RN

Karen V. Allison, CPNP, RN

Lorraine E. Anderson, ANP, RN

Latasha Anderson-Dunkley, ANP, RN

Ramadevi Arcot, ANP, RN

Laurie Augello, AHNP,RN

Nadine Auguste, ACNP, RN

Jennifer Aviado-Langer, FNP, RN

Cheryl D. Barnes, FNP ,RN

Rana Bazzi, ACNP, RN

Alison Berkowitz, ANP, RN

Kimberly A. Berry, ANP, RN

Margaret H. Boelke, FNP, RN

Ayelet Brenner, NP, RN

Devika Brijlall, PNP, RN

Laurie Brusco, ANP, RN

Tara Buchholz, ACNP, RN

Bernice E. Burford, ANP, RN

Regina Byrne, ANP, RN

Maura E. Byrnes-Casey, CPNP, RN

Maureen Caban, ANP, RN

Joanne Lee Candela, ANP, RN

Lisa Canecchia, NP, RN

Maria Elena C. Cantos, ANP, ACNP, RN

Maryann Carousso, FNP, AOCNP, RN

Erin K. Carr, FNP, RN

Anne Regan Casson, CPNP, RN

Kristen Cavanaugh, NP, RN

Mei Ling Chan, NP, RN

Ewa Chauvin, ANP, RN

Cynthia Ciaschi, NP, RN

Laura Ciavolino, ANP, RN

Jennifer Ciminiello. ANP, RN

Keith A. Clement, ANP, RN

Twilight Cofield, ACNP, RN

Kimberly Colantuono, ANP, RN

Nancy Collado, ANP, RN

Mercedes M. Condy, ANP, RN

Erin Ann Conlon, FNP, RN

Catherine Copeland, ACNP, RN

Lenny Coraci, ANP, RN

Rosemarie Corless, CPNP, RN

Zana Correa, ANP, RN

Marissa Corti, ANP, RN

Alison Costalas, ACNP, RN

Margaret Courtney, AOCNP, RN

Nessa M. Coyle, ANP, RN

Joanne Cregg, ANP, RN

Catherine C. Cruz, ANP, RN

Bernadette M. Cuello, ANP, RN

Kristen M. Cullen, AOCNP, RN

Laryn M. Cullen, NP, RN

Rhonda D’Agostino, ACNP, RN

Rebecca G. D’Amore, CPNP, RN

Linda D’Andrea, PNP, RN

Ester C. Dantis, PNP, RN

Dorothea A. Dashiell, CPNP, RN

Denise Dasti, ANP, RN

Deeann M. Davidson, ACNP, RN

Anthony De La Cruz, ANP, RN

Jenny Delaleu, FNP, RN

Susan Derby, GNP, RN

Amy Rose Devigne, FNP, RN

Kleoniki Diamantis, FNP, RN

Deborah Diotallevi, CPNP, RN

Stephanie Dlugacz, ACNP, RN

Maria Donzelli, CPNP, RN

Melissa P. Doyle, CPNP, RN

Lauren Drysdale, ANP, RN

Jane M. Duffy-Weisser, ANP, RN

Megan Dunne, ANP, RN

Christina Durney, CPNP, RN

Nancy E. Edmonds, ANP, RN

Carlene Edwards, FNP, RN

Catherine Ellenberger, ANP, RN

Glenda Espinosa, ANP, RN

Julie Ewy, CPNP, RN

Catherine Ann Featherstone, FNP, RN

Zulay E. Fernandez, ANP, RN

Christine Ferrari, ANP, RN

Cheryl M. Fischer, CPNP, RN

Cristy B. Fitzpatrick, ANP, RN

Deborah A. Fleischer, ACNP, RN

Idania Flete-Olmeda, ANP, RN

Jennifer A. Flood, ANP, RN

Karen A. Flynn, ACNP, RN

Anjelina M. Forbes, CPNP, RN

Crystal Freise, NP, RN

Erin Fusco, FNP, RN

Patricia Gabriel, ANP, RN

Ruth Gargan-Klinger, ANP, RN

Alison Gilgan, FNP, RN

Maryanne M. Giuliante, ANP, RN

Winsome L. Grant, WHCNP, RN

Randolph E. Gross, WHCNP, RN

Michelle Hall, ANP, RN

Elizabeth F. Halton, ANP, RN

Joan M. Hartnett, ANP, RN

Kate Healy, ACNP, RN

Courtney E. Hennelly, FNP, RN

Evlyn L. Hinds, FNP, RN

Maria Hinton, ANP, RN

Ashley Hole, FNP, RN

Karen E. Holritz, ANP, RN

Mi Young Hong, NP, RN

Aletha R. Huckins, FNP, RN

Solange D. Inglis, ANP, RN

Christine Scura Iovino, FNP, RN

Lorraine Jackson, ACNP, RN

Mindy Jaffe, CPNP, RN

Laura A. James, ANP, RN

Jeanine Jerro-Doody, ANP, RN

Latisha A. Jones, ANP, RN

Stacey L. Kaufman, ANP, RN

Sheila Keaveney, ANP, RN

Kathleen J. Keenan, ANP, RN

Elizabeth Kelliher, ANP, GNP, RN

Paulette M. Kelly, FNP, RN

Sheila A. Kenny, FNP, RN

Denise M. Kessel, ANP, RN

Karen Kestenbaum, ANP, RN

Kathleen Kilroy, NP, RN

Jean M. Korycki, CPNP, RN

Nicole Kowalewski, NP, RN

David R. Kraft, ANP, RN

Lauren Kushner, PNP, RN

Kenny M. Lacossiere, ANP, RN

Liza Lee Lagdamen, NP, RN

Patricia Lakin, WHCNP, RN

Mary Layman-Goldstein, ANP, RN

Alexis Leitenberger, NP, RN

Angela Lentini-Rivera, CPNP, RN

Nicole R. Leonhart, ANP, RN

Nicole LeStrange, ANP, RN

Erica G. Levinson, ANP, RN

Isobel M. Lewis, FNP, RN

Christine A. Liebertz, ANP, RN

Yi-Chih Lin, CPNP, RN

Camille L. Lineberry, ACNP, RN

Chhiu-Mei Liu, ANP, RN

Marie-Helene Lofland, ANP, RN

Amy E. Logue, GNP, RN

Helen M. Loumeau, ANP, RN

Andria D. Lyn, ACNP, RN

Peggy Lynch, ANP, RN

Noelia Maamouri, ACNP, RN

Kelly M. Magee, FNP, RN

Jibran Majeed, NP, RN

Jennifer L. Maloney, NP, RN

Melissa A. Manning, ACNP, RN

Denise Margiotta, NP, RN

Marie Kathlyn Marte, ANP, RN

Andrea Martelli, FNP, RN

Leslie V. Matthews, ANP, RN

Shirley Mauzoul, ANP, RN

Susan McCall, NP, RN

Emily J. McCullagh, FNP, RN

Christine McGrade, ANP, RN

Kateri McGuire, CPNP, RN

Julie Ellen Mcmahon, CPNP, RN

Julianne McNamara, FNP, RN

Margaret McSweeney, ACNP, RN

Carol Ann Milazzo-Kiedaisch, FNP, RN

Aida Milcetic, FNP, RN

Mary Montefusco, ACNP, RN

Joanna J. Moulton, CPNP, RN

Kara Ann Muhr, ANP, RN

Yvette Murillo, FNP, RN

Eibhlis Murray, FNP, RN

Joseph B. Narus, GNP, RN

Rachel O. Nebab, ACNP, RN

Katherine G. O’Connor, ANP, RN

MaryAnn P. O’Connor, FNP, RN

Shannon O’Keefe, NP, RN

Marykate O’Rourke, ACNP, RN

Kristen Ohagan, ANP, APRN, RN

Robert U. Okolie, NP, RN

Claudia M. Ortiz, WHNP, RN

Rosemary Ortiz, FNP, RN

Maria Pacis, ANP, RN

Brima Padlan, ANP, RN

Meighan Palazzo, NP, RN

Lauren Panico, NP, RN

Alichia L. Paton, ACNP, RN

Purnima Persaud, NP, RN

Mary C. Petriccione, CPNP, RN

Sandra D. Pezzulli, AOCNP, RN

Bobbi Pino-y-Torres, ANP, RN

Mary Plakovic, FNP, RN

Joan M. Pope, ANP, RN

Paula Portelli, NP, RN

Elaine M. Pottenger, CPNP, RN

Nana Prempeh-Kete Ku, ANP, RN

Erin Punturieri, ANP, RN

Avery Putterman, CPNP, RN

Hilda Quintanilla, ANP, AOCNP, RN

Robin Rawlins-Duell, ANP, RN

Sarah Rebal, NP, RN

Tara A. Reilly, ACNP, RN

Rebecca W. Repetti, ANP, RN

Page 66: innovate - GuideStar

54L MSKCC

DEPARTMENTS OF MEMORIAL HOSPITAL

Martha Rodriguez, ANP, RN

Carol Rossetto, CPNP, RN

Rose Ann Ruddy, ACNP, RN

Mary Rudzewick, ANP, RN

Julianne Ruggiero, CPNP, RN

Tara Russo, FNP, RN

Erin Ryan, NP, RN

Lina Saab, FNP, RN

Joseph Santarpia, NP, RN

Anita Schabel, FNP, RN

Mary A. Schoen, ANP, RN

Sharlene Seecharran, ANP, RN

Jody Selzer, FNP, RN

Yelena Shames, ACNP, RN

Rosanne Sharp, ANP, RN

Caroline Shirzadi, NP, RN

Ana Sjoberg, ANP, RN

Zeta Smikle-Hamilton, ANP, RN

Tammy Son, ACNP, RN

Celeste M. Springer, ANP, RN

Rebecca Steed, WHCNP, RN

Christine Stefanski, FNP, RN

Deborah E. Stein, NP, RN

Rebecca Sturm, NP, RN

Dyana K. Sumner, CRNP, RN

Miho Suzuki, NP, RN

Yekaterina D. Tayban, ACNP, RN

Jennifer Tempesta, NP, RN

Janice Terlizzi, NP, RN

Ursula McPeak Tomlinson, CPNP, RN

Joanne E. Torok-Castanza, CPNP, RN

Kathleen A. Trotta, ANP, RN

Roseann Tucci, CPNP, RN

Leslie Tyson, ANP, RN

Jennifer Valdellon, NP, RN

Jill M. Vanak, ACNP, RN

Nelly Vega-Woo, NP, RN

Stephanie Vitolano, CPNP, RN

Kelly Vuksanaj, ANP, RN

Emily R. Walsh, FNP, RN

Christine D. Waters-Clayton, FNP, RN

Richard Weiner, ANP, RN

Joanne M. Wells, ANP, RN

Elizabeth H. Whittam, FNP, RN

Kerry Williams, ANP, RN

Gloria Y. Wong, ACNP, RN

Christina M. Wray-Asaro, ACNP, RN

Fengxin Wu, ACNP, RN

Jane Yoffe, FNP, RN

Joanna Yohannes-Tomicich, NP, RN

Heidi M. Yulico, GNP, RN

Nicole Zakak, CPNP, RN

Joan M. Zatcky, ACNP, RN

Rebecca Zeuren, ANP, RN

DIRECTOR

Charles D. Lucarelli, RPh

ASSOCIATE DIRECTORS

Stella Lee Eng, RPh

Scott Freeswick, RPh

Raymond J. Muller, RPh

Priti Patel, RPh

SUPERVISORS

Jerry Chow, RPh

Jacqueline Gomes, RPh

Susan Murillo, RPh

Donald Murphy, RPh

Gerald O’Neill, RPh

Marie Ryan, RPh

Faina Shenderov, RPh

Dolores Sleiman, RPh

John Timoney, RPh

Jodi Wald, RPh

Elaine Yam, RPh

Karen Yeung, RPh

CLINICAL MANAGERS

Nelly Adel, RPh

David Gregornik, RPh

CLINICAL COORDINATORS

Stern Bereth, RPh

Manpreet Boparai, RPh

Amelia Chan, RPh

Florina Chuy, RPh

Douglas Deritis, RPh

Joseph Galgano, RPh

Dennis Grossano, RPh

Peter Ho, RPh

Ellie Kashani-Massoumi, RPh

Michael Kellick, RPh

Mark Klang, RPh

Caroline Lau, RPh

Melissa Lee-Teh, RPh

Diane Leone, RPh

Donna McGuffy, RPh

Vivian Park, RPh

Barbara Simon, RPh

Pofan Sin, RPh

Gregory Stelzer, RPh

James Sumka, RPh

Frank Surita, RPh

Edward Tyler, RPh

Frank Zappa, RPh

Anthony Zinga, RPh

CLINICAL SPECIALISTS

Nina Cohen, RPh

Stephen Harnicar, RPh

Sherry Mathew, RPh

Jeanna Miller, RPh

Russell Moore, RPh

Alia Paskovaty, RPh

Melissa Pozotrigo, RPh

Richard Tizon, RPh

Bhatt Valkal, RPh

Daniel Van Meter, RPh

DIVISION OF PHARMACY SERVICES

DIRECTOR

Jane Bowling, DSW, LCSW

SOCIAL WORK SENIOR STAFF

Diane Iannuzzi, LCSW

Rosalind Kleban, LCSW

Anne Martin, PhD, LCSW

POST-TREATMENT RESOURCE PROGRAM

Penny Damaskos, LCSW

DIVISION OF SOCIAL WORK

Page 67: innovate - GuideStar

MSKCC 54M2010 ANNUAL REPORT

PROGRAMS OF THE SLOAN-KETTERING INSTITUTE

DIRECTOR

Thomas J. Kelly, MD, PhD

Benno C. Schmidt Chair of Cancer Research

James P. Allison, PhD

Kathryn V. Anderson, PhD

Eric M. Cottington, PhD

John R. Gunn

Alan Hall, PhD

Kenneth J. Marians, PhD

Joan Massagué, PhD

Nikola P. Pavletich, PhD

Chris Sander, PhD

David A. Scheinberg, MD, PhD

Craig B. Thompson, MD (ex officio)

STEERING COMMITTEE

CHAIR AND MEMBER

Joan Massagué, PhD

Alfred P. Sloan Chair; Howard Hughes Medical Institute Investigator

MEMBERS

Robert Benezra, PhD

Eric C. Holland, MD, PhD

Emily Tow Jackson Chair in Oncology

Craig B. Thompson, MD

ASSOCIATE MEMBER

Johanna A. Joyce, PhD

Geoffrey Beene Junior Faculty Chair

ASSISTANT MEMBERS

Robert J. Klein, PhD

Christine Mayr, MD, PhD

Andrea Ventura, MD, PhD

Geoffrey Beene Junior Faculty Chair

Hans G. Wendel, MD

Professional Support Staff

LABORATORY MEMBERS

Neil S. Lipman, VMD

Felix R. Wolf, DVM, PhD

ASSOCIATE LABORATORY MEMBERS

Linda K. Johnson, DVM

Andrew C. Nicholson, DVM, PhD

ASSISTANT LABORATORY MEMBERS

Paula Paula C. Ezell, DVM

Christine Lieggi, DVM

Sebastien Monette, DVM

Rodolfo J. Ricart-Arbona, DVM

JOINT APPOINTMENT

Kenneth Offit, MD

CANCER BIOLOGY AND GENETICS PROGRAM

CHAIR AND MEMBER

Alan Hall, PhD

Alfred P. Sloan Chair

MEMBERS

Raju S.K. Chaganti, PhD

William E. Snee Chair

Filippo G. Giancotti, MD, PhD

Paul A. Marks, MD

Malcolm A. S. Moore, DPhil

Enid A. Haupt Chair of Cell Biology

Marilyn D. Resh, PhD

Urs Rutishauser, PhD

ASSOCIATE MEMBER

Xuejun Jiang, PhD

ASSISTANT MEMBERS

Cole M. Haynes, PhD

Jidong Liu, PhD

Philipp M. Niethammer, PhD

Michael H. Overholtzer, PhD

Meng-Fu Bryan Tsou, PhD

Professional Support Staff

ASSOCIATE LABORATORY MEMBER

Margaret A. Leversha, PhD

At The Rockefeller University

ASSISTANT MEMBER (AFFILIATE)

Hironori Funabiki, PhD

At Weill Cornell Medical College

MEMBER (AFFILIATE)

Timothy A. Ryan, PhD

CELL BIOLOGY PROGRAM

CHAIR AND MEMBER

Chris Sander, PhD

Tri-Institutional Professor

ASSISTANT MEMBERS

Gregoire Altan-Bonnet, PhD

Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair

Christina S. Leslie, PhD

Joao de Bivar Xavier, PhD

Professional Support Staff

LABORATORY MEMBER

Alex E. Lash, MD

ASSOCIATE LABORATORY MEMBERS

Nicholas D. Socci, PhD

ASSISTANT LABORATORY MEMBERS

Raya Khanin, PhD

At Weill Cornell Medical College

MEMBER (AFFILIATE)

Harel Weinstein, DSc

COMPUTATIONAL BIOLOGY PROGRAM

Page 68: innovate - GuideStar

54N MSKCC

PROGRAMS OF THE SLOAN-KETTERING INSTITUTE

CHAIR AND MEMBER

Kathryn V. Anderson, PhD

Enid A. Haupt Chair in Developmental Biology

MEMBERS

Mary K. Baylies, PhD

Peter Besmer, PhD

Maria Jasin, PhD

William E. Snee Chair

Alexandra L. Joyner, PhD

Courtney Steel Chair in Pediatric Cancer Research

Elizabeth H. Lacy, PhD

Lorenz P. Studer, MD

ASSOCIATE MEMBERS

Anna-Katerina Hadjantonakis, PhD

Eric C. Lai, PhD

Jennifer A. Zallen, PhD

Howard Hughes Medical Institute Early Career Scientist

ASSISTANT MEMBERS

Zhirong Bao, PhD

Mary G. Goll, PhD

Danwie Huangfu, PhD

Julia A. Kaltschmidt, PhD

Song-Hai Shi, PhD

Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair

Professional Support Staff

LABORATORY MEMBERS

Katia O. Manova-Todorova, PhD

Willie H. Mark, PhD

ASSISTANT LABORATORY MEMBER

Mark J. Tomishima, PhD

Frank A. Howard Scholar

Nicholas Tolwinski, PhD

DEVELOPMENTAL BIOLOGY PROGRAM

CHAIR AND MEMBER

James P. Allison, PhD

David H. Koch Chair in Immunologic Studies; Howard Hughes Medical Institute Investigator

MEMBERS

Bo Dupont, MD, DSc

Michael S. Glickman, MD

Ulrich G. Hämmerling, PhD

Alan N. Houghton, MD

Virginia and Daniel K. Ludwig Clinical Chair

Herbert F. Oettgen, MD

Lloyd J. Old, MD

William E. Snee Chair of Cancer Immunology; Director, New York Branch, Ludwig Institute for Cancer Research

Richard J. O’Reilly, MD

Claire L. Tow Chair in Pediatric Oncology Research

Eric G. Pamer, MD

Enid A. Haupt Chair in Clinical Investigation

Alexander Y. Rudensky, PhD

Marcel R. M. van den Brink, MD, PhD

Alan N. Houghton Chair

ASSOCIATE MEMBERS

Lisa K. Denzin, PhD

Derek B. Sant’Angelo, PhD

ASSISTANT MEMBERS

Jayanta Chaudhuri, PhD

Frederick R. Adler Chair for Junior Faculty

Morgan Huse, PhD

Ming Li, PhD

Joseph C. Sun, PhD

Professional Support Staff

LABORATORY MEMBER

Tulia Lindsten, MD, PhD

ASSOCIATE LABORATORY MEMBERS

P. Jan Hendrikx, PhD

Frances Weis-Garcia, PhD

ASSISTANT LABORATORY MEMBERS

Annamalai Selvakumar, PhD

Jianda Yuan, MD, PhD

Joint Appointments

Ronald P. DeMatteo, MD

Leslie H. Blumgart Chair in Surgery

Katharine C. Hsu, MD, PhD

Jedd D. Wolchok, MD, PhD

James W. Young, MD

IMMUNOLOGY PROGRAM

CHAIR AND MEMBER

Kenneth J. Marians, PhD

William E. Snee Chair

MEMBERS

Jerard Hurwitz, PhD

Scott N. Keeney, PhD

Howard Hughes Medical Institute Investigator

Thomas J. Kelly, MD, PhD

Benno C. Schmidt Chair of Cancer Research

Andrew Koff, PhD

John H. J. Petrini, PhD

Paul A. Marks Chair in Molecular Cell Biology

Mark S. Ptashne, PhD

Virginia and Daniel K. Ludwig Chair

Stewart Shuman, MD, PhD

Simon H. Rifkind Chair

Paul Tempst, PhD

ASSOCIATE MEMBER

Prasad V. Jallepalli, MD, PhD

ASSISTANT MEMBERS

Dirk Remus, PhD

Iestyn Whitehouse, PhD

Xiaolan Zhao, PhD

Professional Support Staff

LABORATORY MEMBERS

Hediye Erdjument Bromage, PhD

Agnès Viale, PhD

ASSOCIATE LABORATORY MEMBER

Ricardo Toledo-Crow, PhD

ASSISTANT LABORATORY MEMBER

Mariana M. Yaneva, PhD

At The Rockefeller University

MEMBER (AFFILIATE)

C. David Allis, PhD

Joint Appointment

Simon N. Powell, MD, PhD

Enid A. Haupt Chair in Radiation Oncology

MOLECULAR BIOLOGY PROGRAM

Page 69: innovate - GuideStar

MSKCC 54O2010 ANNUAL REPORT

PROGRAMS OF THE SLOAN-KETTERING INSTITUTE

CHAIR AND MEMBER

David A. Scheinberg, MD, PhD

Vincent Astor Chair

MEMBERS

Colin B. Begg, PhD

Eugene W. Kettering Chair

Ronald G. Blasberg, MD

Murray F. Brennan, MD

Benno C. Schmidt Chair in Clinical Oncology

Bayard D. Clarkson, MD

Enid A. Haupt Chair of Therapeutic Research

Samuel J. Danishefsky, PhD

Eugene W. Kettering Chair

Zvi Fuks, MD

Alfred P. Sloan Chair

David Y. Gin, PhD (deceased 3/21/2011)

Hedvig Hricak, MD, PhD

Carroll and Milton Petrie Chair

Richard N. Kolesnick, MD

Steven M. Larson, MD

Donna and Benjamin M. Rosen Chair in Radiology

C. Clifton Ling, PhD

Stephen D. Nimer, MD

Alfred P. Sloan Chair

Gavril W. Pasternak, MD, PhD

Anne Burnett Tandy Chair of Neurology

Jerome B. Posner, MD

American Cancer Society Clinical Research Professor; George C. Cotzias Chair of Neuro-Oncology

Neal Rosen, MD, PhD

Enid A. Haupt Chair in Medical Oncology

Michel Sadelain, MD, PhD

Stephen and Barbara Friedman Chair

Peter T. Scardino, MD

David H. Koch Chair

ASSOCIATE MEMBERS

Yueming Li, PhD

Derek S. Tan, PhD

ASSISTANT MEMBERS

Luca Cartegni, PhD

Gabriela Chiosis, PhD

Jan Grimm, MD, PhD

Minkui Luo, PhD

Professional Support Staff

LABORATORY MEMBERS

Ting-Chao Chou, PhD

Hakim Djaballah, PhD

Isabelle Rivière, PhD

ASSOCIATE LABORATORY MEMBERS

Elisa de Stanchina, PhD

Ouathek Ouerfelli, PhD

George D. Sukenick, PhD

Nian Wu, PhD

ASSISTANT LABORATORY MEMBERS

Christophe Antczak, PhD

Ying-Xian Pan, PhD

Maria K. Spassova, PhD

At Cornell University

ASSISTANT MEMBER (AFFILIATE)

Hening Lin, PhD

At The Rockefeller University

ASSISTANT MEMBER (AFFILIATE)

Sean Brady, PhD

Joint Appointments

Renier J. Brentjens, MD, PhD

Jason A. Koutcher, MD, PhD

Jason S. Lewis, PhD

MOLECULAR PHARMACOLOGY AND CHEMISTRY PROGRAM

CHAIR AND MEMBER

Nikola P. Pavletich, PhD

Stephen and Barbara Friedman Chair; Howard Hughes Medical Institute Investigator

MEMBERS

Jonathan D. Goldberg, PhD

Stephen and Barbara Friedman Chair; Howard Hughes Medical Institute Investigator

Christopher D. Lima, PhD

Dimitar B. Nikolov, PhD

Dinshaw Patel, PhD

Abby Rockefeller Mauzé Chair of Experimental Therapeutics

ASSISTANT MEMBERS

Stephen B. Long, PhD

Alexandros Pertsinidis, PhD

Professional Support Staff

ASSOCIATE LABORATORY MEMBERS

Yehuda Goldgur, PhD

David M. Zuckerman, BSEE

STRUCTURAL BIOLOGY PROGRAM

Page 70: innovate - GuideStar

54P MSKCC

MEMBERS EMERITIMEMORIAL SLOAN-KETTERING CANCER CENTER

Lowell L. Anderson, PhD

Donald Armstrong, MD

June L. Biedler, PhD

Ronald A. Castellino, MD

E. Eugene Covington, MD

Thomas J. Fahey, Jr, MD

Joseph H. Galicich, Jr., MD

Robert B. Golbey, MD

Susan E. Krown, MD

Walter B. Jones, MD

John L. Lewis, Jr., MD

Philip H. Lieberman, MD

Kenneth O. Lloyd, PhD

Klaus Mayer, MD

Myron R. Melamed, MD

W. P. Laird Myers, MD

Manuel Ochoa Jr., MD

Stuart H. Q. Quan, MD

Richard A. Rifkind, MD

Lawrence N. Rothenberg, PhD

F. Kingsley Sanders, DPhil

Morton K. Schwartz, PhD

Maurice E. Shils, MD, ScD

Francis M. Sirotnak, PhD

Martin Sonenberg, MD, PhD

Maus W. Stearns, MD

Stephen S. Sternberg, MD

C. Chester Stock, PhD

Elliot W. Strong, MD

Osias Stutman, MD

Alan D. Turnbull, MD

Norma Wollner, MD

James M. Woodruff, MD

Samuel D. J. Yeh, MD, ScD

Page 71: innovate - GuideStar

MSKCC 552010 ANNUAL REPORT

LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES MEMORIAL SLOAN-KETTERING CANCER CENTER

SLOAN-KETTERING DIVISIONWEILL CORNELL GRADUATE SCHOOL OF MEDICAL SCIENCES

Chairman of the BoardLouis V. Gerstner, Jr.

President Craig B. Thompson, MD

Provost Thomas J. Kelly, MD, PhD

Treasurer John R. Gunn

DeanKenneth J. Marians, PhD

Assistant TreasurerMichael P. Gutnick

Secretary Carolyn Bonheur (through April 2011)

Trustees Richard I. BeattieRichard N. FosterStephen Friedman Ellen V. Futter

Louis V. Gerstner, Jr.Jonathan N. GrayerDavid H. KochHutham S. Olayan

Benjamin M. RosenNorman C. SelbyCraig B. Thompson, MDDouglas A. Warner III

DirectorThomas J. Kelly, MD, PhD

Director, Graduate StudiesKenneth J. Marians, PhD

Graduate ProgramCo-Chairs

Biochemistry and Structural Biology Unit Nikola P. Pavletich, PhD

Molecular Biology UnitStewart Shuman, MD, PhD

Cell Biology and Genetics UnitAlan Hall, PhD

Pharmacology UnitDavid A. Scheinberg, MD, PhD

Immunology and Microbial Pathogenesis UnitJames P. Allison, PhD

Page 72: innovate - GuideStar

56 MSKCC

For the second year in a row, the Center received more than one million gifts, with the total of 1,022,400 donations in 2010 marking an all-time high. Reflecting the ongoing generosity of its supporters, Memorial Sloan-Kettering recorded $208,719,583 in cash receipts during the course of the year. And, at a time when the Center underwent a transition in leadership that culminated in the appointment of Craig B. Thompson as President and CEO, the Campaign benefited enormously from the steady guidance of its co-chairs, Douglas A. Warner III and Louis V. Gerstner, Jr.

Of the many gifts received during the year, the following exemplified the commit-ment to making a difference that is shared by all Memorial Sloan-Kettering’s donors:

• A contribution of $5 million from the Peserga International Foundation will provide timely support for advanced research into cancer.

• Charlotte and William E. Ford III made a commitment of $5 million to create the Theresa Feng Initiative in the Brain Tumor Center, including the endowment

of the Theresa Feng Professorship in Neurosurgery.

• The Commonwealth Foundation for Cancer Research is providing an addi-tional $5 million on behalf of Alice and William H. Goodwin, Jr., to support special initiatives in the Experimental Therapeutics Center. The gift brings the Foundation’s total giving for the ETC to $45 million.

• A gift of more than $3.5 million from the Trust of Philip R. Mallory is being used to establish The Mildred Courtney Mallory Fund for Cancer Research.

• New contributions totaling $3.5 million from Board member David H. Koch bring his total giving during the Campaign to more than $52 million. Among the initiatives established through his support are the David H. Koch Center for the Immunologic Control of Cancer and the David H. Koch Chair.

Memorial Sloan-Kettering also benefited enormously from the dedication of volun-teers who took part in athletic events and community fundraising activities to support

innovation in research and treatment. On November 7, the 2010 ING New York City Marathon brought out thousands of athletes, including 725 who ran on behalf of the Center as members of Fred’s Team. Through their participation in that marathon and other events during the course of the year, Fred’s Team members generated $4.5 million for an array of research initiatives — the highest one-year total in the history of the program.

Some 4,500 people participated in the most recent Cycle for Survival indoor cycling events, raising a total of $4.6 million to support research into rare cancers at Memorial Sloan-Kettering. Since its founding in 2007, Cycle for Survival has grown to include high-profile gatherings in New York City and Chicago, and on Long Island, with satellite teams joining in from as far away as London and Hong Kong.

At every level of support, the generosity shown by Memorial Sloan-Kettering’s bene-factors serves to fuel the latest advances in understanding and treating cancer. Their gifts, both large and small, offer a source of immedi-ate encouragement while laying the groundwork for even greater progress in years to come.

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

(Top) Emily Dodd and Peggy Conlon run the ING New York City Marathon with Fred’s Team

(Bottom) A New York City Cycle for Survival event

The Campaign for Memorial Sloan-Kettering continued to make steady progress in 2010, with gifts and pledges as of December 31 totaling more than $2.224 billion.

Page 73: innovate - GuideStar

MSKCC 56A2010 ANNUAL REPORT

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

$100,000,000 or More

The Estate of Geoffrey Beene

Mortimer B. Zuckerman

$50,000,000 — $99,999,999

David H. Koch

The Leonard and Evelyn Lauder Foundation

Virginia and D. K. Ludwig Fund for Cancer Research

The Starr Foundation

$25,000,000 — $49,999,999

The Atlantic Philanthropies

Mr. and Mrs. Jack Byrne

The Louis V. Gerstner, Jr. Foundation, Inc.

Mr. and Mrs. William H. Goodwin, Jr., and the Commonwealth Foundation for Cancer Research

The Sidney Kimmel Foundation

The Tow Foundation

$20,000,000 — $24,999,999

Anonymous

Stanley F. and Fiona Druckenmiller

$10,000,000 — $19,999,999

Trust of Burton Abrams

The Elmer and Mamdouha Bobst Foundation

The Breast Cancer Research Foundation

The Stephen and Barbara Friedman Foundation

The Arnold and Arlene Goldstein Family Foundation

The Donald B. and Catherine C. Marron Foundation

Prostate Cancer Foundation

Robertson Foundation

Laurance S. Rockefeller

Robert F. X. Sillerman and Laura Baudo Sillerman through their Tomorrow Foundation

The Simons Foundation

Mr. and Mrs. Douglas A. Warner III

$5,000,000 — $9,999,999

Anonymous

Bristol-Myers Squibb Company

The Carson Family Charitable Trust

The Steven A. and Alexandra M. Cohen Foundation, Inc.

Charlotte and Bill Ford III

Mr. and Mrs. Frederic B. Garonzik

Mr. and Mrs. Philip H. Geier, Jr.

Alan and Sandra Gerry

Estate of Sherlock Hibbs

The Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation

Trust of L. H. P. Klotz

John W. Kluge

The Lebensfeld Foundation

Estate of Tse Kyung Lee

Martin S. and Sheila Major and Family

The Robert and Kate Niehaus Foundation

Peserga International Foundation

Mr. and Mrs. John S. Reed

Laurance S. Rockefeller Fund

Dorothy Rose and Dr. Milton Rose

Donna and Benjamin Rosen

Allan H. Selig

The Peter Jay Sharp Foundation

Mr. and Mrs. Richard Siegal

The Society of MSKCC Thrift Shop

Estate of Margaret McCormack Sokol

The William and Lynda Steere Foundation

Stop & Shop Supermarket Company, Inc.

UBS

Sue and Edgar Wachenheim III

Michael A. and Zena Wiener

$2,500,000 — $4,999,999

Anonymous

Mr. and Mrs. Bruce Adam

The Allbritton Foundation

Bethany Allen

Lance Armstrong Foundation

Estate of Eleanor Backer

Band of Parents Foundation

The Arthur & Rochelle Belfer Foundation

Estate of Lillian R. Berkman

The James E. and Diane W. Burke Foundation, Inc.

Mrs. D. Wayne Calloway

Iris and B. Gerald Cantor Foundation

The Kristen Ann Carr Fund

James D. Carter

The Irma L. and Abram S. Croll Charitable Trust

Estate of Elizabeth M. Frelinghuysen

Estate of Francis Gonzalez

Mr. and Mrs. Jonathan N. Grayer

William Randolph Hearst Foundations

Estate of Irma A. Howard

ICAP

W. M. Keck Foundation

Estate of Martin C. Kessler

F. M. Kirby Foundation, Inc.

Susan G. Komen for the Cure

Henry and Marie-Josée Kravis

The Lymphoma Foundation

The Leon Lowenstein Foundation, Inc., and Robert and John Bendheim

Trust of Philip R. Mallory

The T. J. Martell Foundation for Leukemia, Cancer and AIDS Research

Estate of Charles J. Mauro

The Abby R. Mauzé Charitable Trust

Melanoma Research Alliance Foundation

Florence Miner

Gloria Miner

The Naddisy Foundation

The Samuel I. Newhouse Foundation

Ronald O. Perelman

Estate of Catherine R. Price

Frederick Henry Prince Memorial Fund

Bruce C. Ratner

The Robbins Family Foundation

Estate of Marilyn L. Schaefer

Estate of Grace A. Shapro

The Joachim Silbermann Family

Paul E. Singer

Joan and Joel Smilow

Stand Up to Cancer

Swim Across America, Inc.

The Joseph and Arlene Taub Foundation

Trust of Jane Toplitt

Margaretta J. Taylor

TOSA Foundation

$1,000,000 — $2,499,999

Anonymous

Mr. and Mrs. Andrew B. Abramson

Mr. and Mrs. Frederick R. Adler

Mr. and Mrs. Fred M. Alger III

Alliance for Cancer Gene Therapy

Stephen and Madeline Anbinder

John M. Angelo and Judy Hart Angelo

The Award of Courage Corporation

The Batishwa Fellowship

Trust of Edgar D. Baumgartner

Estate of Mary Ann Benjamin

Mr. and Mrs. Daniel C. Benton

Allen and Joan Bildner

The Anita and Leonard Boxer Family Foundation

Breast Cancer Alliance, Inc.

Estate of Helen Brown

Trust of Emil A. Buelens

Estate of Diane B. Burkhart

Estate of Nizza Burstyn

The Burnett Foundation

Cancer Research Institute

Estate of Marion B. Carstairs

Robert B. Catell

John and Michael Chandris

Pei-Yuan Chia and the Chia Family Foundation

Trust of Charles P. Ciaffone

Trust of George Clegg

The Comer Science and Education Foundation

Trust of James J. Corbalis, Jr.

Countess Moira Foundation

Mr. and Mrs. Peter O. Crisp

Cure Breast Cancer Foundation, Inc.

Estate of Helen M. Curry

Trust of Margaret E. Dahm

Dennis D. Dammerman

Estate of Charles E. Dillman

Gloria DiPietro-Cooper

The Doris Duke Charitable Foundation

Entertainment Industry Foundation

The Eunice Foundation

Estate of Harry Fagen

Farmer Family Foundation

Trust of Harold Farrington

Estate of Barbara D. Finberg

The Jerome and Anne C. Fisher Charitable Foundation

Page 74: innovate - GuideStar

56B MSKCC

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

Flight Attendant Medical Research Institute

The Stephanie and Lawrence Flinn, Jr. Charitable Trust

Estate of Harry N. Forman

Lorraine Friedman

Estate of Jeanette R. Fulham

Fund for Ophthalmic Knowledge

Estate of Frank H. Gabriel

Gabrielle’s Angel Foundation

Sara Gadd

Estate of Thomas Gardiner

Trust of Virginia L. Garrison

Trust of Florence K. Geffen

The Lawrence M. Gelb Foundation, Inc.

Richard L. Gelb

Genentech

General Electric Company

Eileen Genet Fund for Ovarian Cancer Research and Prevention

Trust of Josephine A. Gilmore

Estate of Anna H. Gleason

Miriam and Alan Goldberg

Golfers Against Cancer Foundation

The Gordon Fund

Trust of Jane H. Gordon

Grass Family Foundation

The Marion and Louis Grossman Foundation

Mr. and Mrs. Robert Grossman

Trust of Helen Guerin

Hackers for Hope

Mr. and Mrs. James J. Hagan

Mr. and Mrs. John J. Hannan

Estate of Margaret H. Hanson

Stephen P. Hanson

Jamie and Jeffrey Harris

Mr. and Mrs. Lloyd Hascoe

The Lita Annenberg Hazen Foundation

Hazen Polsky Foundation

The Heckscher Foundation for Children

Mr. and Mrs. Benjamin W. Heineman, Jr.

Marie B. Hilliard

The Charles and Marjorie Holloway Foundation, Inc.

Estate of Harriet Huber

Estate of Dorris Hutchison

Trust of Harry C. Jaecker, Jr.

Estate of Clarence W. Johnson

Estate of Wilda Johnson

Trust of Marion Kahn

Estate of Mary B. Ketcham

Mr. and Mrs. Matania Kochavi

Estate of Rosemarie Krulish

The Thomas G. Labrecque Foundation

Trust of Grace Fay Lamb

Philippe Laub

Estate of Wilhelmina LeJeune

Leon Levy Foundation

Estate of Ada Leventhal

Dr. Nancy Alpern Levin

The LisaBeth Foundation

The Litwin Foundation

Robert S. Ludwig and Gwenyth E. Rankin

Lydian Asset Management, LP

The Maloris Foundation

Trust of Estelle A. Manning

Margaux’s Miracle Foundation

Mr. and Mrs. Joseph L. Martino

The G. Harold & Leila Mathers Foundation

Mrs. William L. Matheson

Merrill Lynch & Co. Foundation, Inc.

Fred and Marie-Noelle Meyer

Estate of Robert C. Mitchell

Trust of Douglas C. Mohl

Estate of Warren A. Montel

Mushett Family Foundation, Inc.

Stavros S. Niarchos Foundation

Nonna’s Garden Foundation

The Olayan Group

Estate of Frederick Pelda

John and Francie Pepper

Perry Capital LLC

Estate of Jeanne Poli

Laura and Christopher A. Pucillo

Mrs. Katharine J. Rayner

Charles H. Revson Foundation

Estate of Edith Roberts

The Jim & Linda Robinson Foundation

The Felix and Elizabeth Rohatyn Foundation

The Laura Rosenberg Foundation, Inc.

Estate of Lillian E. Rosenmerkel

Juliet Rosenthal Foundation, Inc.

Jack Rudin

The Louis & Rachel Rudin Foundation

The May & Samuel Rudin Family Foundation

The Peter M. Sacerdote Foundation

Lewis A. Sanders

Fayez Sarofim & Co.

Estate of Margaret W. Schafer

Mr. and Mrs. Norman C. Selby

Dr. David E. and Beth Kobliner Shaw

Trust of Henry H. Shepard

Mr. and Mrs. H. Virgil Sherrill

Mr. and Mrs. Stephen C. Sherrill

Alfred J. and Stephanie Shuman through the Windmill Lane Foundation

Mr. and Mrs. Herbert J. Siegel

M. Steven and S. David Silbermann

The Rosanne H. Silbermann Foundation

Mary Ann and Arthur M. Siskind through the Siskind Family Sarcoma Fund

The Skirball Foundation

Trust of William Kirkland Smith

Trust of Emily V. Smyth

Trust of Clemance and Edwin Snyder

The Society of MSKCC Special Projects Committee

Ira Sohn Conference Foundation, Inc.

Peter J. Solomon Family Foundation

The Society of MSKCC

The Sontag Foundation

Sportsmen for Charity

Estate of Stanley R. Stones

Mr. and Mrs. David K. Storrs

George Strawbridge, Jr.

The Margaret Dorrance Strawbridge Foundation of PA

The Jeffrey Steiner Family Foundation

The Sussman Family Fund

Trust of M. Allen Swift

Tarnopol Family Foundation

Estate of Lillian Tomek

Anthony and Carole Trapani

The Trump Group

Universal Network Television

The V Foundation for Cancer Research

Trust of Edward W. Vollintine

Joan and Sanford I. Weill

Louis and Jane Weinstock

The Lillian S. Wells Foundation, Inc.

Mr. and Mrs. Clay T. Whitehead

Estate of Carolyn H. Wilson

Winterburn Foundation

Diana S. Wister

The Wolfensohn Family Foundation

Mr. and Mrs. Robert Wright

Zev’s Fund Inc.

$500,000 — $999,999

Estate of Marguerite Abrams

Alex’s Lemonade Stand

Allen & Company, Inc.

American Skin Association

Anonymous

Roland Arthur

Aventis Pharmaceuticals, Inc.

Mr. and Mrs. Robert C. Baker Family Foundation

Estate of Eileen W. Bamberger

The Arnold and Mabel Beckman Foundation

Trust of William T. Benitt

The Besen Family

Jamie Nicholls & Fran Biondi Charitable Trust

Betty, James, and Thomas Blake (The Thomas Blake, Sr. Memorial Fund)

The Blue Dot Foundation

Trust of Ethelvida Boehme

Estate of William Boehme

Mr. and Mrs. David Boies

Trust of Frederick W. Bonacker, Jr.

Estate of Adele Bozio

Trust of Nancy J. Bradford

Mr. and Mrs. Peter Bren

The Andrea and Charles Bronfman Philanthropies, Inc.

Mrs. Edwin M. Burke

The Cancer Research Foundation of America

The Richard E. Capri Foundation on behalf of the Wolf Family

Estate of Richard B. Carman

The Tina and Richard V. Carolan Foundation

James & Patricia Cayne Charitable Trust

Trust of Betty R. Ciaffone

Citigroup

The Simon & Eve Colin Foundation

Estate of Harry J. Colish

The Connecticut Sports Foundation

Constant Convocation Center

The Elaine Terner Cooper Foundation

Trust of Faye Copeland

Estate of Leonard Corso

Estate of Helen M. Cramer

The Dana Foundation

Mr. and Mrs. Marvin H. Davidson

Davis Enterprises

Estate of Sandra Newman Dawson

Page 75: innovate - GuideStar

MSKCC 56C2010 ANNUAL REPORT

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

The Thompson Dean Family Foundation

The DeGroot Family Foundation

Annette and Oscar de la Renta

Deutsche Bank Securities Inc.

Trust of James Douglas

Estate of Louis Duenweg

The Emerald Foundation

Mr. and Mrs. David Epstein

Arthur Falcone

Estate of Beatrice Feinstein

Estate of Alice H. Ficht

Trust of Alice D. Fiedler

Trust of Marie Finch

Trust of Ira S. French

The Michael J. Fox Foundation

Estate of Joseph G. Gaumont

Estate of Lillian B. George

The Gerber Foundation

Estate of Thelma Gish

GIST Cancer Research Fund

Mr. and Mrs. Robert S. Goldberg

Goldman Sachs & Company

The Horace W. Goldsmith Foundation

Peter M. Guggenheimer

The Marc Haas Foundation

Mr. and Mrs. William W. Haerther, Jr.

Estate of Ethel V. Haldeman

Evelyn A. J. Hall Charitable Trust

Mr. and Mrs. William B. Harrison, Jr.

Estate of Ruth H. Hewlett

Marie B. Hilliard

The Patricia M. Hynes and Roy L. Reardon Foundation

IBM Corporation

Deanne and Arthur Indursky

Mrs. H. Anthony Ittelson

Johnson & Johnson

Estate of Horace A. Jones

Fritz and Adelaide Kauffmann Foundation

Kinetics Foundation

Estate of Joan E. Kinley

Estate of Hazel V. Knapp

Estate of Ruth Koch

The Koodish Family Charitable Trust

The Jacob & Valeria Langeloth Foundation

Trust of Charles T. Larus

Lazard Capital Markets

Harold F. Levinson

Life Raft Group

Trust of Martin C. and Margaret V. Lohsen

Trust of Louis J. Lombardi

Earle I. Mack Foundation

Estate of Lucille Knowles

Freedman Mann

Trust of John C. McCormick

Estate of Ralph Melson

Estate of Ruth Vitow Messias

Wilma S. Mills

The Ambrose Monell Foundation

J. P. Morgan Chase

The Norman M. Morris Foundation

The William T. Morris Foundation

Trust of Paula Moss

Mr. and Mrs. Charles H. Mott

Trust of Saul Nathonsohn

News Corporation

The New York Community Trust

The New York Yankees Foundation

Trust of Melba M. O’Connell

The Sylvan and Ann Oestreicher Foundation

Trust of Jo Anne H. Olmsted

E. Stanley O’Neal

Estate of Beatrice P. K. Palestin

Elsa U. Pardee Foundation

The Pediatric Cancer Foundation

The Perelman Family Foundation

Trust of Elizabeth L. Perkins

Pfizer Inc.

Estate of Lucie Picard

Margot Rosenberg Pulitzer Foundation

The Mitchell P. Rales Family Foundation

John Bradbury Reed

Trust of Irene Dorothy Reel

Estate of Agnes Rezler

Drs. Helena and David Rodbard

Alexander J. Roepers

Shafi Roepers

Trust of William C. Rogers

The Arthur Ross Foundation, Inc.

Trust of Edward G. Ryder

Joseph J. Santry

Estate of George W. Schneider III

Estate of Alana M. Schuster

The Beatrice & Samuel A. Seaver Foundation

The Seraph Foundation

The Shen Family Foundation

Trust of William and Isabelle Sherlock

Evelyn R. Simmers Charitable Trust

Trust of Barbara K. Snader

The Society of MSKCC Associates Committee

Estate of Katherine R. Sonneman

Spin4Survival

St. Baldrick’s Foundation

The John R. and Inge P. Stafford Foundation

Estate of Helen E. Steadman

Bonnie and Steven E. Stern

The Mel Stottlemyre Myeloma Foundation

Mr. and Mrs. Paul A. Street

Trust of James Strobridge

The Michael Sweig Foundation

The Craig D. Tifford Foundation, Inc.

Barbara Davies Troisi Foundation

Estate of Stanley F. Tucker

Tudor Investment Corporation

Daniel P. and Grace I. Tully Foundation

Turner Construction Company

United Way of Tri-State

Uniting Against Lung Cancer

Trust of Ward M. Vanderpool

Variety – The Children’s Charity

Richard C. Vergobbi

Estate of Christine Villano

Lucy R. Waletzky, MD

Trust of Thomas J. Watson, Jr.

Estate of Ruth C. Weismann

Trust of Reamer W. Wigle

Mr. and Mrs. Sam Wilderman

The Meryl and Charles Witmer Charitable Foundation

Trust of Richard A. Yudkin

Estate of Anna M. Zavatt

Ronald Zung

$250,000 — $499,999

Trust of George Aaron

Accelerate Brain Cancer Cure (ABC2) Foundation

Estate of John D. Adams, Jr.

The Louis & Bessie Adler Foundation

The Rita Allen Foundation

The Alliance Against ASPS Foundation

American Brain Tumor Foundation

American Health Assistance Foundation

The Ametek Foundation, Inc.

Dorothy A. Anderson

Trust of Eileen Alpert

Anonymous

Estate of Anita S. Appel

Mr. and Mrs. Frank W. Appleton, Jr.

Arms Wide Open Childhood Cancer Foundation

Joyce Ashley

Estate of Rose Ashton-Irvine

Aventis Pharmaceutical

Avon Foundation

Estate of William C. Bahn, Jr.

The Banbury Fund

Estate of Marcia Batten

Betsy L. Battle

Richard I. Beattie

Estate of Ethel A. Bell

Trust of Virginia Poole Benjamin

The Bie Family Foundation

The Lisa E. Bilotti Foundation

The Nancy and Robert S. Blank Foundation

Albert and Betty Bodian

The Bondi Foundation

Trust of Lillian Borchardt

The Louis L. Borick Foundation

The Albert C. Bostwick Foundation

Trust of Alice M. Branch

The Braver Foundation

Estate of Paul P. Brieloff

Trust of Dorothy Fielder Brown

Estate of Madalyn B. Bryant

The Bugas Fund

Hilary and Joseph A. Califano, Jr.

Cancer Support Services, Inc.

Estate of Georgia M. Catrini

Trust of Ruth C. Celarek

Estate of Burdette G. Chamberlin

The Y. C. Ho/Helen and Michael Chiang Foundation

Joan Chorney

CIBC World Markets Corporation

Estate of Dorothy L. Cobb

Trust of Joan F. Cobb

Frances B. Cohen

Mr. and Mrs. John K. Colgate, Jr.

The Community Foundation for Northern Virginia – Hanlon Family Fund

Estate of Robert I. Conley

Estate of Lillian Copperman

Carlos A. Cordeiro Foundation

Estate of Leonard Cossack

The Cowles Charitable Trust

Chandler Cox Foundation

Estate of Mary O. Craft

Estate of Edna W. Curl

Trust of DeWitt S. Davidson

Trust of Richard L. Davies

Estate of Frederick W. Davis

Trust of Marion E. Dean

Trust of Carolyn B. Denney

Hester Diamond Foundation

Page 76: innovate - GuideStar

56D MSKCC

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

The Dickson Foundation

The DiMenna Foundation, Inc.

Elizabeth K. Dollard Charitable Trust

The Walter S. and Lucienne B. Driskill Foundation

Mr. and Mrs. Barclay Ehrler

The Mitzi and Warren Eisenberg Foundation

Eli Lilly & Co.

Rita H. Schaefer Elliott

The Charles Engelhard Foundation

Trust of June K. Evans

Trust of Lillian Evans

Lord Evans of Watford

Anthony B. Evnin

Trust of Sarah W. Ewing

Mr. and Mrs. Barton Faber

Estate of Giuliana Fantini

Trust of Mary E. Farrell

The Feinstein Family Foundation

Paul Felzen

The Fibrolamellar Cancer Foundation

Estate of Selma Fine

The Grace J. Fippinger Foundation, Inc.

Jeanne Donovan Fisher

The Jodi Spiegel Fisher Cancer Foundation

Aaron I. Fleischman Foundation

The Floren Family Foundation

Fondazione Italiana

Leonardo Giambrone

For the Love of Life

The Terry Fox Run for Cancer Research

The Evan Frankel Foundation

Mr. and Mrs. Lewis Frankfort

The Edna R. Fredel Charitable

Lead Annuity Trust

Estate of Frank O. Fredericks

The Fribourg Foundation

Estate of Gerard M. Friedman

Estate of Regina M. Gallichio

Estate of Norman D. Galloway

Trust of Esther B. Garnsey

Estate of Mildred B. Gehrke

Joe and Ellen Gellert

Genzyme

The Aaron and Betty Gilman Family Foundation

The Albert and Pearl Ginsberg Foundation

The Joyce & Irving Goldman Family Foundation

Alfred G. & Hope P. Goldstein Fund

Granary Associates

Mr. and Mrs. Alan I. Greene

Virginia and Howard Groombridge

Mr. and Mrs. Martin D. Gross

Robert C. Halboth

Mrs. Melville W. Hall

Mr. and Mrs. Stephen L. Hammerman

Gladys and Roland Harriman Foundation

Susanne and Shelley Harrison

Trust of Abraham Hases

Estate of Irma Hayes

Mr. and Mrs. Charles Heimbold, Jr.

Estate of Judith B. Helfant

Heyman-Merrin Family Foundation

The Catie Hoch Foundation

Estate of Laverne Hodges

Estate of Martha Holloway

Mr. and Mrs. D. Gregory Horrigan

Estate of Karen L. Hudson

William Lawrence & Blanche Hughes Foundation

Edith M. Hunter

IBM International Foundation

Bruce H. Jacobs

Trust of Clyde H. Jacobs

The Rona Jaffe Foundation

Janssen Pharmaceutica Products LP

Estate of Mira Jelin

The Jewish Communal Fund

The Robert Wood Johnson Foundation

Estate of Al Jolson

Estate of Robert L. Jones

Max Kade Foundation, Inc.

Mr. and Mrs. Robert B. Kay

Estate of Helen Keena

Trust of Fenton O. Keister

Mr. and Mrs. John R. Kennedy

Trust of Paul and Fran Knight

Joel Koschitzky

Mr. and Mrs. Marvin H. Koslow

The Fred W. Kramer Charitable Trust

Cheryl Gordon Krongard

Estate of Harriette H. Kussin

Estate of Sidney Lacher

Mr. and Mrs. Joseph M. La Motta

Estate of Harriet L. Lampert

Vivian F. Laube

Lavelle Fund for the Blind, Inc.

Betty Reid Lawson

Trust of Joseph Lebednik

The Lerner Foundation

Estate of Donald LeRoy

Mr. and Mrs. Allan L. Levey

Trust of Leona Levy

The Anne Boyd Lichtenstein Foundation

Estate of John E. Liebmann

Pauline H. Lin

Live4Life Foundation

Estate of Marian J. Looser

Mr. and Mrs. Edward Lundy

The Lustgarten Foundation for Pancreatic Research

Lymphoma Research Foundation

Estate of Julian Malkiel

Manhasset Women’s Coalition Against Breast Cancer

The Lois H. Mann Charitable Foundation

Estate of Albert Manning

Estate of Marvin Margolies

Mrs. John L. Marion

The Marmot Foundation

Estate of Edith Lipphardt Martens

Estate of Elizabeth Martin

Trust of Richard and Betty Martin

Estate of Ann L. Martinez

Trust of Anthony J. Masard

The Lucille and Paul Maslin Foundation

Trust of Cecelia Matarazzo

Estate of Harry H. Maus

Max Cure Foundation

The Mayday Fund

Mr. and Mrs. Louis V. Mazzella

MBNA America Bank

The MBNA Education Foundation

Donald J. McCarraher

Mary Jane McCarthy

The Michael W. McCarthy Foundation

The James S. McDonnell Foundation

Estate of Charles McGreevy

Estate of Alan McMaster

MeadWestvaco Corporation

The Merck Company Foundation

Estate of Despina Messinesi

Trust of Russell H. Michel

Mrs. Minot K. Milliken

Young Ae Lim and Joonsikk Moon

Estate of Dorothea K. Money

Morgan Stanley

Trust of Edmund L. Murray

The National Brain Tumor Society

National Childhood Cancer Foundation

Carole and Raymond Neag

Trust of Louise F. Neely

Estate of Ann M. Nelson

Muriel Neumann

New York Workers’ Compensation Bar Association

James G. Niven

Occidental Petroleum Corporation

Grace Oughton Cancer Foundation

Eileen and James A. Paduano

PepsiCo Foundation, Inc.

The Perkin Fund

Estate of Ann Perkins

Estate of Claude E. Petruzzi

Mr. and Mrs. Jeroen Henk L. Pit

Jean D. Pitcher

Josephine K. Poling

Polo Ralph Lauren Corporation

Estate of Elizabeth Polotaye

Trust of Helen M. Price

Estate of Seymour Price

Project A.L.S.

Prudential Financial, Inc.

Mrs. Jenice Pulver

Purdue Pharma LP

Leslie C. Quick and Regina A. Quick Charitable Trust

Trust of Anne Ressner

The Andréa Rizzo Dance Therapy Fund

Trust of Lillian Robbins

Estate of Sandra Sheppard Rodgers

Estate of Nathan Rothstein

Estate of Wilhelmina T. Rouget

The Selma and Lawrence Ruben Foundation

David Mark Rubenstein

Mrs. Orhan I. Sadik-Khan

Mrs. Edmond J. Safra

Dr. Nathan E. Saint-Amand

Mr. and Mrs. Herbert E. Saks

Mara and Ricky Sandler

Trust of Erika Saphier

Trust of Edwin & Grace Sayers

Estate of Christine C. Scanlan

Trusts of Anabel M. Scarborough and Walter L. Scarborough

The Milton Schamach Foundation, Inc.

Trust of Jennie C. Schneider

Trust of Crystal Schull

Estate of Bertha Schulman

The Schultz Foundation

The Nina and Ivan Selin Family Foundation

Estate of Gladys N. Severud

Page 77: innovate - GuideStar

MSKCC 56E2010 ANNUAL REPORT

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

The Shanken Family Foundation

Estate of Odette Sharow

Trust of Minnie M. Shaw

Hope Sheridan Foundation

Nancy Shevell

Renee and Irwin Shishko

Estate of Lillian M. Siemionko

Leonard and Donna Simon

Trust of Angie S. Skinner

The Gordon H. and Norma Smith Family Foundation

Estate of Robert A. Smith

Roberta A. Smith

Estate of William E. Snee

Ms. Beryl Snyder

The Seth Sprague Educational and Charitable Foundation

The Robert Steel Foundation for Pediatric Cancer Research

Trust of Frederick T. Steinberg

Trust of Charles M. Stevenson

Estate of Sonia Stolin-Moresco

The Daniel P. Sullivan Clinical Fellowship Fund

Ping Y. Tai Foundation

Frank N. Tedesco

Estate of Ida Tepper

Trust of Annette M. Terdina

Estate of Stella R. Thater

Thrasher Research Fund

Mr. and Mrs. Carl W. Timpson, Jr.

Estate of Michael Z. Toman

Mr. Steven Trost

United Hospital Fund of New York

United Leukemia Fund Inc.

United Way of New York City

Estate of Eleanor B. Vogel

The Wasily Family Foundation

Estate of Ingeborg K. Watson

The Scott Weingard Memorial Fund

Effie Wells-Lonning

Mr. and Mrs. Harold S. Wertheimer

Trust of Ida Wharton

Whitehall Foundation

John C. Whitehead

Estate of Ruth Whitfield

Mr. and Mrs. Frank C. Whittelsey III

The Jesse R. Wike Charitable Trust

Mr. and Mrs. Sam Wilderman

Kendrick R. Wilson, III

Trust of Vincent J. Zappolo

Deborah A. Zoullas

Nicholas B. Zoullas

$100,000 — $249,999

A & P Foundation

The Louis & Anne Abrons Foundation, Inc.

Mr. and Mrs. Laszlo Adam

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

The Francis X. Ahearn, Sr. Foundation

Daniel G. Alexander

Robert and Elaine Allen

Mr. and Mrs. Robert I. Alpern

The Amaturo Foundation, Inc.

The American Ireland Fund

The American Italian Cancer Foundation

Amgen, Inc.

Estate of Maurice Amzalak

Mr. and Mrs. Harold F. Anderson

Warren and Lillian Anderson

Anonymous

Mr. and Mrs. Jerome V. Ansel

Estate of Mark J. Anton

Mr. and Mrs. Rand V. Araskog

Mr. and Mrs. William J. Armfield IV

Kym S. Arnone

The Aronson Family Foundation

Mary Kay Ash Charitable Foundation

Autism Speaks

B*Cured

Trust of Maureen E. Bacchi

Dr. Joseph J. Bailey

Elliot A. Baines

The Baird Family Fund

Estate of Harold P. Bannister

Mr. and Mrs. Robert L. Barbanell

Trust of James R. Barber

Trust of Margaret D. Barber

Trust of Grace M. Barry

Estate of Kaethe F. Barry

Estate of Patricia A. Barry

Trust of Eileen L. Batten

Estate of Thelma Beatty

Trust of Gertrude E. Beck

Rosalie Becker

Estate of Charles R. Beechler

Estate of Robert D. Bennett

Corinne Berezuk and Michael Stieber

Bergstein Family Foundation

Rita S. and Bernard S. Berkowitz

Estate of Tony P. Bernabich

The Bill Bernbach Foundation

Robert Berne

Mrs. Louis Bernstein

Bid-Service LLC

Jill and Darius Bikoff Foundation

Estate of Margaret L. Bingman

Biomet

BJ’s Charitable Foundation

Alexander Blass

Bill Blass Licensing Company, Inc.

Mr. and Mrs. James A. Block

Estate of Vivian K. Blonder

The Walter & Adi Blum Foundation, Inc.

Trust of Eli Blumenfeld

Harold and Adele Blumenkrantz

Estate of Simon P. Blustone

Bruce Bocina

Estate of Marti A. Boden

Estate of Marjorie R. Boselly

Mr. and Mrs. Kevin A. Bousquette

Alan F. Bovee

William R. Boyle

Estate of Mary C. Brabson

Estate of Elsie L. Bradford

Brahman Capital

Brain Tumor Funders’ Collaborative

Anna M. and Mark R. Brann

Milton Brenner

Estate of Mae Bridewell

Bridgemill Foundation

Trust of Marie H. Brock

Terri Brodeur Breast Cancer Foundation

Estate of Edna Brodie

Randall Brooks

Carl and Nickey Brown

Catherine D. Brown

Trust of Ruth Ann Brown

Estate of Vernon Brunelle

Elizabeth Bucher

Janna Bullock

Trust of Florence Bunn

Tory Burch

Mr. and Mrs. Franz H. Burda

Estate of Louise V. Burnett

Mr. and Mrs. Harold Busch

The Paul Nabil Bustany Foundation

Gilbert and Ildiko Butler Family Foundation, Inc.

Estate of Lillian A. Byman

Mr. and Mrs. Bruce L. Calhoun

Trust of Marilyn Campbell

Cancer Research & Treatment Fund

Leah Rush Cann

Estate of Edward A. Cantor

The Paul Robert Carey Foundation

Caring for Carcinoid Foundation

Mr. and Mrs. Kenneth Carmel

Estate of William K. Carson

Colon B. Carter

Trust of Winifred T. Carter

Estate of Elsie Cartotto

Joan (Perkowski) Cashin Foundation

Casual Male Corp.

The Cayuga Foundation

Estate of Charlotte A. Celian

Trust of George F. Chagnot

Margaret Anne Chappell

Estate of Franklin Chenenky

Estate of Camille Chericone

Child Neurology Foundation

Childhood Brain Tumor Foundation

The Children’s Brain Tumor Foundation

Children’s Neuroblastoma Cancer Foundation

Mr. and Mrs. Allen Chipman

Florence Chu, MD

Estate of Lyman W. Clardy

The Clark Foundation

Cleveland Clinic Health System

Clarence L. Coleman Jr. and Lillian S. Coleman Foundation

James J. Coleman, Jr.

Estate of Gertrude T. Coles

Robert and Maryann Collin

Arthur R. Collins

Estate of Lila V. Collins

Terry S. Collins

The Julien Collot Foundation, Inc.

Consolidated Edison Company of New York

Dudley P. Cook

Mr. and Mrs. Errol M. Cook

Mrs. William B. Cook

Cookies for Kids’ Cancer

E. Gerald Cooper

Sharon Levine Corzine

Estate of G. R. Couch

Courtesy Associates, Inc.

Estate of Edith C. Cox

Trust of Franklin C. Craig

Trust of Louise Crites

Bruce Crystal

Cure Childhood Cancer

Custom Design Communications, Inc.

Page 78: innovate - GuideStar

56F MSKCC56F MSKCC

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

Filomen M. D’Agostino Foundation Corp.

Rosetta B. Damilano

Estate of Richard Daniels

The Gloria and Sidney Danziger Foundation, Inc.

The E. S. P. Das Foundation

The Arthur Vining Davis Foundations

The Ellen and Gary Davis Foundation

Mrs. Roger J. Davis

Roxana V. Dawson

Estate of Jean Decker

Estate of Libiro DeFilippis

The Lawrence and Florence DeGeorge Charitable Trust

Lynn DeGregorio

Anthony Del Bove

Estate of Helen Demitriades

The De Rosa Foundation for Colon Cancer Research and Prevention

Ernst and Paula Deutsch Foundation

The DeWitt Wallace Fund

Mr. and Mrs. Anthony Diaco

The Miriam & Arthur Diamond Charitable Trust

The Ernest & Jeanette Dicker Foundation

Estate of Richard I. Diennor

Estate of Maurice A. Donovan

John R. Doss

Michael Douglas and Catherine Zeta-Jones

Percy S. Douglas

The William C. Dowling Foundation

Susie M. Downing

Jane Clausen Drorbaugh

Dr. Scholl Foundation

Dr. Jeffrey Duban

Trust of Patricia P. Duffy

Estate of Doris M. Dunham

The Durst Organization, Inc.

Estate of Laura D. Eastman

The Eberstadt-Kuffner Fund Inc.

Doris M. Edwards

E. E. Cruz Company

Mr. and Mrs. Blair W. Effron

Trust of Raymond Ehrlich

Estate of Elinor Ehrman

Estate of Estelle Eisenstat

Martin Elk League for Cancer Research

Trust of Arnold B. and Joan S. Elkind

Mr. and Mrs. Richard S. Emmet

Empire Blue Cross & Blue Shield

Andrew J. Entwistle

Estate of Lillian Epps

Rafael Etzion

The Evslin Family Foundation

Trust of James D. Ezzell

Family Reach Foundation

Mr. and Mrs. Alfonso Fanjul, Jr.

Mr. and Mrs. James T. Fantaci

Estate of Marion E. Feigenbaum

Gretchen V. and Samuel M. Feldman

The Corinne Feller Memorial Fund

Trust of Thelma F. Fernandez

Hilary Carla Feshbach

Fetzer Institute

Mrs. Frederick Fialkow

Gloria S. Fine

First Quality Enterprises, Inc.

Randee and Howard Fischer

Estate of James K. Fisher

Estate of William and Frederica Fissell

Trust of Loretta B. Fitzgerald

Mr. and Mrs. Thomas M. Fitzgerald III

The Francis Florio Fund of the New York Community Trust

Steve Forbes

Trust of William Forbes

Richard N. Foster

Four Seasons Hotel – New York

Claire and Meyer W. Frank and Leann Frank Charitable Foundation

Trust of Irene R. Frank

Helen Frankenthaler Foundation

Mr. and Mrs. David Lee Frankfurt

Trust of Jill and Jayne Franklin

Gloria Freed

Frey Family Foundation, Inc.

Knawm Friedman

Richard M. Furlaud

Mr. and Mrs. Thomas J. Gahan

Trust of Ralph W. Gaines

Estate of Anne Gallagher

Mr. and Mrs. Robert M. Gardiner

Trust of William G. Genner, Sr.

Panayotis Gerolymatos

Estate of Theresa A. Ghiringhello

Marlene and Alan Gilbert

Liane Ginsberg

Mr. and Mrs. William H. Girvan

The Glades Foundation

Mr. and Mrs. Eugene J. Glaser

Glenwood Management Corporation

Trust of Glenn R. Gobble

Mr. and Mrs. Bradley Goldberg

Leslie H. Goldberg

Trust of Marc S. Goldberg

The Goldhirsh Foundation

Estate of Elizabeth B. Golding

Daniel S. Goldman

The Barbara L. Goldsmith Foundation

Susan Wallack Goldstein

Trust of Manuel and Anne Goodman

The Gordon Family Foundation, Inc.

Mr. and Mrs. Sheldon M. Gordon

Arthur A. Gosnell

Trust of Louise S. Gosse

Marietta A. Goulandris

Julie Gould Fund for Medical Research

Estate of Richard P. Gould

Felice M. Grad

Graff Diamonds

Grantham Mayo Van Otterloo & Co.

The Grateful Foundation, Inc.

Estate of Harvey R. Graveline

Susan Zises Green

Brigadier General and Mrs. William S. Greenberg

Estate of Edythe Griffinger

Trust of William C. Griffith, Jr.

Trust of Vernon H. Grigg

Estate of Evelyn Gross

Estate of J. Stanley Gross

Trust of Lambert J. Gross

Trust of William Gross

Estate of Anthony Grosso

Allen J. Grubman

Audrey and Martin Gruss Foundation

Estate of Wanda Grzymala

Guardsmark, LLC

Marilyn B. Gula Mountains of Hope Foundation

Trust of Elizabeth Guon

Estate of Gloria E. Gurney

Gurney Foundation

Hachette Filipacchi Media U.S.

Jayma Meyer Hack and Bruce L. Hack

The Hagedorn Fund

The Laverna Hahn Trust

Estate of Margaret S. Hahn

Estate of Elizabeth W. Hall

Estate of Mazie J. Hall

Estate of Helen Sue Hameetman

Trust of Florence M. Hammer

Milton and Miriam Handler Foundation

Estate of Marion K. Hardwicke

Dorothy Harlow

Estate of Mary Jane Harrington

Perry Harten

Laura Hartenbaum Breast Cancer Foundation

Mr. and Mrs. William R. Hartong

Have A Chance, Inc.

Morris A. Hazan Family Foundation

The Colon Cancer Foundation

Trust of Lonie G. Hearn

Hecht & Company Philanthropic Foundation

Trust of Shirley S. Heiligman

Mr. and Mrs. Robert M. Hendrickson

Mr. and Mrs. John Hennessy

The Maxine R. and Richard L. Henry Trust

Estate of Robert Hensel, Jr.

Carolina Herrera, Ltd.

Trust of Leon Hershaft

Trust of Marie Hesselbach

Estate of Manny Hilfman

The Hillcrest Foundation

Hillenbrand Family Foundation

Trust of Myfanwy Hinkle

Estate of Vladimir Hladik

Estate of Edward B. Hodge

Estate of Marion Hoffman

Estate of Ruth M. Hoffman

Trust of Steward B. Hoffman, Sr.

Hoffman-La Roche Inc.

Deborah H. and Sigmar K. Hofmann

Mrs. Carolyn T. Holden

Estate of Lillian E. Holdren

Estate of Herman L. Hoops

Hope Funds for Cancer Research

Alfred Samson Hou

Robert Howard Family Foundation

Evelyn Huber

The Howard Hughes Medical Institute

Nancy Hughes

Edna Hunt

Carol Hunter

Page 79: innovate - GuideStar

MSKCC 56G2010 ANNUAL REPORT

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

James B. Hunter

Syde Hurdus Foundation, Inc.

Mr. and Mrs. David W. Ichel

Estate of Priscilla T. Iden

Inamed Corporation

Incyte Corporation

The Interpublic Group of Companies

Irish Society of Medical Oncology

It Figures LLC

Harry A. Jacobs, Jr.

Mr. and Mrs. Stanley R. Jaffe

Trust of Ann E. Jennings

The Jewish Communal Fund

The JMB Hope Foundation

The Samuel C. Johnson Trust

The Kahn Charitable Foundation

Trust of Frank J. Kahn

Kallan’s Klan

Jane Kalmus

Harry P. Kamen Family Foundation

Trust of Mildred Kaminsky

Estate of Eleanor Kane

Estate of Bernard Kantor

Steve and Meghan Kanzer

Marie H. Karger

The Karma Foundation

Trust of Jerry Katz

Trust of Toby Katz

Edward M. Kaufman

Trust of John Kaufmann, Jr.

Mr. and Mrs. Robert M. Kavner

Thomas F. Kearns

Mr. and Mrs. Brian G. Kelly

Estate of Ruth C. Kelly

Mrs. Ann Kelman and the late Dr. Charles D. Kelman

Eleanora and Michael Kennedy

J. Kevin Kenny

John A. Kent

Estate of Herman Kerner

The Glenn D. Kesselhaut Children’s Joy Fund

Estate of Mary F. Kessler

Mr. and Mrs. Peter A. Kessler

The Kettering Family Foundation

Estate of Henri Khouri

Doris and Floyd Kimble Foundation

Pamela and Dwaine Kimmet

The King Family Charitable Lead Trust

Mr. James W. Kinnear II

Patricia A. Kirby

David L. Klein, Jr. Foundation

Robert D. Klemme

The Esther and Joseph Klingenstein Fund

Trust of Estelle Knapp

Fernand Koch

Estate of Gale K. Kokubu

Emanuel Kondoleon

The Koppelman Family Foundation

The Gwen L. Kosinski Foundation

Robert A. Kotick

Mr. and Mrs. Jerome I. Kroll

Mr. and Mrs. Jeffrey W. Kronthal

Mr. and Mrs. William L. Kronthal

Trust of Grace E. Kruse

The Lakeside Foundation

Estate of Schubert L. Lamb

Estate of Marvadene B. LaMonica

The Edward & Kinga Lampert Foundation

Emma Landau

Mr. and Mrs. Barry Lang

Estate of Annie Langen

Estate of Anne Lanigan

J. Clair and Pamela Lanning

Dr. Gerald D. Laubach

Mrs. Lois H. Lazaro

Trust of Edwin S. Lee, Jr.

Mr. and Mrs. Thomas V. Leeds

The Lefkofsky Family Foundation

The Richard S. and Karen LeFrak Charitable Foundation

Lehman Brothers Inc.

Karen and James Lehrburger

Mr. and Mrs. Lewis E. Lehrman

Trust of Martha B. Leigh

In memory of Stacey Leondis

The Leukemia & Lymphoma Society

Leukemia Research Foundation

Estate of Dina Levinsky

Estate of Erna T. Lewine

Linda Lipay

Trust of Wilhelmina I. Lipfert

Ira A. Lipman

Lisa’s Heart Kids’ Cancer Research Fund

The Harold I. & Faye B. Liss Foundation

Mr. and Mrs. Martin Liss

Julia Little

Demarest Lloyd, Jr. Foundation

Harry J. Lloyd Charitable Trust

Estate of Margaret S. Longwell

Estate of Anthony Lopez

Milton Lowenstein

James J. and Marianne B. Lowrey

The Lucerne Foundation

Lung Cancer Research Foundation

Mr. and Mrs. Alexander P. Lynch

Trust of John F. Lynch

Estate of Kathleen E. Lynch

Estate of Charles S. Lyons

Estate of Melvin E. Lyons

The M and N Fund in Community Funds, Inc.

MacDonald-Peterson Foundation

Josiah Macy, Jr. Foundation

Mr. and Mrs. Duncan MacMillan

The Arthur and Holly Magill Foundation

Estate of Margaret E. Maihl

Estate of Margaret H. Mairs

The Maguy Foundation

Mr. and Mrs. Irving H. Malitson

Elissa Caterfino Mandel

Estate of Harry Marder

Estate of Ida Mae Margolis

Trust of Carlton G. Marie

Mr. and Mrs. Bernard Marin

Edward J. Marino

Susan and Morris Mark

Jerome S. and Maria Markowitz

Trust of Sarah Marks

Estate of Benjamin Marmer

The Christina & Paul Martin Foundation

Dorothy Marx

Estate of Rita B. Masse

James Mathos

The Hale Matthews Foundation

Trust of Walter J. Matthews

The Matt’s Promise Foundation

Maverick Capital Charities

Maynard Childhood Cancer Foundation

The Helen & William Mazer Foundation

Mr. Michael Mazzucca

Estate of Ann C. McBride

Mr. and Mrs. Thomas McCullough

Mr. and Mrs. Jeffrey A. McDermott

McDonald Financial Group

Ralph McDonough

The Dextra Baldwin McGonagle Foundation

The McKnight Endowment Fund for Neuroscience

Estate of Geoffrey McLoughlin

Estate of Mary E. McMaster

Mr. and Mrs. David B. McQueary

The Meckler Foundation

Melanoma Research Foundation

Estate of Dorris M. Mendelsohn

Estate of Irving M. Mendelson

Estate of Lorraine Mensing

The Reuven Merker Charitable Foundation, Inc.

Estate of Amy Joan Meskin

Mesothelioma Applied Research Fund

Mr. Robert A. Metzler

Estate of Abby E. Meyer

Mrs. Sidney Michael

Trust of William M. Michaelson

Trust of Florence B. Mickels

The Mike and Steve Foundation

The Millbank Foundation for Rehabilitation

Elaine P. Miles

Eleanor F. Miley

Carolyn Rosen Miller Family Foundation

Mr. and Mrs. Matthew Miller

Mrs. Mary E. S. Milligan

Mr. and Mrs. James W. Milton

Melissa and Robert Mittman

Estate of Catherine Mohan

Estate of Irene Mokrzycki

Trust of Celestine Elizabeth Moloney

Estate of William Monaghan

Arthur R. Montgomery

John and Hee-Jung Moon

Estate of Pauline Moor

Trust of Anny S. Moore

Mr. and Mrs. Charles V. Moore

Estate of Percy W. Moore

Estate of Barbara B. Morgan

Melissa and Chappy Morris

Alfred L. and Annette S. Morse Foundation

Manuel and Mercedes Mosteiro

Virginia M. Mueller

Estate of Irving Mulde

Mr. and Mrs. Thomas W. Murphy III

Ernest Muth

Edith L. Nathanson

The National Genetics Foundation, Inc.

NBC Universal

Estate of Leslie A. Nelkin

Trust of Jerome Nerenberg

Page 80: innovate - GuideStar

56H MSKCC

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

New York City District Council of Carpenters Relief and Charity Fund

Gerald L. Nichols and Jacqueline W. Nichols Foundation

Trust of Robert F. Novak

NYS Fraternal Order of Police Foundation

The Michael A. O’Bannon Foundation

Estate of Ernestine A. O’Connell

Mr. and Mrs. Jeremiah O’Connor

Trust of Emily C. O’Grady

Estate of Grace O’Hare

Oki Data Americas, Inc.

The Okonite Company

Mr. and Mrs. John D. Opie

Optiscan

Estate of Elaine Orbach

Otis Elevator Company

The William & Jane Overman Foundation

Parfums de Coeur Ltd.

The Parnassus Foundation

Trust of Edith Pattison

Estate of Herman L. Paul, Jr.

Mr. and Mrs. Kenneth Pearlman

Pediatric Brain Tumor Foundation

Pells-Mayton Foundation

Trust of James A. Pemberton

Mort Perlroth

Pershing Square Foundation

Estate of Frederick D. Petrie

The Pew Charitable Trusts

Samantha and Ernst Pfenninger

Trust of Peter H. Pflugk

Trust of Charles V. Pickup

Estate of Irene Pickup

Mr. Alessandro Pinto

Estate of Beatrice Pockrass

Cherie Henderson and David Poppe

Janis Z. Porch

Trust of Ann C. Porterfield

Estate of Edna G. Potter

Trust of Ruth S. Prall

Prevent Cancer Foundation

Rita Price

Estate of Ardys M. and Harold I. Proctor

The Proctor & Gamble Company

The William H. Prusoff Foundation

Dr. and Mrs. Mark Ptashne

Robert Pufahl

Richard I. Purnell Fund

Estate of Richard I. Purnell

Roselyn Flaum Radcliffe

Stewart Rahr

Muriel Rains

Mary L. Ralph Philanthropic Fund

John H. Rassweiler

Abigail T. Reardon

Estate of Phyllis E. Redmerski

Elenore Reed

Estate of Martha Cuneo Reed

Samuel P. Reed

The Beatrice Renfield Foundation

Mr. and Mrs. Ira L. Rennert

Olivier and Yosun Reza

Estate of Roland S. Rhode

The Rice Family Foundation

Martin Rich

Anne S. Richardson Fund

Trust of A. Leslie Richardson

Dee Dee Ricks

Estate of Harry Rinehimer

Estate of Elizabeth M. Ringo

Trust of Victoria Rinius

The Fannie E. Rippel Foundation

Estate of Norma Risman

The Ritter Family Foundation

Irene Ritter Foundation

Abigail Rittmeyer

The RMF Family Fund, Inc.

Mr. and Mrs. Stephen Robert

Bernard and Elaine Roberts

Estate of Floyd B. Roberts

Vivien Rock

Rodale, Inc.

Estate of Maria Rolfe

Vittorina Rolfo

Sheldon Rose

Taryn Rose International

Estate of Sylvia Rosenberg

Trust of Ilsa Rosenblum

Trust of Evelyn Rosenstein

Estate of Sylvia Ross

Estate of Eva L. Rothberg

Mr. and Mrs. Eric A. Rothfeld

Estate of Geraldine E. Rove

Denise Rover

Estate of Pearl Rubin

Mr. and Mrs. Mitchell E. Rudin

Estate of Maria Stella Ruggirello

Estate of Eileen B. Ruthrauff

The Derald H. Ruttenberg Foundation

The Raymond & Beverly Sackler Fund for the Arts and Sciences

The Saibel Foundation

Estate of V. Edward Salamon

Mr. and Mrs. Eugene L. Salem

Mr. and Mrs. William R. Salomon

Trust of Sidney Samuels

Henry Sanborn

The Sandler Family

Mrs. Barbara Santangelo

The Saw Island Foundation

Trust of Paul C. Sawyer

Estate of Ida M. Scagliarini

Scalamandré Silks

Didi and Oscar S. Schafer

Peter L. Schaffer

Estate of Richard Scharff

Estate of Josephine L. Schiff

Estate of Billie Schneider

The Schneider-Kaufmann Foundation, Inc.

Mrs. Silvia A. Schnur

Mr. and Mrs. Paul C. Schorr IV

Trust of Lola Schug

Estate of Harold B. Schwartz

Estate of Rosalind Schwartzbach

Trust of Paul J. Schwarz

Mrs. Arline Schwarzman

Trust of Robert E. Schwenk

Mr. and Mrs. John W. Scully

Estate of Jewel C. Seab

The Jean & Charles Segal Foundation

Mr. David Sekiguchi

The Select Equity Group Foundation

R. B. Sellars Foundation

The Jacqueline Seroussi Memorial Foundation

Seventh District Association, Inc.

L. J. Sevin

Harold Shames

Estate of Reuben Shane

Estate of Saul Shapiro

The Sharma Foundation

Estate of Bernice Baruch Shawl

William R. Sheldon

Estate of Alice Sherwin

Estate of Leo A. Shifrin, MD

Mr. and Mrs. Stanley B. Shopkorn

Mr. and Mrs. William Shulevitz

Mr. and Mrs. Steven J. Sidewater

The Muriel F. Siebert Foundation

Estate of Ruth Siegmann

Estate of Mary Siekert

Trust of Walter Silberfarb

The Grace, George, and Judith Silverburgh Foundation

The Seymour Simon Charitable Trust

Marilyn M. Simpson Charitable Trust

Simpson Thacher & Bartlett

Trust of Otto K. & Harriet J. Singer

Estate of Shirley Singer

Estate of Madeline Sisia

Estate of Evelyn M. Skolnick

Estate of Alvin F. Sloan

Suse Smetana

The Randall and Kathryn Smith Foundation

Estate of Woodrow Q. Smith

Estate of Dorothy Smolen

Catherine M. Smolich

Trust of Robert J. Smutny

Mr. and Mrs. Jay T. Snyder

The Harry & Estelle Soicher Foundation

Trust of Robert Solnick

Professor and Mrs. C. Alan Soons

Soros Fund Charitable Foundation

Sotheby’s

The Roy M. Speer Foundation

Estate of Regina W. Spence

Estate of DeAnne Spencer

Estate of Agnes Spillmer

The Seth Sprague Educational and Charitable Foundation

The St. Giles Foundation

Ronald Stafford Cancer Support Foundation, Inc.

Estate of Sanford L. Steelman

Estate of Dennis Stein

The Fred & Sharon Stein Foundation

Mrs. Nancy Steinfeld

The Ernest E. Stempel Foundation

Mr. and Mrs. Howard Stern

Estate of Irene Stern

Estate of Winona H. Stevens

The Guy M. Stewart Cancer Fund

J. McLain Stewart

Estate of Rebecca Stohl

Mr. and Mrs. Norman L. Stone

Estate of Clair B. Stough

Trust of May Strang

Estate of Herta Strauss

Geraldine Stutz Trust Inc.

Page 81: innovate - GuideStar

MSKCC 56I2010 ANNUAL REPORT

THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER

Trust of Mary R. Suchanski

Mr. and Mrs. Robert J. Sullivan

Timothy P. Sullivan Charitable Lead Trust

Estate of Sandra Syms

Dorothy D. Taggart Trust

J. T. Tai & Co. Foundation, Inc.

Trust of Andrew Taras

Trust of Joyce A. Taras

Edward Tarby

Estate of Ruth N. Taub

Tay-bandz, Inc.

Estate of Florence G. Taylor

Estate of Gertrude S. Taylor

Team Luke vs. Neuroblastoma

Telethon Italy – US Foundation

Estate of Walter G. Terwedow

Mr. and Mrs. Andrew S. Thomas

Estate of Robert P. Thome

Trust of Vernon Thompson

Thrill Hill Productions

Estate of Margaret R. Tomas

Estate of Milton Topolsky

Estate of John J. Tormey

The Tortuga Foundation

Trust of Angelina Ann Tovar

Jill Tracey

Estate of Rita L. Tracey

Trust of Helen A. Trahin

Trust of Dorothy B. Traufield

Beatrice Travis-Cole

The Robert Mize & Isa White Trimble Family Foundation

The W. James & Jane K. Truettner Foundation

Thomas N. Tryforos

Estate of Ina Tuckman

Estate of R. Read Tull

Lucien L. and Shirley Turk

The Tyler Foundation

Ahavas Tzedek Foundation

David V. Uihlein, Sr.

Trust of Irwin C. Unger

Mr. and Mrs. Mark D. Unger

The Lucy & Eleanor S. Upton Charitable Foundation

The Valley Foundation

Valley of the Sun United Way

Vanguard Charitable Endowment Fund

The Varnum DeRose Trust

The Vasey Foundation

The Victoria’s Smile Foundation

Trust of Eva Vida

The Family of Maria Elena Villanueva

Estate of Dorothy Voelker

Trust of Anna L. Vogel

Estate of Gertrude Vogel

Trust of Beverly Wachtel

Wachtell, Lipton, Rosen & Katz

The Paul E. and Mary Wagner Trust

Estate of Lillie M. Waldon

Mr. and Mrs. Paul D. Walsh

Estate of Frances M. Wanek

Warren/Soden/Hopkins Family Foundation

The Washington Post Company

Mr. and Mrs. Bruce Wasserstein

Estate of Shirley F. Watkins

Jesse and Doris Weaver

Mr. and Mrs. Bradford G. Weekes II

Mr. and Mrs. John G. Weiger

Mrs. John L. Weinberg

Danny M. Weinheim

The Isak & Rose Weinman Foundation, Inc.

Mr. and Mrs. Michael Weisberg

Estate of Gertrude Weiss

John A. Weissenbach and Ann Southworth

Trust of Gertrude Wellisch

The Nina W. Werblow Charitable Trust

Estate of E. Olga Wesner

Mrs. Elizabeth G. Weymouth

Estate of Frank A. Widenski

Mr. and Mrs. Gene Wilder

The Wilf Family Foundation

Williams Trading LLC

Trust of Helen A. Wilson

James B. Wittrock

The Henry Wolf Foundation

Estate of Gordon Wootton

Estate of Bernadette Wyrough

Alfred D. Youngwood

The Patricia J. and Edward W. Zeh Charitable Foundation

The Zickler Family Foundation

The Isaac Ziegler Charitable Trust

Stanley Shalom Zielony Foundation

Ziff Brothers Investment, LLC

Martha E. Zimmer

Larry and Anne Zimmerman

Page 82: innovate - GuideStar

2010 ANNUAL REPORT MSKCC 57

THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER

Courtney ArnotMuffie Potter AstonMrs. Alan J. BlinkenMrs. Andrew M. BlumTory BurchMrs. Bryan J. CareyMrs. Michael CarrNancy CoffeyDianne G. CraryJennifer CreelMrs. Michael J. A. DarlingMrs. Marvin H. DavidsonMrs. Hilary DickWebb Egerton

Ruth G. FleischmannMrs. Lars ForsbergMrs. Robert M. GardinerMrs. Mark V. GiordanoMrs. Peter S. GregoryMrs. Roger P. Griswold, Jr.Alexia Hamm RyanMrs. Andrew P. HeaneyMrs. Kenneth JosephVictoria Greenleaf KempnerMrs. Michael KennedyMrs. Richard S. LeFrakMrs. Roman Martinez IVMrs. Brian A. McCarthy

Mrs. S. Christopher Meigher IIIMrs. Richard A. MillerMrs. George F. MossMrs. George K. MossMrs. Richard T. PerkinDebra L. PipinesMrs. Samuel F. Pryor IVMrs. Bambi PutnamMs. Dee Dee RicksShafi RoepersMrs. Louis RoseMrs. Benjamin M. RosenMrs. Elizabeth SavageMrs. Paul C. Schorr IV

Mrs. Stephen C. SherrillMrs. Bryan SnyderMrs. Paul SorosMrs. Richard J. SterneMrs. Andrew S. ThomasBarbara Dana TollisMrs. Jerome L. VillalbaMrs. Douglas A. Warner IIIMrs. Martha WebsterMrs. Thomas E. Zacharias

Mrs. Thomas V. LeedsPresident

Mrs. John B. Glass, Jr. Vice President

Mrs. Scott C. JohnstonTreasurer

Mrs. James Halsey BellAssistant Treasurer

Mrs. Thomas S. GloverVice President

Mrs. Thomas M. Fitzgerald III Secretary

Alexis Robinson WallerAssistant Secretary

Dr. Annette U. RickelVice President

ADMINISTRATIVE BOARD

Mrs. Andres BausiliMrs. Kevin A. BousquetteMrs. Henry R. BreckMrs. D. Wayne CallowayMrs. W. Ward CareyMrs. Edmund M. CarpenterNancy Mulholland ConroyMrs. James F. Curtis III

Mrs. Christopher R. DavisMrs. James H. DeanMr. Thompson DeanAntonia Paepcke DuBrulMrs. Thomas J. Fahey, Jr.Mrs. Lee M. Gammill, Jr.Mrs. Roberto de GuardiolaMrs. Peter K. Hills

Mrs. John S. HilsonMrs. Ann F. JefferyJulie KammererJeanette W. LoebSuzanne McDonnell LongMrs. Minot K. MillikenMrs. Charles H. MottMrs. Charles D. Peebler, Jr.

Mrs. François de Saint PhalleMrs. Roy R. PlumEvelyn Angevine SillaLeith Rutherfurd TalamoMrs. Michael L. TarnopolMrs. Cecil WolfsonDebbie Zoullas

SUSTAINING BOARD

Mrs. Rand V. AraskogMrs. Charles A. Dana, Jr.

Mrs. John R. Drexel IIIMrs. Donald B. Marron

Mrs. Milton PetrieLinda Gosden Robinson

Mrs. H. Virgil Sherrill

ADVISORY COUNCIL

FOUNDER

Mrs. Edward C. Delafield

Mrs. Coleman P. BurkeMrs. Edwin M. BurkeMrs. William M. CarsonMrs. Walter B. DelafieldMrs. Charles H. Dyson

Mrs. Bruce A. GimbelMrs. William O. HarbachAlison Barr HowardMrs. Peter D. JonesMrs. Kerryn King

Mrs. Arie L. KopelmanMrs. Derek L. LimbockerJean Remmel LittleMrs. M. Anthony MayMrs. Jay H. McDowell

Mrs. Frank A. Metz, Jr.Mrs. Bijan Safai

PAST PRESIDENTS

Page 83: innovate - GuideStar

58 MSKCC

THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER

Founded in 1946, The Society of MSKCC is a volunteer organization that works to ensure the well-being and comfort of patients, raise funds for cancer research and treatment, and provide public education on the prevention, early detection, and treatment of cancer.

The Society’s annual Health Education Seminar in March drew Society supporters to hear Peter T. Scardino, Chair of MSKCC’s Department of Surgery, Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, and Moshe Shike, Director of Clinical Nutrition, discuss “Hot Topics in Cancer Prevention.”

An evening of dining and dancing and a performance by Grammy Award winner Mary J. Blige brought more than 400 guests to The Society’s third annual Spring Ball in May at The Pierre hotel. The event honored Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program (HOPP). A live initiative entitled Putting Genomes into Practice, led by Sotheby’s auctioneer and MSKCC Board member James G. Niven, raised funds to support HOPP research in the area of cancer genomics. The event raised $1,400,000 and was sponsored by David Yurman.

Members of The Society’s Children’s Committee helped with everything from dress and tuxedo donations and distributions to the pinning on of corsages and boutonnieres at June’s Pediatric Prom. The event, one of the most highly anticipated days of the year in MSKCC’s Department of Pediatrics, allows children and teenagers who are being treated for cancer — many of whom may have been forced to miss their own school proms — to celebrate one of life’s special moments with friends, family, and Pediatrics’ doctors, nurses, and other support staff.

Established in 1946, the Annual Appeal is The Society’s oldest fundraising cam-paign. For more than six decades, Society members have raised funds for a specific MSKCC program. In 2010, the Appeal, called “Targeting Melanoma,” raised $1 million to support melanoma research at the Center. In

21

Page 84: innovate - GuideStar

MSKCC 592010 ANNUAL REPORT

particular, the funds will support the develop-ment of targeted therapies designed to attack this deadly form of skin cancer.

A tradition since 1989, The Society’s Annual Preview Party for the International Fine Art and Antique Dealers Show in October drew more than 1,000 guests to the Park Avenue Armory for a private preview of vetted museum-quality art and antiques. The event raised more than $660,000 for MSKCC’s programs in patient care, research, and education. It was sponsored by Giorgio Armani and 1STDIBS with additional support from ELLE DECOR.

New York’s Four Seasons restaurant was the setting in November for the annual Fall Party hosted by the Associates Committee, which raised funds for The Society’s Pediatric Family Housing Endowment. The endow-ment pays for overnight stays for children and their families who go for treatment in MSKCC’s Department of Pediatrics and are unable to afford this expense on their own. The Associates Committee has pledged to raise $2 million over five years for the program. The evening of cocktails, dinner, and dancing raised more than $340,000. The event was sponsored by Gucci.

In March, the Associates Committee transformed the iconic toy store FAO Schwarz into a children’s wonderland for the

20th annual Bunny Hop. Also benefiting the Pediatric Housing Endowment, the event raised more than $353,000. The event was sponsored by Brooks Brothers with additional support from UBS Private Wealth Management. Tina Fey was Honorary Chairman and attended the party.

Funded by the Social Services Committee, the Social Work Fellowship offers a singular learning opportunity for social work students enrolled in a master’s degree program. For ten weeks during the summer, the students — who have completed one year of field study and are about to begin their second year — work at MSKCC, learning about the needs of oncol-ogy patients in a multidisciplinary context that provides both classroom and clinical components. Fellows then return to MSKCC for the fall and spring semesters as second-year interns. Since its establishment in 1996, 43 fellows have completed the program.

Since The Society’s inception, a corner-stone of its mission has been funding leading-edge research. Many of the projects The Society has supported have since become permanent programs and fixtures of MSKCC. The Society’s Research Grants support important clinical and translational research projects of the Center’s medical faculty and nursing staff. In 2010, six research proposals received grants.

1 Young partygoers dance up a storm at the annual Pediatric Prom.

2 (From left) Annual Appeal Vice Chairmen Elizabeth Miller and Lavinia Snyder, Society President Heather Leeds, Annual Appeal Chairman Eleanora Kennedy, and Annual Appeal Vice Chairman Burwell Schorr.

3 (From left) Antique Show Co-Chairmen Libby Fitzgerald, Lisa McCarthy, Michel Witmer, Daisy Soros, Melinda Blinken, and Society President Heather Leeds.

4 (From left) Health Education Seminar (HES) Associates Committee Co-Chairman Susie Kovner, HES Co-Chairman Jamee Gregory, HES presenters Peter Scardino and Moshe Shike, HES Co-Chairman Karen LeFrak, HES presenter Larry Norton, Associates Committee Co-Chairman Kate Schroeder, and Society President Heather Leeds.

5 (From left) Spring Ball Co-Chairmen Shelley Carr and Dee Dee Ricks, Society President Heather Leeds, honoree Charles Sawyers, and Spring Ball Co-Chairmen Tory Burch and Jamie Tisch.

6 (From left) Fall Party Co-Chairmen Allison Aston, Eleanor Ylvisaker, Ferebee Taube, and Veronica Swanson Beard.

5

3 4

6

Page 85: innovate - GuideStar

60 MSKCC

WAYS OF GIVING TO MEMORIAL SLOAN-KETTERING

Those generous friends and benefactors who wish to support the Center as part of the Campaign for Memorial Sloan-Kettering can choose from a range of initiatives designed to benefit the institution at every level — its talented people; its outstanding programs of research, education, and cancer care; and the ongoing demand for the most up-to-date facilities and equipment. The Center especially welcomes donations that help meet its general operating needs, since these provide maximum flexibility in seizing new opportunities as they arise.

All gifts, regardless of size, really do make a difference. Contributions may take a number of forms, including:

• Gifts of cash or cash equivalents, either paid outright in a single installment or as a pledge to be fulfilled over a period of several years. A cash gift may entitle the donor to a charitable deduction of up to 50 per-cent of adjusted gross income annually, with a carry-over provision of up to five years should the value of the gift exceed 50 percent of the individual donor’s adjusted gross income.

• Gifts of appreciated securities, which offer donors a range of potential benefits such as the avoidance of capital gains taxes when the securities have been held long term — that is, for more than one year. Such gifts are deductible up to 30 percent of adjusted gross income annually, with a carry-over provision of up to five years should the value of the gift exceed 30 percent of the individual donor’s adjusted gross income.

• Planned gifts, which may help particular donors realize their philanthropic goals more efficiently and comfortably than through outright gifts. These arrangements also allow larger contributions than might otherwise be possible. Planned gifts take a variety of forms, including life income plans such as charitable gift annuities with their relatively generous payout rates and charitable remainder and lead trusts. Individuals who opt to support Memorial Sloan-Kettering through planned gifts may also do so through bequests provided for in their estate plans or by naming the Center as beneficiary of insurance policies or pre-federal income tax qualified plans such as an IRA and certain retirement plans.

• Gifts of real estate and personal property, which may also provide significant tax benefits. In most cases, gifts of real estate allow a donor to claim a tax deduction based on the full market value of the property when it has been held for at least one year.

For information about these and other ways of making a gift to the Campaign, please contact:

Richard K. NaumVice President for DevelopmentMemorial Sloan-Kettering Cancer Center633 Third Avenue, 28th FloorNew York, NY 10017646-227-3529 Telephone646-227-3909 Fax

Page 86: innovate - GuideStar

Memorial Sloan-Kettering Cancer Center’s commitment to conduct business in a sustainable way includes adopting green practices with respect to this report. This Annual Report is printed on Utopia One X: Green and is FSC-certified, contains a minimum of 20% post-consumer recovered fiber, and is manufactured with electricity in the form of renewable energy.

FSC is the Forest Stewardship Council, a nonprofit organization devoted to encouraging the responsible management of the world’s forests. FSC sets high standards that ensure forestry is practiced in an environmentally responsible, socially beneficial, and economically viable way.

Special thanks toHalina Frydman, CJ Postighone, Michael Quinlan, and Stephanie Luedke for sharing their experiences with us.

Design byIdeas On Purpose, New York www.ideasonpurpose.com

Photography byMario Morgado Matthew Septimus

Additional photography byAmos Chan Richard Dewitt Patrick McMullan Juliana Thomas

Printing byFinlay

© Copyright 2011 Memorial Sloan-Kettering Cancer Center

Produced byThe Department of Public Affairs Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 212-639-3573 Telephone 212-639-3576 Fax [email protected]

Vice President, Public AffairsKathy Lewis

Director, Public Affairs and Editorial StrategiesAnne B. O’Malley

WriterCelia Gittelson

Annual report contributorsAnne Clear Julie Grisham Eva Kiesler Ha Ly Joe Pisarchick Christina Schoen James Stallard

Page 87: innovate - GuideStar

62 MSKCC

1275 York Avenue New York, NY 10065

General Information212-639-2000

Physician Referral Service800-525-2225

On the Internetwww.mskcc.org

www.mskcc.org/annualreport2010

Follow us on www.facebook.com/sloankettering www.twitter.com/sloan_kettering www.youtube.com/mskcc